ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0019336,phenol-containing compound catabolic process,3/157,12/18888,0.000117313141708928,0.107381233012351,0.0992187845557213,FAH/MAOB/PDE1B,3
GO:0048934,peripheral nervous system neuron differentiation,3/157,15/18888,0.00023821673030493,0.107381233012351,0.0992187845557213,HOXD9/NEFH/ONECUT2,3
GO:0048935,peripheral nervous system neuron development,3/157,15/18888,0.00023821673030493,0.107381233012351,0.0992187845557213,HOXD9/NEFH/ONECUT2,3
GO:0050804,modulation of chemical synaptic transmission,13/157,493/18888,0.000248631522259216,0.107381233012351,0.0992187845557213,ADGRB1/ADRA2A/CALB2/EGR2/NEFH/NLGN4X/NOG/RIMS1/SLC1A3/SNAP25/SNCAIP/SYBU/TACR2,13
GO:0099177,regulation of trans-synaptic signaling,13/157,494/18888,0.000253540500710808,0.107381233012351,0.0992187845557213,ADGRB1/ADRA2A/CALB2/EGR2/NEFH/NLGN4X/NOG/RIMS1/SLC1A3/SNAP25/SNCAIP/SYBU/TACR2,13
GO:0002385,mucosal immune response,4/157,38/18888,0.000272122729554515,0.107381233012351,0.0992187845557213,H2BC4/H2BC8/NOS2/PIGR,4
GO:0090083,regulation of inclusion body assembly,3/157,17/18888,0.000351694871862806,0.107381233012351,0.0992187845557213,CLU/HSPA2/SNCAIP,3
GO:0018958,phenol-containing compound metabolic process,6/157,113/18888,0.000364195135069716,0.107381233012351,0.0992187845557213,CPQ/DIO2/FAH/MAOB/PDE1B/SNCAIP,6
GO:0002251,organ or tissue specific immune response,4/157,42/18888,0.00040212857195963,0.107381233012351,0.0992187845557213,H2BC4/H2BC8/NOS2/PIGR,4
GO:0060348,bone development,8/157,215/18888,0.000443357692041088,0.107381233012351,0.0992187845557213,BMPR1B/CBS/CLDN18/GPR68/HSD17B1/NSD2/RUNX2/TULP3,8
GO:0010721,negative regulation of cell development,9/157,288/18888,0.000696254726974654,0.137880837311315,0.12740000005383,CEBPA/CLDN18/FRZB/GPR68/NOG/PIK3R1/SEMA4A/SEMA6D/SFRP1,9
GO:0023061,signal release,12/157,487/18888,0.000783710640423255,0.137880837311315,0.12740000005383,ADRA2A/GPR68/MAOB/NOS2/POMC/RIMS1/SFRP1/SNAP25/SNCAIP/SV2A/SYBU/TACR2,12
GO:0007422,peripheral nervous system development,5/157,90/18888,0.000926821403358949,0.137880837311315,0.12740000005383,ADGRB1/EGR2/HOXD9/NEFH/ONECUT2,5
GO:0009953,dorsal/ventral pattern formation,5/157,90/18888,0.000926821403358949,0.137880837311315,0.12740000005383,BMPR1B/GREM2/NOG/SFRP1/TULP3,5
GO:1901606,alpha-amino acid catabolic process,5/157,90/18888,0.000926821403358949,0.137880837311315,0.12740000005383,ASRGL1/CBS/FAH/HAAO/NOS2,5
GO:0070841,inclusion body assembly,3/157,24/18888,0.00100308171380614,0.137880837311315,0.12740000005383,CLU/HSPA2/SNCAIP,3
GO:0002762,negative regulation of myeloid leukocyte differentiation,4/157,54/18888,0.0010517482526151,0.137880837311315,0.12740000005383,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0014033,neural crest cell differentiation,5/157,93/18888,0.00107438634072611,0.137880837311315,0.12740000005383,FRZB/NRTN/SEMA4A/SEMA6D/SFRP1,5
GO:0008045,motor neuron axon guidance,3/157,26/18888,0.00127295668175175,0.137880837311315,0.12740000005383,ALCAM/EGR2/NOG,3
GO:0009065,glutamine family amino acid catabolic process,3/157,26/18888,0.00127295668175175,0.137880837311315,0.12740000005383,ASRGL1/FAH/NOS2,3
GO:0060740,prostate gland epithelium morphogenesis,3/157,26/18888,0.00127295668175175,0.137880837311315,0.12740000005383,CYP7B1/NOG/SFRP1,3
GO:0170040,proteinogenic amino acid catabolic process,4/157,57/18888,0.0012886031239119,0.137880837311315,0.12740000005383,ASRGL1/CBS/FAH/NOS2,4
GO:0046883,regulation of hormone secretion,8/157,254/18888,0.00130935559791918,0.137880837311315,0.12740000005383,ADRA2A/GPR68/NOS2/POMC/SFRP1/SNAP25/SYBU/TACR2,8
GO:0002227,innate immune response in mucosa,3/157,27/18888,0.00142339329080574,0.143644106263812,0.132725181414605,H2BC4/H2BC8/NOS2,3
GO:0007409,axonogenesis,11/157,455/18888,0.00150595394928096,0.14589681860634,0.134806656680898,ADGRB1/ALCAM/BMPR1B/EGR2/LIMK1/NEFH/NOG/OLFM1/SEMA4A/SEMA6D/SNAP25,11
GO:0060512,prostate gland morphogenesis,3/157,28/18888,0.00158453824903801,0.147605832275771,0.136385761840275,CYP7B1/NOG/SFRP1,3
GO:0170035,L-amino acid catabolic process,4/157,61/18888,0.0016592525807038,0.14884110186906,0.137527133979582,ASRGL1/CBS/FAH/NOS2,4
GO:0009063,amino acid catabolic process,5/157,111/18888,0.00235168669729565,0.187771524403353,0.173498309740331,ASRGL1/CBS/FAH/HAAO/NOS2,5
GO:0045671,negative regulation of osteoclast differentiation,3/157,33/18888,0.00256004471183394,0.187771524403353,0.173498309740331,CLDN18/PIK3R1/SFRP1,3
GO:0050796,regulation of insulin secretion,6/157,167/18888,0.00275080345340739,0.187771524403353,0.173498309740331,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:0035567,non-canonical Wnt signaling pathway,4/157,71/18888,0.00289764422532725,0.187771524403353,0.173498309740331,FRZB/FZD10/PLEKHA4/SFRP1,4
GO:0045670,regulation of osteoclast differentiation,4/157,71/18888,0.00289764422532725,0.187771524403353,0.173498309740331,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0006527,arginine catabolic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,FAH/NOS2,2
GO:0019614,catechol-containing compound catabolic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,MAOB/PDE1B,2
GO:0042420,dopamine catabolic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,MAOB/PDE1B,2
GO:0042424,catecholamine catabolic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,MAOB/PDE1B,2
GO:2000271,positive regulation of fibroblast apoptotic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,PRDM11/SFRP1,2
GO:0061035,regulation of cartilage development,4/157,72/18888,0.00304853063146408,0.187771524403353,0.173498309740331,BMPR1B/FRZB/NOG/RUNX2,4
GO:0048705,skeletal system morphogenesis,7/157,229/18888,0.00308275954303462,0.187771524403353,0.173498309740331,BMPR1B/CBS/HOXD9/NOG/RUNX2/SFRP1/TULP3,7
GO:0048675,axon extension,5/157,119/18888,0.00317862613564718,0.187771524403353,0.173498309740331,ALCAM/LIMK1/OLFM1/SEMA4A/SEMA6D,5
GO:1903707,negative regulation of hemopoiesis,5/157,119/18888,0.00317862613564718,0.187771524403353,0.173498309740331,CEBPA/CLDN18/GPR68/PIK3R1/SFRP1,5
GO:0006703,estrogen biosynthetic process,2/157,11/18888,0.00359458947788423,0.195618224531001,0.18074855289361,HSD17B1/HSD17B2,2
GO:2001204,regulation of osteoclast development,2/157,11/18888,0.00359458947788423,0.195618224531001,0.18074855289361,CLDN18/GPR68,2
GO:0050806,positive regulation of synaptic transmission,6/157,177/18888,0.00366403239216987,0.195618224531001,0.18074855289361,CALB2/NOG/RIMS1/SLC1A3/SNAP25/TACR2,6
GO:1990138,neuron projection extension,6/157,177/18888,0.00366403239216987,0.195618224531001,0.18074855289361,ALCAM/LIMK1/OLFM1/RIMS1/SEMA4A/SEMA6D,6
GO:0048846,axon extension involved in axon guidance,3/157,38/18888,0.00384016556131058,0.195618224531001,0.18074855289361,ALCAM/SEMA4A/SEMA6D,3
GO:1902284,neuron projection extension involved in neuron projection guidance,3/157,38/18888,0.00384016556131058,0.195618224531001,0.18074855289361,ALCAM/SEMA4A/SEMA6D,3
GO:0002573,myeloid leukocyte differentiation,7/157,239/18888,0.00389813713092121,0.195618224531001,0.18074855289361,CEBPA/CLDN18/GPR68/IL1RL1/PDE1B/PIK3R1/SFRP1,7
GO:0030072,peptide hormone secretion,7/157,242/18888,0.00417207623236977,0.195618224531001,0.18074855289361,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU/TACR2,7
GO:0060560,developmental growth involved in morphogenesis,7/157,243/18888,0.00426655679612307,0.195618224531001,0.18074855289361,ALCAM/LIMK1/OLFM1/RIMS1/SEMA4A/SEMA6D/SFRP1,7
GO:0000727,double-strand break repair via break-induced replication,2/157,12/18888,0.0042900447451193,0.195618224531001,0.18074855289361,GINS2/MCM4,2
GO:0002638,negative regulation of immunoglobulin production,2/157,12/18888,0.0042900447451193,0.195618224531001,0.18074855289361,CD22/IL13RA2,2
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/157,12/18888,0.0042900447451193,0.195618224531001,0.18074855289361,BMPR1B/SFRP1,2
GO:0040001,establishment of mitotic spindle localization,3/157,40/18888,0.00444338228770057,0.195618224531001,0.18074855289361,ESPL1/GPSM2/PKHD1,3
GO:0046879,hormone secretion,8/157,311/18888,0.00454960835689003,0.195618224531001,0.18074855289361,ADRA2A/GPR68/NOS2/POMC/SFRP1/SNAP25/SYBU/TACR2,8
GO:0002790,peptide secretion,7/157,247/18888,0.00466077833273763,0.195618224531001,0.18074855289361,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU/TACR2,7
GO:0045926,negative regulation of growth,7/157,247/18888,0.00466077833273763,0.195618224531001,0.18074855289361,FRZB/MT1F/NOG/PRDM11/SEMA4A/SEMA6D/SFRP1,7
GO:0048863,stem cell differentiation,7/157,248/18888,0.00476349551154248,0.195618224531001,0.18074855289361,FRZB/NOG/NRTN/RUNX2/SEMA4A/SEMA6D/SFRP1,7
GO:0042417,dopamine metabolic process,3/157,41/18888,0.00476526641095336,0.195618224531001,0.18074855289361,MAOB/PDE1B/SNCAIP,3
GO:0008589,regulation of smoothened signaling pathway,4/157,85/18888,0.00552197824948748,0.221794523917663,0.204935094027968,RUNX2/SFRP1/TULP3/WDR11,4
GO:0009914,hormone transport,8/157,322/18888,0.00558607182451588,0.221794523917663,0.204935094027968,ADRA2A/GPR68/NOS2/POMC/SFRP1/SNAP25/SYBU/TACR2,8
GO:0090175,regulation of establishment of planar polarity,2/157,14/18888,0.00585095201819829,0.228207048185455,0.210860178383362,PKHD1/SFRP1,2
GO:0090276,regulation of peptide hormone secretion,6/157,197/18888,0.00614141045724544,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:2000027,regulation of animal organ morphogenesis,4/157,89/18888,0.00649125273905061,0.228207048185455,0.210860178383362,NOG/PKHD1/RUNX2/SFRP1,4
GO:0002791,regulation of peptide secretion,6/157,200/18888,0.00659784005130657,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:0030073,insulin secretion,6/157,200/18888,0.00659784005130657,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:0060026,convergent extension,2/157,15/18888,0.00671444975479728,0.228207048185455,0.210860178383362,FRZB/SFRP1,2
GO:1901160,primary amino compound metabolic process,2/157,15/18888,0.00671444975479728,0.228207048185455,0.210860178383362,MAOB/PDE1B,2
GO:2000052,positive regulation of non-canonical Wnt signaling pathway,2/157,15/18888,0.00671444975479728,0.228207048185455,0.210860178383362,PLEKHA4/SFRP1,2
GO:0090087,regulation of peptide transport,6/157,202/18888,0.00691551416755285,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:0007269,neurotransmitter secretion,5/157,144/18888,0.00710027508976279,0.228207048185455,0.210860178383362,RIMS1/SNAP25/SNCAIP/SV2A/TACR2,5
GO:0099643,signal release from synapse,5/157,144/18888,0.00710027508976279,0.228207048185455,0.210860178383362,RIMS1/SNAP25/SNCAIP/SV2A/TACR2,5
GO:0030516,regulation of axon extension,4/157,92/18888,0.0072879935958208,0.228207048185455,0.210860178383362,LIMK1/OLFM1/SEMA4A/SEMA6D,4
GO:0048762,mesenchymal cell differentiation,7/157,269/18888,0.00734029971902509,0.228207048185455,0.210860178383362,FRZB/NOG/NRTN/OLFM1/SEMA4A/SEMA6D/SFRP1,7
GO:0050708,regulation of protein secretion,7/157,269/18888,0.00734029971902509,0.228207048185455,0.210860178383362,ADRA2A/GPR68/MYOM1/NOS2/SFRP1/SNAP25/SYBU,7
GO:0007224,smoothened signaling pathway,5/157,146/18888,0.00751522095167814,0.228207048185455,0.210860178383362,NOG/RUNX2/SFRP1/TULP3/WDR11,5
GO:0006836,neurotransmitter transport,6/157,206/18888,0.00758393171174375,0.228207048185455,0.210860178383362,RIMS1/SLC1A3/SNAP25/SNCAIP/SV2A/TACR2,6
GO:0015833,peptide transport,7/157,271/18888,0.00763075961899175,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU/TACR2,7
GO:0007158,neuron cell-cell adhesion,2/157,16/18888,0.00763202762304783,0.228207048185455,0.210860178383362,NCAM2/NLGN4X,2
GO:0009074,aromatic amino acid family catabolic process,2/157,16/18888,0.00763202762304783,0.228207048185455,0.210860178383362,FAH/HAAO,2
GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway",2/157,16/18888,0.00763202762304783,0.228207048185455,0.210860178383362,PLEKHA4/SFRP1,2
GO:0030850,prostate gland development,3/157,49/18888,0.0078476155679985,0.229170216486662,0.211750132665758,CYP7B1/NOG/SFRP1,3
GO:0048704,embryonic skeletal system morphogenesis,4/157,94/18888,0.00785347975573614,0.229170216486662,0.211750132665758,HOXD9/NOG/RUNX2/TULP3,4
GO:1900120,regulation of receptor binding,2/157,17/18888,0.00860273865653916,0.243880767143487,0.225342479441546,GREM2/NOG,2
GO:1902969,mitotic DNA replication,2/157,17/18888,0.00860273865653916,0.243880767143487,0.225342479441546,BRCA2/MCM4,2
GO:0045638,negative regulation of myeloid cell differentiation,4/157,97/18888,0.00875459439803056,0.243880767143487,0.225342479441546,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0010043,response to zinc ion,3/157,51/18888,0.00876405985552951,0.243880767143487,0.225342479441546,DDX19A/HAAO/MT1F,3
GO:1903531,negative regulation of secretion by cell,5/157,152/18888,0.00886106833551893,0.243880767143487,0.225342479441546,ADRA2A/IL13RA2/MAOB/SFRP1/TACR2,5
GO:0006576,biogenic amine metabolic process,4/157,98/18888,0.00906933849858198,0.244905281472183,0.226289116610831,HAAO/MAOB/PDE1B/SNCAIP,4
GO:0007612,learning,5/157,153/18888,0.00910052656172438,0.244905281472183,0.226289116610831,NLGN4X/NOG/PDE1B/SNAP25/TACR2,5
GO:0048167,regulation of synaptic plasticity,6/157,216/18888,0.00945752190196465,0.245403355553077,0.226749330221149,ADGRB1/CALB2/EGR2/NOG/RIMS1/SNAP25,6
GO:0016082,synaptic vesicle priming,2/157,18/18888,0.00962564771987709,0.245403355553077,0.226749330221149,SNAP25/SV2A,2
GO:0036035,osteoclast development,2/157,18/18888,0.00962564771987709,0.245403355553077,0.226749330221149,CLDN18/GPR68,2
GO:0046851,negative regulation of bone remodeling,2/157,18/18888,0.00962564771987709,0.245403355553077,0.226749330221149,CLDN18/SFRP1,2
GO:0098751,bone cell development,2/157,18/18888,0.00962564771987709,0.245403355553077,0.226749330221149,CLDN18/GPR68,2
GO:0045667,regulation of osteoblast differentiation,5/157,156/18888,0.00984565662311848,0.248397711887427,0.229516074350328,BMPR1B/CEBPA/NOG/RUNX2/SFRP1,5
GO:0007517,muscle organ development,8/157,359/18888,0.0104290838849131,0.256847863482465,0.23732389837182,ADGRB1/EGR2/HOXD9/HSD17B1/MKX/MYL3/MYOM1/NOG,8
GO:0006525,arginine metabolic process,2/157,19/18888,0.0106998313794882,0.256847863482465,0.23732389837182,FAH/NOS2,2
GO:0042402,cellular biogenic amine catabolic process,2/157,19/18888,0.0106998313794882,0.256847863482465,0.23732389837182,MAOB/PDE1B,2
GO:0006584,catecholamine metabolic process,3/157,56/18888,0.0113200549686376,0.256847863482465,0.23732389837182,MAOB/PDE1B/SNCAIP,3
GO:0009712,catechol-containing compound metabolic process,3/157,56/18888,0.0113200549686376,0.256847863482465,0.23732389837182,MAOB/PDE1B/SNCAIP,3
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,3/157,56/18888,0.0113200549686376,0.256847863482465,0.23732389837182,ADRA2A/GPR68/SYBU,3
GO:0051223,regulation of protein transport,9/157,440/18888,0.0114323704825313,0.256847863482465,0.23732389837182,ADRA2A/GPR68/MYOM1/NOS2/PIK3R1/SFRP1/SNAP25/SYBU/ZFAND1,9
GO:0006520,amino acid metabolic process,7/157,295/18888,0.0118139372042964,0.256847863482465,0.23732389837182,ASRGL1/CBS/FAH/HAAO/NOS2/PEPD/SLC1A3,7
GO:0032253,dense core granule localization,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,SNAP25/SYBU,2
GO:0032332,positive regulation of chondrocyte differentiation,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,BMPR1B/RUNX2,2
GO:0034755,iron ion transmembrane transport,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,MMGT1/SLC25A37,2
GO:0071391,cellular response to estrogen stimulus,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,CLDN18/SFRP1,2
GO:2000269,regulation of fibroblast apoptotic process,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,PRDM11/SFRP1,2
GO:0001755,neural crest cell migration,3/157,57/18888,0.0118773578489001,0.256847863482465,0.23732389837182,NRTN/SEMA4A/SEMA6D,3
GO:0051293,establishment of spindle localization,3/157,57/18888,0.0118773578489001,0.256847863482465,0.23732389837182,ESPL1/GPSM2/PKHD1,3
GO:1901616,organic hydroxy compound catabolic process,3/157,57/18888,0.0118773578489001,0.256847863482465,0.23732389837182,FAH/MAOB/PDE1B,3
GO:0030316,osteoclast differentiation,4/157,107/18888,0.0122377648805518,0.25884935344453,0.239173247608792,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0009306,protein secretion,8/157,370/18888,0.0123391091370449,0.25884935344453,0.239173247608792,ADRA2A/GPR68/MYOM1/NOS2/SFRP1/SNAP25/SYBU/TACR2,8
GO:0035592,establishment of protein localization to extracellular region,8/157,371/18888,0.0125246976430744,0.25884935344453,0.239173247608792,ADRA2A/GPR68/MYOM1/NOS2/SFRP1/SNAP25/SYBU/TACR2,8
GO:0006937,regulation of muscle contraction,5/157,167/18888,0.0129356431941343,0.25884935344453,0.239173247608792,ADRA2A/CLIC2/MYL3/TACR2/TMEM38A,5
GO:0006268,DNA unwinding involved in DNA replication,2/157,21/18888,0.0129983864963136,0.25884935344453,0.239173247608792,GINS2/MCM4,2
GO:0009310,amine catabolic process,2/157,21/18888,0.0129983864963136,0.25884935344453,0.239173247608792,MAOB/PDE1B,2
GO:0034104,negative regulation of tissue remodeling,2/157,21/18888,0.0129983864963136,0.25884935344453,0.239173247608792,CLDN18/SFRP1,2
GO:0048791,calcium ion-regulated exocytosis of neurotransmitter,2/157,21/18888,0.0129983864963136,0.25884935344453,0.239173247608792,RIMS1/SNAP25,2
GO:0061387,regulation of extent of cell growth,4/157,109/18888,0.0130265273875637,0.25884935344453,0.239173247608792,LIMK1/OLFM1/SEMA4A/SEMA6D,4
GO:0090497,mesenchymal cell migration,3/157,59/18888,0.0130386544674784,0.25884935344453,0.239173247608792,NRTN/SEMA4A/SEMA6D,3
GO:0030509,BMP signaling pathway,5/157,168/18888,0.0132455249960174,0.259980734358988,0.240218628035642,BMPR1B/GREM2/NOG/RUNX2/SFRP1,5
GO:0007173,epidermal growth factor receptor signaling pathway,4/157,110/18888,0.0134327866073029,0.259980734358988,0.240218628035642,ADRA2A/GRB7/PIGR/REPS2,4
GO:0007411,axon guidance,6/157,234/18888,0.0136268285344569,0.259980734358988,0.240218628035642,ALCAM/BMPR1B/EGR2/NOG/SEMA4A/SEMA6D,6
GO:0097485,neuron projection guidance,6/157,234/18888,0.0136268285344569,0.259980734358988,0.240218628035642,ALCAM/BMPR1B/EGR2/NOG/SEMA4A/SEMA6D,6
GO:0060350,endochondral bone morphogenesis,3/157,60/18888,0.0136427716830141,0.259980734358988,0.240218628035642,BMPR1B/CBS/RUNX2,3
GO:0030038,contractile actin filament bundle assembly,4/157,111/18888,0.0138470333329106,0.259980734358988,0.240218628035642,LIMK1/PHACTR1/PIK3R1/SFRP1,4
GO:0043149,stress fiber assembly,4/157,111/18888,0.0138470333329106,0.259980734358988,0.240218628035642,LIMK1/PHACTR1/PIK3R1/SFRP1,4
GO:0071692,protein localization to extracellular region,8/157,379/18888,0.014084157611013,0.26182036068791,0.241918417498586,ADRA2A/GPR68/MYOM1/NOS2/SFRP1/SNAP25/SYBU/TACR2,8
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,2/157,22/18888,0.0142209684509691,0.26182036068791,0.241918417498586,CLIC2/TMEM38A,2
GO:1902106,negative regulation of leukocyte differentiation,4/157,112/18888,0.0142693177583832,0.26182036068791,0.241918417498586,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0048588,developmental cell growth,6/157,238/18888,0.0147038691510396,0.266812862936178,0.246531421010176,ALCAM/LIMK1/OLFM1/RIMS1/SEMA4A/SEMA6D,6
GO:0051048,negative regulation of secretion,5/157,173/18888,0.0148703122277187,0.266812862936178,0.246531421010176,ADRA2A/IL13RA2/MAOB/SFRP1/TACR2,5
GO:0051653,spindle localization,3/157,62/18888,0.0148982155269193,0.266812862936178,0.246531421010176,ESPL1/GPSM2/PKHD1,3
GO:0042445,hormone metabolic process,6/157,240/18888,0.0152640320550323,0.266812862936178,0.246531421010176,CEL/CPQ/DIO2/HSD17B1/HSD17B2/RDH16,6
GO:0006590,thyroid hormone generation,2/157,23/18888,0.0154912457474367,0.266812862936178,0.246531421010176,CPQ/DIO2,2
GO:0031290,retinal ganglion cell axon guidance,2/157,23/18888,0.0154912457474367,0.266812862936178,0.246531421010176,ALCAM/BMPR1B,2
GO:0032252,secretory granule localization,2/157,23/18888,0.0154912457474367,0.266812862936178,0.246531421010176,SNAP25/SYBU,2
GO:0006813,potassium ion transport,6/157,241/18888,0.0155496024666094,0.266812862936178,0.246531421010176,ADRA2A/KCNK12/SLC1A3/SLC9A3/SNAP25/TMEM38A,6
GO:1902905,positive regulation of supramolecular fiber organization,5/157,175/18888,0.0155560179328688,0.266812862936178,0.246531421010176,C15orf62/CLU/FCHSD2/LIMK1/SFRP1,5
GO:0042886,amide transport,7/157,312/18888,0.015643033252245,0.266812862936178,0.246531421010176,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU/TACR2,7
GO:0090257,regulation of muscle system process,6/157,245/18888,0.0167289893132946,0.282285908044046,0.260828302186815,ADRA2A/CLIC2/GTF2IRD1/MYL3/TACR2/TMEM38A,6
GO:0042430,indole-containing compound metabolic process,2/157,24/18888,0.0168083515686758,0.282285908044046,0.260828302186815,HAAO/PDE1B,2
GO:0009308,amine metabolic process,4/157,118/18888,0.016974479983376,0.282285908044046,0.260828302186815,HAAO/MAOB/PDE1B/SNCAIP,4
GO:0071772,response to BMP,5/157,180/18888,0.0173619760250966,0.282285908044046,0.260828302186815,BMPR1B/GREM2/NOG/RUNX2/SFRP1,5
GO:0071773,cellular response to BMP stimulus,5/157,180/18888,0.0173619760250966,0.282285908044046,0.260828302186815,BMPR1B/GREM2/NOG/RUNX2/SFRP1,5
GO:0001655,urogenital system development,3/157,66/18888,0.0175991627228121,0.282285908044046,0.260828302186815,CYP7B1/NOG/SFRP1,3
GO:0017156,calcium-ion regulated exocytosis,3/157,66/18888,0.0175991627228121,0.282285908044046,0.260828302186815,ADRA2A/RIMS1/SNAP25,3
GO:0035773,insulin secretion involved in cellular response to glucose stimulus,3/157,66/18888,0.0175991627228121,0.282285908044046,0.260828302186815,ADRA2A/GPR68/SYBU,3
GO:0042446,hormone biosynthetic process,3/157,66/18888,0.0175991627228121,0.282285908044046,0.260828302186815,DIO2/HSD17B1/HSD17B2,3
GO:1903306,negative regulation of regulated secretory pathway,2/157,25/18888,0.0181714300513378,0.288296729702289,0.266382218847871,ADRA2A/IL13RA2,2
GO:0046888,negative regulation of hormone secretion,3/157,67/18888,0.0183141966637849,0.288296729702289,0.266382218847871,ADRA2A/SFRP1/TACR2,3
GO:0051222,positive regulation of protein transport,6/157,251/18888,0.0186117413487353,0.288296729702289,0.266382218847871,GPR68/MYOM1/PIK3R1/SNAP25/SYBU/ZFAND1,6
GO:0051495,positive regulation of cytoskeleton organization,5/157,184/18888,0.018903042186308,0.288296729702289,0.266382218847871,C15orf62/FCHSD2/GPSM2/LIMK1/SFRP1,5
GO:0030278,regulation of ossification,4/157,122/18888,0.0189444441423342,0.288296729702289,0.266382218847871,BMPR1B/EGR2/RUNX2/SFRP1,4
GO:0030326,embryonic limb morphogenesis,4/157,122/18888,0.0189444441423342,0.288296729702289,0.266382218847871,HOXD9/NOG/RUNX2/TULP3,4
GO:0035113,embryonic appendage morphogenesis,4/157,122/18888,0.0189444441423342,0.288296729702289,0.266382218847871,HOXD9/NOG/RUNX2/TULP3,4
GO:0035019,somatic stem cell population maintenance,3/157,68/18888,0.0190452009712495,0.288296729702289,0.266382218847871,NOG/POU5F1/SFRP1,3
GO:0046847,filopodium assembly,3/157,68/18888,0.0190452009712495,0.288296729702289,0.266382218847871,FGD5/MIEN1/PIK3R1,3
GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,2/157,26/18888,0.01957963616547,0.290931771734775,0.268816961496862,CLIC2/TMEM38A,2
GO:0042537,benzene-containing compound metabolic process,2/157,26/18888,0.01957963616547,0.290931771734775,0.268816961496862,FAH/HAAO,2
GO:0044346,fibroblast apoptotic process,2/157,26/18888,0.01957963616547,0.290931771734775,0.268816961496862,PRDM11/SFRP1,2
GO:0008202,steroid metabolic process,7/157,329/18888,0.0202833322515399,0.299311516977469,0.276559731015733,CEBPA/CUBN/CYP7B1/HSD17B1/HSD17B2/RDH16/SULT2B1,7
GO:0001952,regulation of cell-matrix adhesion,4/157,125/18888,0.0205111606959152,0.299311516977469,0.276559731015733,ONECUT2/PIK3R1/PKHD1/SFRP1,4
GO:0042593,glucose homeostasis,6/157,258/18888,0.020986011126475,0.299311516977469,0.276559731015733,ADRA2A/CEBPA/GPR68/PIK3R1/POMC/SYBU,6
GO:0007141,male meiosis I,2/157,27/18888,0.0210321355954431,0.299311516977469,0.276559731015733,BRCA2/HSPA2,2
GO:0070193,synaptonemal complex organization,2/157,27/18888,0.0210321355954431,0.299311516977469,0.276559731015733,HSPA2/SHOC1,2
GO:2000050,regulation of non-canonical Wnt signaling pathway,2/157,27/18888,0.0210321355954431,0.299311516977469,0.276559731015733,PLEKHA4/SFRP1,2
GO:0045600,positive regulation of fat cell differentiation,3/157,71/18888,0.0213341994479028,0.299311516977469,0.276559731015733,CEBPA/FRZB/SFRP1,3
GO:0006898,receptor-mediated endocytosis,6/157,259/18888,0.0213411870898952,0.299311516977469,0.276559731015733,CLU/CUBN/FCHSD2/GRK3/SFTPD/SNAP25,6
GO:0033500,carbohydrate homeostasis,6/157,259/18888,0.0213411870898952,0.299311516977469,0.276559731015733,ADRA2A/CEBPA/GPR68/PIK3R1/POMC/SYBU,6
GO:0030308,negative regulation of cell growth,5/157,190/18888,0.0213793940698192,0.299311516977469,0.276559731015733,FRZB/PRDM11/SEMA4A/SEMA6D/SFRP1,5
GO:0030514,negative regulation of BMP signaling pathway,3/157,72/18888,0.0221292285268784,0.303128163303895,0.28008625980446,GREM2/NOG/SFRP1,3
GO:1904888,cranial skeletal system development,3/157,72/18888,0.0221292285268784,0.303128163303895,0.28008625980446,NOG/RUNX2/TULP3,3
GO:0002761,regulation of myeloid leukocyte differentiation,4/157,128/18888,0.0221554312213343,0.303128163303895,0.28008625980446,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0048706,embryonic skeletal system development,4/157,128/18888,0.0221554312213343,0.303128163303895,0.28008625980446,HOXD9/NOG/RUNX2/TULP3,4
GO:0060485,mesenchyme development,7/157,336/18888,0.0224476825518523,0.303128163303895,0.28008625980446,FRZB/NOG/NRTN/OLFM1/SEMA4A/SEMA6D/SFRP1,7
GO:0010165,response to X-ray,2/157,28/18888,0.0225281046220897,0.303128163303895,0.28008625980446,BRCA2/SFRP1,2
GO:0048843,negative regulation of axon extension involved in axon guidance,2/157,28/18888,0.0225281046220897,0.303128163303895,0.28008625980446,SEMA4A/SEMA6D,2
GO:0016049,cell growth,9/157,496/18888,0.0230247157306676,0.305181256935247,0.281983290123141,ALCAM/FRZB/LIMK1/OLFM1/PRDM11/RIMS1/SEMA4A/SEMA6D/SFRP1,9
GO:0002377,immunoglobulin production,5/157,194/18888,0.0231425903345221,0.305181256935247,0.281983290123141,CD22/EXO1/IGKV2D-28/IL13RA2/NSD2,5
GO:0050864,regulation of B cell activation,4/157,130/18888,0.0232951217342961,0.305181256935247,0.281983290123141,CD22/NSD2/SFRP1/TNFRSF13C,4
GO:0009064,glutamine family amino acid metabolic process,3/157,74/18888,0.0237673523214207,0.305181256935247,0.281983290123141,ASRGL1/FAH/NOS2,3
GO:0001558,regulation of cell growth,8/157,418/18888,0.0237696814978834,0.305181256935247,0.281983290123141,FRZB/LIMK1/OLFM1/PRDM11/RIMS1/SEMA4A/SEMA6D/SFRP1,8
GO:0007127,meiosis I,4/157,131/18888,0.0238781078137886,0.305181256935247,0.281983290123141,BRCA2/ESPL1/HSPA2/SHOC1,4
GO:0038127,ERBB signaling pathway,4/157,131/18888,0.0238781078137886,0.305181256935247,0.281983290123141,ADRA2A/GRB7/PIGR/REPS2,4
GO:0003209,cardiac atrium morphogenesis,2/157,29/18888,0.0240667300060413,0.305181256935247,0.281983290123141,NOG/NSD2,2
GO:0007263,nitric oxide mediated signal transduction,2/157,29/18888,0.0240667300060413,0.305181256935247,0.281983290123141,CBS/NOS2,2
GO:0042403,thyroid hormone metabolic process,2/157,29/18888,0.0240667300060413,0.305181256935247,0.281983290123141,CPQ/DIO2,2
GO:0050951,sensory perception of temperature stimulus,2/157,29/18888,0.0240667300060413,0.305181256935247,0.281983290123141,ADRA2A/TRPM8,2
GO:0030323,respiratory tube development,5/157,197/18888,0.0245250581795159,0.308841907703668,0.285365681158676,CEBPA/CLDN18/NOG/SFTPD/TULP3,5
GO:0002637,regulation of immunoglobulin production,3/157,75/18888,0.0246104410350156,0.308841907703668,0.285365681158676,CD22/IL13RA2/NSD2,3
GO:0043032,positive regulation of macrophage activation,2/157,30/18888,0.0256472088722543,0.320193504580412,0.295854400772722,CEBPA/IL1RL1,2
GO:0045669,positive regulation of osteoblast differentiation,3/157,77/18888,0.0263446301457225,0.327213816476615,0.30234107254956,BMPR1B/CEBPA/RUNX2,3
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/157,31/18888,0.0272687485957111,0.328958684555345,0.303953306690714,CLIC2/TMEM38A,2
GO:0031646,positive regulation of nervous system process,2/157,31/18888,0.0272687485957111,0.328958684555345,0.303953306690714,EGR2/RIMS1,2
GO:0051491,positive regulation of filopodium assembly,2/157,31/18888,0.0272687485957111,0.328958684555345,0.303953306690714,MIEN1/PIK3R1,2
GO:0150117,positive regulation of cell-substrate junction organization,2/157,31/18888,0.0272687485957111,0.328958684555345,0.303953306690714,PIK3R1/SFRP1,2
GO:0048469,cell maturation,5/157,205/18888,0.0284682487273294,0.328958684555345,0.303953306690714,BRCA2/CEBPA/GLDN/HEATR3/RUNX2,5
GO:0061982,meiosis I cell cycle process,4/157,139/18888,0.0288607124715089,0.328958684555345,0.303953306690714,BRCA2/ESPL1/HSPA2/SHOC1,4
GO:0007611,learning or memory,6/157,278/18888,0.0288804638395674,0.328958684555345,0.303953306690714,EGR2/NLGN4X/NOG/PDE1B/SNAP25/TACR2,6
GO:0042113,B cell activation,6/157,278/18888,0.0288804638395674,0.328958684555345,0.303953306690714,CD22/EXO1/NSD2/PIK3R1/SFRP1/TNFRSF13C,6
GO:0001958,endochondral ossification,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,CBS/RUNX2,2
GO:0009072,aromatic amino acid metabolic process,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,FAH/HAAO,2
GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,GPR68/SYBU,2
GO:0036075,replacement ossification,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,CBS/RUNX2,2
GO:0045879,negative regulation of smoothened signaling pathway,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,RUNX2/TULP3,2
GO:0051642,centrosome localization,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,GPSM2/PKHD1,2
GO:0061036,positive regulation of cartilage development,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,BMPR1B/RUNX2,2
GO:0061037,negative regulation of cartilage development,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,FRZB/NOG,2
GO:0061842,microtubule organizing center localization,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,GPSM2/PKHD1,2
GO:1901020,negative regulation of calcium ion transmembrane transporter activity,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,ADRA2A/CLIC2,2
GO:0014032,neural crest cell development,3/157,80/18888,0.0290657136642625,0.328958684555345,0.303953306690714,NRTN/SEMA4A/SEMA6D,3
GO:0008203,cholesterol metabolic process,4/157,141/18888,0.0301956886482136,0.337229269287954,0.311595213397449,CEBPA/CUBN/CYP7B1/SULT2B1,4
GO:0030099,myeloid cell differentiation,8/157,439/18888,0.030581514541932,0.337229269287954,0.311595213397449,CEBPA/CLDN18/GPR68/HEATR3/IL1RL1/PDE1B/PIK3R1/SFRP1,8
GO:0051216,cartilage development,5/157,209/18888,0.0305822213529138,0.337229269287954,0.311595213397449,BMPR1B/CBS/FRZB/NOG/RUNX2,5
GO:0002063,chondrocyte development,2/157,33/18888,0.0306318906867671,0.337229269287954,0.311595213397449,BMPR1B/RUNX2,2
GO:0035115,embryonic forelimb morphogenesis,2/157,33/18888,0.0306318906867671,0.337229269287954,0.311595213397449,HOXD9/RUNX2,2
GO:0043171,peptide catabolic process,2/157,33/18888,0.0306318906867671,0.337229269287954,0.311595213397449,ANPEP/CPQ,2
GO:0046928,regulation of neurotransmitter secretion,3/157,82/18888,0.0309593806016631,0.339292397363022,0.313501515404314,RIMS1/SNCAIP/TACR2,3
GO:0048841,regulation of axon extension involved in axon guidance,2/157,34/18888,0.0323719580420152,0.352713482253344,0.325902413521061,SEMA4A/SEMA6D,2
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,3/157,84/18888,0.0329164661962264,0.352713482253344,0.325902413521061,BMPR1B/PIK3R1/SFRP1,3
GO:0007266,Rho protein signal transduction,4/157,145/18888,0.0329738093503239,0.352713482253344,0.325902413521061,ADRA2A/C15orf62/LIMK1/SYNJ2BP,4
GO:0060048,cardiac muscle contraction,4/157,145/18888,0.0329738093503239,0.352713482253344,0.325902413521061,CLIC2/MYL3/TMEM38A/TNNI2,4
GO:0061448,connective tissue development,6/157,288/18888,0.0334757715863838,0.352713482253344,0.325902413521061,BMPR1B/CBS/FRZB/HSD17B1/NOG/RUNX2,6
GO:0061053,somite development,3/157,85/18888,0.0339187035601315,0.352713482253344,0.325902413521061,FRZB/NOG/SFRP1,3
GO:0031032,actomyosin structure organization,5/157,215/18888,0.0339343348190218,0.352713482253344,0.325902413521061,LIMK1/MYOM1/PHACTR1/PIK3R1/SFRP1,5
GO:0000132,establishment of mitotic spindle orientation,2/157,35/18888,0.0341500160092606,0.352713482253344,0.325902413521061,GPSM2/PKHD1,2
GO:0030224,monocyte differentiation,2/157,35/18888,0.0341500160092606,0.352713482253344,0.325902413521061,GPR68/PDE1B,2
GO:0099171,presynaptic modulation of chemical synaptic transmission,2/157,35/18888,0.0341500160092606,0.352713482253344,0.325902413521061,ADRA2A/NOG,2
GO:0048732,gland development,8/157,449/18888,0.0342557333979317,0.352713482253344,0.325902413521061,BRCA2/CEBPA/CYP7B1/FRZB/HOXD9/NOG/ONECUT2/SFRP1,8
GO:0050714,positive regulation of protein secretion,4/157,147/18888,0.0344171637789388,0.352713482253344,0.325902413521061,GPR68/MYOM1/SNAP25/SYBU,4
GO:0170039,proteinogenic amino acid metabolic process,4/157,147/18888,0.0344171637789388,0.352713482253344,0.325902413521061,ASRGL1/CBS/FAH/NOS2,4
GO:1901605,alpha-amino acid metabolic process,5/157,216/18888,0.0345143540824592,0.352713482253344,0.325902413521061,ASRGL1/CBS/FAH/HAAO/NOS2,5
GO:0032024,positive regulation of insulin secretion,3/157,86/18888,0.0349366849197803,0.352713482253344,0.325902413521061,GPR68/SNAP25/SYBU,3
GO:0048864,stem cell development,3/157,86/18888,0.0349366849197803,0.352713482253344,0.325902413521061,NRTN/SEMA4A/SEMA6D,3
GO:0051321,meiotic cell cycle,6/157,291/18888,0.0349417385271383,0.352713482253344,0.325902413521061,ANAPC13/BRCA2/ESPL1/EXO1/HSPA2/SHOC1,6
GO:0071805,potassium ion transmembrane transport,5/157,217/18888,0.0351005063526109,0.352713482253344,0.325902413521061,KCNK12/SLC1A3/SLC9A3/SNAP25/TMEM38A,5
GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,CST2/PIGR,2
GO:0006882,intracellular zinc ion homeostasis,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,MT1F/SLC30A7,2
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,CLIC2/TMEM38A,2
GO:0045920,negative regulation of exocytosis,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,ADRA2A/IL13RA2,2
GO:0060317,cardiac epithelial to mesenchymal transition,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,NOG/OLFM1,2
GO:0070633,transepithelial transport,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,CLDN18/SLC1A3,2
GO:0071425,hematopoietic stem cell proliferation,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,BRCA2/CEBPA,2
GO:0008306,associative learning,3/157,87/18888,0.0359703675130372,0.352713482253344,0.325902413521061,NOG/PDE1B/SNAP25,3
GO:0050679,positive regulation of epithelial cell proliferation,5/157,219/18888,0.0362912618086281,0.354425145566521,0.32748396691487,CYP7B1/NOG/PKHD1/RUNX2/SFRP1,5
GO:0035107,appendage morphogenesis,4/157,150/18888,0.0366502923411674,0.355012077204729,0.328026283687797,HOXD9/NOG/RUNX2/TULP3,4
GO:0035108,limb morphogenesis,4/157,150/18888,0.0366502923411674,0.355012077204729,0.328026283687797,HOXD9/NOG/RUNX2/TULP3,4
GO:0060541,respiratory system development,5/157,220/18888,0.0368958897906528,0.355012077204729,0.328026283687797,CEBPA/CLDN18/NOG/SFTPD/TULP3,5
GO:0061515,myeloid cell development,3/157,88/18888,0.0370197058777249,0.355012077204729,0.328026283687797,CLDN18/GPR68/HEATR3,3
GO:0001736,establishment of planar polarity,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,PKHD1/SFRP1,2
GO:0003230,cardiac atrium development,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,NOG/NSD2,2
GO:0007164,establishment of tissue polarity,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,PKHD1/SFRP1,2
GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,CYP7B1/SFRP1,2
GO:0070873,regulation of glycogen metabolic process,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,POMC/PPP1R3F,2
GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,CLIC2/TMEM38A,2
GO:0001843,neural tube closure,3/157,89/18888,0.0380846519174461,0.355703564525924,0.328665208475863,NOG/SFRP1/TULP3,3
GO:1902652,secondary alcohol metabolic process,4/157,152/18888,0.0381845279837903,0.355703564525924,0.328665208475863,CEBPA/CUBN/CYP7B1/SULT2B1,4
GO:0060606,tube closure,3/157,90/18888,0.0391651549663632,0.36344063344265,0.335814153895899,NOG/SFRP1/TULP3,3
GO:0045055,regulated exocytosis,5/157,225/18888,0.0400119867375655,0.369881801062533,0.341765704315244,ADRA2A/IL13RA2/RIMS1/SNAP25/SV2A,5
GO:0016125,sterol metabolic process,4/157,155/18888,0.0405542012628829,0.373110834793321,0.34474928713573,CEBPA/CUBN/CYP7B1/SULT2B1,4
GO:0006874,intracellular calcium ion homeostasis,6/157,302/18888,0.0406693890939045,0.373110834793321,0.34474928713573,CALB2/CLIC2/PKHD1/SV2A/TMEM38A/TRPM8,6
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,2/157,39/18888,0.0416274362058635,0.377609177867421,0.34890569435705,NOG/RUNX2,2
GO:0050892,intestinal absorption,2/157,39/18888,0.0416274362058635,0.377609177867421,0.34890569435705,ADRA2A/CEL,2
GO:0071312,cellular response to alkaloid,2/157,39/18888,0.0416274362058635,0.377609177867421,0.34890569435705,SLC1A3/TMEM38A,2
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7/157,385/18888,0.0421868588313496,0.381255866005704,0.352275184114097,CLU/EXO1/IL13RA2/IL1RL1/KLRC1/NSD2/SEMA4A,7
GO:0030902,hindbrain development,4/157,158/18888,0.0430059057037942,0.385766591763251,0.356443032764862,CBS/EGR2/NLGN4X/NOG,4
GO:0008210,estrogen metabolic process,2/157,40/18888,0.0435844916752404,0.385766591763251,0.356443032764862,HSD17B1/HSD17B2,2
GO:0044060,regulation of endocrine process,2/157,40/18888,0.0435844916752404,0.385766591763251,0.356443032764862,POMC/TACR2,2
GO:0046676,negative regulation of insulin secretion,2/157,40/18888,0.0435844916752404,0.385766591763251,0.356443032764862,ADRA2A/SFRP1,2
GO:0051492,regulation of stress fiber assembly,3/157,94/18888,0.043641637548774,0.385766591763251,0.356443032764862,LIMK1/PIK3R1/SFRP1,3
GO:0051952,regulation of amine transport,3/157,94/18888,0.043641637548774,0.385766591763251,0.356443032764862,ADRA2A/SV2A/TACR2,3
GO:0051656,establishment of organelle localization,8/157,472/18888,0.0438202712607224,0.385937079976253,0.356600561532233,ESPL1/GPSM2/IL13RA2/NEFH/PKHD1/SNAP25/SYBU/WDR11,8
GO:0019722,calcium-mediated signaling,5/157,232/18888,0.0446365567762252,0.391701958376875,0.361927230000972,CD22/CLIC2/POMC/TMEM38A/TRPM8,5
GO:0014020,primary neural tube formation,3/157,95/18888,0.0447990801320839,0.391708924476199,0.361933666581077,NOG/SFRP1/TULP3,3
GO:0033260,nuclear DNA replication,2/157,41/18888,0.0455752211759731,0.394225663172168,0.364259098571876,BRCA2/MCM4,2
GO:0035136,forelimb morphogenesis,2/157,41/18888,0.0455752211759731,0.394225663172168,0.364259098571876,HOXD9/RUNX2,2
GO:0050913,sensory perception of bitter taste,2/157,41/18888,0.0455752211759731,0.394225663172168,0.364259098571876,CST2/PIGR,2
GO:0015850,organic hydroxy compound transport,6/157,311/18888,0.0457745470522419,0.394540757866655,0.364550241742148,ABCA8/ADRA2A/CEL/CLU/MAOB/POMC,6
GO:0016079,synaptic vesicle exocytosis,3/157,96/18888,0.0459717252713341,0.394835172365855,0.364822276695992,RIMS1/SNAP25/SV2A,3
GO:0021675,nerve development,3/157,97/18888,0.0471595060438864,0.400293843413718,0.369866013776159,EGR2/NRTN/SLC1A3,3
GO:0051017,actin filament bundle assembly,4/157,163/18888,0.0472742817411089,0.400293843413718,0.369866013776159,LIMK1/PHACTR1/PIK3R1/SFRP1,4
GO:0170033,L-amino acid metabolic process,4/157,163/18888,0.0472742817411089,0.400293843413718,0.369866013776159,ASRGL1/CBS/FAH/NOS2,4
GO:0009409,response to cold,2/157,42/18888,0.0475989376148434,0.400293843413718,0.369866013776159,HSPA2/TRPM8,2
GO:0050912,detection of chemical stimulus involved in sensory perception of taste,2/157,42/18888,0.0475989376148434,0.400293843413718,0.369866013776159,CST2/PIGR,2
GO:0051294,establishment of spindle orientation,2/157,42/18888,0.0475989376148434,0.400293843413718,0.369866013776159,GPSM2/PKHD1,2
GO:0006942,regulation of striated muscle contraction,3/157,98/18888,0.0483623534400539,0.404896347552985,0.374118664391171,CLIC2/MYL3/TMEM38A,3
GO:0050673,epithelial cell proliferation,8/157,482/18888,0.0484805701033714,0.404896347552985,0.374118664391171,BRCA2/CLDN18/CYP7B1/NOG/PKHD1/RUNX2/SFRP1/SYNJ2BP,8
GO:0072593,reactive oxygen species metabolic process,5/157,238/18888,0.0488455399509957,0.406542603990761,0.375639782730392,ADGRB1/CBS/MAOB/NOS2/SFTPD,5
GO:0051588,regulation of neurotransmitter transport,3/157,99/18888,0.049580196419114,0.407675661215269,0.376686712044705,RIMS1/SNCAIP/TACR2,3
GO:0060349,bone morphogenesis,3/157,99/18888,0.049580196419114,0.407675661215269,0.376686712044705,BMPR1B/CBS/RUNX2,3
GO:0060412,ventricular septum morphogenesis,2/157,43/18888,0.0496549628647829,0.407675661215269,0.376686712044705,NOG/NSD2,2
GO:0070296,sarcoplasmic reticulum calcium ion transport,2/157,43/18888,0.0496549628647829,0.407675661215269,0.376686712044705,CLIC2/TMEM38A,2
GO:0001678,intracellular glucose homeostasis,4/157,166/18888,0.0499444274189314,0.408666902731931,0.377602605592632,ADRA2A/GPR68/PIK3R1/SYBU,4
GO:0000041,transition metal ion transport,3/157,100/18888,0.0508129619644094,0.411923216951805,0.380611395210368,MMGT1/SLC25A37/SLC30A7,3
GO:0002220,innate immune response activating cell surface receptor signaling pathway,3/157,100/18888,0.0508129619644094,0.411923216951805,0.380611395210368,KLRC1/PIK3R1/TNIP3,3
GO:0061572,actin filament bundle organization,4/157,167/18888,0.0508526184428528,0.411923216951805,0.380611395210368,LIMK1/PHACTR1/PIK3R1/SFRP1,4
GO:0071526,semaphorin-plexin signaling pathway,2/157,44/18888,0.0517426276648675,0.415552766605671,0.38396504924319,SEMA4A/SEMA6D,2
GO:0120178,steroid hormone biosynthetic process,2/157,44/18888,0.0517426276648675,0.415552766605671,0.38396504924319,HSD17B1/HSD17B2,2
GO:0009416,response to light stimulus,6/157,321/18888,0.051896792257271,0.415552766605671,0.38396504924319,BRCA2/H2AC25/NOG/PDE1B/PIK3R1/SLC1A3,6
GO:0050890,cognition,6/157,322/18888,0.0525352872753506,0.415552766605671,0.38396504924319,EGR2/NLGN4X/NOG/PDE1B/SNAP25/TACR2,6
GO:0060070,canonical Wnt signaling pathway,6/157,323/18888,0.0531785783110751,0.415552766605671,0.38396504924319,FRZB/FZD10/NOG/PLEKHA4/SFRP1/TMEM198,6
GO:0001841,neural tube formation,3/157,102/18888,0.0533229591317311,0.415552766605671,0.38396504924319,NOG/SFRP1/TULP3,3
GO:0008585,female gonad development,3/157,102/18888,0.0533229591317311,0.415552766605671,0.38396504924319,BMPR1B/BRCA2/SFRP1,3
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,3/157,102/18888,0.0533229591317311,0.415552766605671,0.38396504924319,BRCA2/CLU/PIK3R1,3
GO:0007519,skeletal muscle tissue development,4/157,170/18888,0.0536314776532709,0.415552766605671,0.38396504924319,EGR2/HOXD9/HSD17B1/MYOM1,4
GO:0001504,neurotransmitter uptake,2/157,45/18888,0.0538612715213369,0.415552766605671,0.38396504924319,SLC1A3/SNAP25,2
GO:0032881,regulation of polysaccharide metabolic process,2/157,45/18888,0.0538612715213369,0.415552766605671,0.38396504924319,POMC/PPP1R3F,2
GO:0044786,cell cycle DNA replication,2/157,45/18888,0.0538612715213369,0.415552766605671,0.38396504924319,BRCA2/MCM4,2
GO:0048701,embryonic cranial skeleton morphogenesis,2/157,45/18888,0.0538612715213369,0.415552766605671,0.38396504924319,RUNX2/TULP3,2
GO:0090278,negative regulation of peptide hormone secretion,2/157,45/18888,0.0538612715213369,0.415552766605671,0.38396504924319,ADRA2A/SFRP1,2
GO:0050678,regulation of epithelial cell proliferation,7/157,407/18888,0.05387430582749,0.415552766605671,0.38396504924319,BRCA2/CYP7B1/NOG/PKHD1/RUNX2/SFRP1/SYNJ2BP,7
GO:0055074,calcium ion homeostasis,6/157,326/18888,0.0551372672033389,0.422602725210401,0.390479114171547,CALB2/CLIC2/PKHD1/SV2A/TMEM38A/TRPM8,6
GO:1904951,positive regulation of establishment of protein localization,6/157,326/18888,0.0551372672033389,0.422602725210401,0.390479114171547,GPR68/MYOM1/PIK3R1/SNAP25/SYBU/ZFAND1,6
GO:0010469,regulation of signaling receptor activity,3/157,104/18888,0.0558917233276903,0.422606877260212,0.390482950608549,ADRA2A/GREM2/NOG,3
GO:0002701,negative regulation of production of molecular mediator of immune response,2/157,46/18888,0.0560102426096318,0.422606877260212,0.390482950608549,CD22/IL13RA2,2
GO:0002792,negative regulation of peptide secretion,2/157,46/18888,0.0560102426096318,0.422606877260212,0.390482950608549,ADRA2A/SFRP1,2
GO:0030517,negative regulation of axon extension,2/157,46/18888,0.0560102426096318,0.422606877260212,0.390482950608549,SEMA4A/SEMA6D,2
GO:0061383,trabecula morphogenesis,2/157,46/18888,0.0560102426096318,0.422606877260212,0.390482950608549,NOG/SFRP1,2
GO:0015837,amine transport,3/157,105/18888,0.057197941041441,0.428193536511512,0.395644947030934,ADRA2A/SV2A/TACR2,3
GO:0110020,regulation of actomyosin structure organization,3/157,105/18888,0.057197941041441,0.428193536511512,0.395644947030934,LIMK1/PIK3R1/SFRP1,3
GO:0048638,regulation of developmental growth,6/157,330/18888,0.0578162167192872,0.428193536511512,0.395644947030934,LIMK1/NOG/OLFM1/RIMS1/SEMA4A/SEMA6D,6
GO:0016054,organic acid catabolic process,5/157,250/18888,0.0579458321875377,0.428193536511512,0.395644947030934,ASRGL1/CBS/FAH/HAAO/NOS2,5
GO:0046395,carboxylic acid catabolic process,5/157,250/18888,0.0579458321875377,0.428193536511512,0.395644947030934,ASRGL1/CBS/FAH/HAAO/NOS2,5
GO:0050919,negative chemotaxis,2/157,47/18888,0.0581888976774358,0.428193536511512,0.395644947030934,SEMA4A/SEMA6D,2
GO:0055010,ventricular cardiac muscle tissue morphogenesis,2/157,47/18888,0.0581888976774358,0.428193536511512,0.395644947030934,MYL3/NOG,2
GO:0140353,lipid export from cell,2/157,47/18888,0.0581888976774358,0.428193536511512,0.395644947030934,NOS2/POMC,2
GO:0022900,electron transport chain,4/157,175/18888,0.0584431001370571,0.428193536511512,0.395644947030934,HAAO/MAOB/POR/RDH16,4
GO:0046545,development of primary female sexual characteristics,3/157,106/18888,0.0585186047007889,0.428193536511512,0.395644947030934,BMPR1B/BRCA2/SFRP1,3
GO:0032231,regulation of actin filament bundle assembly,3/157,107/18888,0.0598536289263726,0.428518987100915,0.395945658905883,LIMK1/PIK3R1/SFRP1,3
GO:0042088,T-helper 1 type immune response,2/157,48/18888,0.0603966019487156,0.428518987100915,0.395945658905883,IL1RL1/SEMA4A,2
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/157,48/18888,0.0603966019487156,0.428518987100915,0.395945658905883,BMPR1B/SFRP1,2
GO:0071214,cellular response to abiotic stimulus,6/157,334/18888,0.0605723112268837,0.428518987100915,0.395945658905883,BRCA2/GPR68/H2AC25/MAP3K14/PIK3R1/SFRP1,6
GO:0104004,cellular response to environmental stimulus,6/157,334/18888,0.0605723112268837,0.428518987100915,0.395945658905883,BRCA2/GPR68/H2AC25/MAP3K14/PIK3R1/SFRP1,6
GO:0060291,long-term synaptic potentiation,3/157,108/18888,0.0612029267723439,0.428518987100915,0.395945658905883,CALB2/NOG/SNAP25,3
GO:1901890,positive regulation of cell junction assembly,3/157,108/18888,0.0612029267723439,0.428518987100915,0.395945658905883,ADGRB1/SEMA4A/SFRP1,3
GO:0008542,visual learning,2/157,49/18888,0.0626327290287461,0.428518987100915,0.395945658905883,NOG/PDE1B,2
GO:0010171,body morphogenesis,2/157,49/18888,0.0626327290287461,0.428518987100915,0.395945658905883,GREM2/NOG,2
GO:0051489,regulation of filopodium assembly,2/157,49/18888,0.0626327290287461,0.428518987100915,0.395945658905883,MIEN1/PIK3R1,2
GO:0098815,modulation of excitatory postsynaptic potential,2/157,49/18888,0.0626327290287461,0.428518987100915,0.395945658905883,NLGN4X/RIMS1,2
GO:1903170,negative regulation of calcium ion transmembrane transport,2/157,49/18888,0.0626327290287461,0.428518987100915,0.395945658905883,ADRA2A/CLIC2,2
GO:0001649,osteoblast differentiation,5/157,257/18888,0.0636747818890482,0.428518987100915,0.395945658905883,BMPR1B/CEBPA/NOG/RUNX2/SFRP1,5
GO:0042116,macrophage activation,3/157,110/18888,0.0639439879934213,0.428518987100915,0.395945658905883,CEBPA/CLU/IL1RL1,3
GO:0006310,DNA recombination,6/157,339/18888,0.0641260804674806,0.428518987100915,0.395945658905883,BRCA2/EXO1/GINS2/MCM4/NSD2/SHOC1,6
GO:0071478,cellular response to radiation,4/157,181/18888,0.0645119138772303,0.428518987100915,0.395945658905883,BRCA2/H2AC25/PIK3R1/SFRP1,4
GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",2/157,50/18888,0.0648966608101142,0.428518987100915,0.395945658905883,PLEKHA4/SFRP1,2
GO:0090263,positive regulation of canonical Wnt signaling pathway,3/157,111/18888,0.0653355700673244,0.428518987100915,0.395945658905883,PLEKHA4/SFRP1/TMEM198,3
GO:0090277,positive regulation of peptide hormone secretion,3/157,111/18888,0.0653355700673244,0.428518987100915,0.395945658905883,GPR68/SNAP25/SYBU,3
GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,3/157,111/18888,0.0653355700673244,0.428518987100915,0.395945658905883,C15orf62/MIEN1/PIK3R1,3
GO:0060538,skeletal muscle organ development,4/157,182/18888,0.0655543912013467,0.428518987100915,0.395945658905883,EGR2/HOXD9/HSD17B1/MYOM1,4
GO:0021700,developmental maturation,6/157,341/18888,0.0655814110235935,0.428518987100915,0.395945658905883,BRCA2/CEBPA/GLDN/HEATR3/RUNX2/SYBU,6
GO:0010719,negative regulation of epithelial to mesenchymal transition,2/157,51/18888,0.0671877873796891,0.428518987100915,0.395945658905883,NOG/SFRP1,2
GO:0046850,regulation of bone remodeling,2/157,51/18888,0.0671877873796891,0.428518987100915,0.395945658905883,CLDN18/SFRP1,2
GO:0048286,lung alveolus development,2/157,51/18888,0.0671877873796891,0.428518987100915,0.395945658905883,CLDN18/SFTPD,2
GO:0051496,positive regulation of stress fiber assembly,2/157,51/18888,0.0671877873796891,0.428518987100915,0.395945658905883,LIMK1/SFRP1,2
GO:0089718,amino acid import across plasma membrane,2/157,51/18888,0.0671877873796891,0.428518987100915,0.395945658905883,SLC1A3/SLC36A4,2
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,2/157,51/18888,0.0671877873796891,0.428518987100915,0.395945658905883,BMPR1B/SFRP1,2
GO:0003002,regionalization,7/157,429/18888,0.0674177650711807,0.428518987100915,0.395945658905883,BMPR1B/EGR2/GREM2/HOXD9/NOG/SFRP1/TULP3,7
GO:0032956,regulation of actin cytoskeleton organization,6/157,344/18888,0.0678006442664969,0.428518987100915,0.395945658905883,C15orf62/FCHSD2/FZD10/LIMK1/PIK3R1/SFRP1,6
GO:0002793,positive regulation of peptide secretion,3/157,113/18888,0.0681603734593243,0.428518987100915,0.395945658905883,GPR68/SNAP25/SYBU,3
GO:0009314,response to radiation,7/157,431/18888,0.0687423109155374,0.428518987100915,0.395945658905883,BRCA2/H2AC25/NOG/PDE1B/PIK3R1/SFRP1/SLC1A3,7
GO:0030838,positive regulation of actin filament polymerization,2/157,52/18888,0.0695055069265518,0.428518987100915,0.395945658905883,C15orf62/FCHSD2,2
GO:0042572,retinol metabolic process,2/157,52/18888,0.0695055069265518,0.428518987100915,0.395945658905883,CEL/RDH16,2
GO:0048640,negative regulation of developmental growth,3/157,114/18888,0.0695934053187269,0.428518987100915,0.395945658905883,NOG/SEMA4A/SEMA6D,3
GO:0048736,appendage development,4/157,186/18888,0.0698120860725249,0.428518987100915,0.395945658905883,HOXD9/NOG/RUNX2/TULP3,4
GO:0060173,limb development,4/157,186/18888,0.0698120860725249,0.428518987100915,0.395945658905883,HOXD9/NOG/RUNX2/TULP3,4
GO:0051963,regulation of synapse assembly,3/157,115/18888,0.0710400622014013,0.428518987100915,0.395945658905883,ADGRB1/SEMA4A/SNAP25,3
GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,2/157,53/18888,0.0718492256508731,0.428518987100915,0.395945658905883,EXO1/NSD2,2
GO:0002208,somatic diversification of immunoglobulins involved in immune response,2/157,53/18888,0.0718492256508731,0.428518987100915,0.395945658905883,EXO1/NSD2,2
GO:0032330,regulation of chondrocyte differentiation,2/157,53/18888,0.0718492256508731,0.428518987100915,0.395945658905883,BMPR1B/RUNX2,2
GO:0045190,isotype switching,2/157,53/18888,0.0718492256508731,0.428518987100915,0.395945658905883,EXO1/NSD2,2
GO:0060688,regulation of morphogenesis of a branching structure,2/157,53/18888,0.0718492256508731,0.428518987100915,0.395945658905883,NOG/SFRP1,2
GO:0008361,regulation of cell size,4/157,188/18888,0.0719932615851094,0.428518987100915,0.395945658905883,LIMK1/OLFM1/SEMA4A/SEMA6D,4
GO:0044344,cellular response to fibroblast growth factor stimulus,3/157,116/18888,0.0725002462716929,0.428518987100915,0.395945658905883,NOG/RUNX2/SFRP1,3
GO:0060828,regulation of canonical Wnt signaling pathway,5/157,268/18888,0.0733000927241601,0.428518987100915,0.395945658905883,FRZB/NOG/PLEKHA4/SFRP1/TMEM198,5
GO:0038093,Fc receptor signaling pathway,2/157,54/18888,0.0742183576737305,0.428518987100915,0.395945658905883,LIMK1/PIGR,2
GO:0006941,striated muscle contraction,4/157,191/18888,0.075329842789007,0.428518987100915,0.395945658905883,CLIC2/MYL3/TMEM38A/TNNI2,4
GO:0071695,anatomical structure maturation,5/157,271/18888,0.07605627831313,0.428518987100915,0.395945658905883,BRCA2/CEBPA/GLDN/HEATR3/RUNX2,5
GO:0006936,muscle contraction,6/157,355/18888,0.0763093325754572,0.428518987100915,0.395945658905883,ADRA2A/CLIC2/MYL3/TACR2/TMEM38A/TNNI2,6
GO:0007140,male meiotic nuclear division,2/157,55/18888,0.0766123249478569,0.428518987100915,0.395945658905883,BRCA2/HSPA2,2
GO:0031644,regulation of nervous system process,3/157,119/18888,0.0769609659847091,0.428518987100915,0.395945658905883,EGR2/NLGN4X/RIMS1,3
GO:0030324,lung development,4/157,193/18888,0.0775971127903383,0.428518987100915,0.395945658905883,CEBPA/CLDN18/NOG/SFTPD,4
GO:0009410,response to xenobiotic stimulus,7/157,444/18888,0.0777324810267804,0.428518987100915,0.395945658905883,AADAC/CES3/MAOB/NOS2/POR/SFRP1/SLC1A3,7
GO:0110053,regulation of actin filament organization,5/157,273/18888,0.0779247110384756,0.428518987100915,0.395945658905883,C15orf62/FCHSD2/LIMK1/PIK3R1/SFRP1,5
GO:0010717,regulation of epithelial to mesenchymal transition,3/157,120/18888,0.0784742577075011,0.428518987100915,0.395945658905883,NOG/OLFM1/SFRP1,3
GO:0071466,cellular response to xenobiotic stimulus,4/157,194/18888,0.0787435237894081,0.428518987100915,0.395945658905883,AADAC/CES3/NOS2/POR,4
GO:0002455,humoral immune response mediated by circulating immunoglobulin,2/157,56/18888,0.0790305571693094,0.428518987100915,0.395945658905883,CLU/EXO1,2
GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2/157,56/18888,0.0790305571693094,0.428518987100915,0.395945658905883,IL1RL1/KLRC1,2
GO:0001503,ossification,7/157,446/18888,0.0791741209681646,0.428518987100915,0.395945658905883,BMPR1B/CBS/CEBPA/EGR2/NOG/RUNX2/SFRP1,7
GO:0002698,negative regulation of immune effector process,3/157,121/18888,0.080000570731909,0.428518987100915,0.395945658905883,CD22/IL13RA2/KLRC1,3
GO:0030510,regulation of BMP signaling pathway,3/157,121/18888,0.080000570731909,0.428518987100915,0.395945658905883,GREM2/NOG/SFRP1,3
GO:0046660,female sex differentiation,3/157,121/18888,0.080000570731909,0.428518987100915,0.395945658905883,BMPR1B/BRCA2/SFRP1,3
GO:0001514,selenocysteine incorporation,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,DIO2,1
GO:0001915,negative regulation of T cell mediated cytotoxicity,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,KLRC1,1
GO:0006451,translational readthrough,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,DIO2,1
GO:0016081,synaptic vesicle docking,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,SNAP25,1
GO:0017038,protein import,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,CLU,1
GO:0018242,protein O-linked glycosylation via serine,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,GALNT16,1
GO:0018243,protein O-linked glycosylation via threonine,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,GALNT16,1
GO:0032988,protein-RNA complex disassembly,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,ZFAND1,1
GO:0035655,interleukin-18-mediated signaling pathway,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,PIK3R1,1
GO:0048263,determination of dorsal identity,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,GREM2,1
GO:0048865,stem cell fate commitment,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,SFRP1,1
GO:0051307,meiotic chromosome separation,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,ESPL1,1
GO:0051660,establishment of centrosome localization,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,PKHD1,1
GO:0060052,neurofilament cytoskeleton organization,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,NEFH,1
GO:0060346,bone trabecula formation,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,SFRP1,1
GO:0060525,prostate glandular acinus development,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,SFRP1,1
GO:0071314,cellular response to cocaine,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,SLC1A3,1
GO:0071351,cellular response to interleukin-18,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,PIK3R1,1
GO:0072172,mesonephric tubule formation,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,NOG,1
GO:0090179,planar cell polarity pathway involved in neural tube closure,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,SFRP1,1
GO:0090184,positive regulation of kidney development,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,NOG,1
GO:0097090,presynaptic membrane organization,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,NLGN4X,1
GO:0097104,postsynaptic membrane assembly,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,NLGN4X,1
GO:0140059,dendrite arborization,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,PHACTR1,1
GO:1902513,regulation of organelle transport along microtubule,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,NEFH,1
GO:1904338,regulation of dopaminergic neuron differentiation,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,SFRP1,1
GO:1904383,response to sodium phosphate,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,RUNX2,1
GO:1990504,dense core granule exocytosis,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,SNAP25,1
GO:2000849,regulation of glucocorticoid secretion,1/157,10/18888,0.0800987216433633,0.428518987100915,0.395945658905883,POMC,1
GO:0002768,immune response-regulating cell surface receptor signaling pathway,6/157,360/18888,0.0803692599315247,0.428518987100915,0.395945658905883,CD22/KLRC1/LIMK1/PIGR/PIK3R1/TNIP3,6
GO:0010038,response to metal ion,6/157,360/18888,0.0803692599315247,0.428518987100915,0.395945658905883,CEBPA/DDX19A/HAAO/HSD17B1/MAOB/MT1F,6
GO:0007632,visual behavior,2/157,57/18888,0.0814724916900516,0.428518987100915,0.395945658905883,NOG/PDE1B,2
GO:0060632,regulation of microtubule-based movement,2/157,57/18888,0.0814724916900516,0.428518987100915,0.395945658905883,NEFH/TACR2,2
GO:0060986,endocrine hormone secretion,2/157,57/18888,0.0814724916900516,0.428518987100915,0.395945658905883,POMC/TACR2,2
GO:0031334,positive regulation of protein-containing complex assembly,4/157,197/18888,0.0822334880489955,0.428518987100915,0.395945658905883,C15orf62/CLU/FCHSD2/PPP2R5B,4
GO:0140013,meiotic nuclear division,4/157,197/18888,0.0822334880489955,0.428518987100915,0.395945658905883,BRCA2/ESPL1/HSPA2/SHOC1,4
GO:0001838,embryonic epithelial tube formation,3/157,123/18888,0.0830918427760223,0.428518987100915,0.395945658905883,NOG/SFRP1/TULP3,3
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,4/157,198/18888,0.0834136126394406,0.428518987100915,0.395945658905883,GREM2/NOG/ONECUT2/SFRP1,4
GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,2/157,58/18888,0.083937573431438,0.428518987100915,0.395945658905883,EXO1/NSD2,2
GO:0006826,iron ion transport,2/157,58/18888,0.083937573431438,0.428518987100915,0.395945658905883,MMGT1/SLC25A37,2
GO:0015804,neutral amino acid transport,2/157,58/18888,0.083937573431438,0.428518987100915,0.395945658905883,SLC1A3/SLC36A4,2
GO:0042733,embryonic digit morphogenesis,2/157,58/18888,0.083937573431438,0.428518987100915,0.395945658905883,NOG/TULP3,2
GO:0048168,regulation of neuronal synaptic plasticity,2/157,58/18888,0.083937573431438,0.428518987100915,0.395945658905883,EGR2/NOG,2
GO:0099504,synaptic vesicle cycle,4/157,199/18888,0.0846020836351877,0.428518987100915,0.395945658905883,NLGN4X/RIMS1/SNAP25/SV2A,4
GO:0071774,response to fibroblast growth factor,3/157,124/18888,0.0846565905429838,0.428518987100915,0.395945658905883,NOG/RUNX2/SFRP1,3
GO:0022612,gland morphogenesis,3/157,125/18888,0.0862339371785675,0.428518987100915,0.395945658905883,CYP7B1/NOG/SFRP1,3
GO:1903305,regulation of regulated secretory pathway,3/157,125/18888,0.0862339371785675,0.428518987100915,0.395945658905883,ADRA2A/IL13RA2/RIMS1,3
GO:0003229,ventricular cardiac muscle tissue development,2/157,59/18888,0.0864252547985945,0.428518987100915,0.395945658905883,MYL3/NOG,2
GO:1903409,reactive oxygen species biosynthetic process,2/157,59/18888,0.0864252547985945,0.428518987100915,0.395945658905883,ADGRB1/MAOB,2
GO:0031345,negative regulation of cell projection organization,4/157,201/18888,0.0870039281594803,0.428518987100915,0.395945658905883,RTCA/SEMA4A/SEMA6D/WDR44,4
GO:0000050,urea cycle,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,CEBPA,1
GO:0000098,sulfur amino acid catabolic process,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,CBS,1
GO:0001820,serotonin secretion,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,MAOB,1
GO:0002765,immune response-inhibiting signal transduction,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,KLRC1,1
GO:0002887,negative regulation of myeloid leukocyte mediated immunity,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,IL13RA2,1
GO:0006568,tryptophan metabolic process,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,HAAO,1
GO:0006686,sphingomyelin biosynthetic process,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,ABCA8,1
GO:0010172,embryonic body morphogenesis,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,GREM2,1
GO:0015808,L-alanine transport,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,SLC36A4,1
GO:0021561,facial nerve development,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,EGR2,1
GO:0021604,cranial nerve structural organization,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,EGR2,1
GO:0021610,facial nerve morphogenesis,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,EGR2,1
GO:0022605,mammalian oogenesis stage,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,BMPR1B,1
GO:0032275,luteinizing hormone secretion,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,TACR2,1
GO:0032754,positive regulation of interleukin-5 production,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,IL1RL1,1
GO:0035581,sequestering of extracellular ligand from receptor,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,GREM2,1
GO:0042428,serotonin metabolic process,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,PDE1B,1
GO:0045050,protein insertion into ER membrane by stop-transfer membrane-anchor sequence,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,MMGT1,1
GO:0048241,epinephrine transport,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,ADRA2A,1
GO:0048262,determination of dorsal/ventral asymmetry,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,GREM2,1
GO:0051386,regulation of neurotrophin TRK receptor signaling pathway,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,PPP2R5B,1
GO:0051593,response to folic acid,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,CBS,1
GO:0060272,embryonic skeletal joint morphogenesis,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,NOG,1
GO:0060315,negative regulation of ryanodine-sensitive calcium-release channel activity,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,CLIC2,1
GO:0060433,bronchus development,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,TULP3,1
GO:0060601,lateral sprouting from an epithelium,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,NOG,1
GO:0061370,testosterone biosynthetic process,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,HSD17B1,1
GO:0062111,zinc ion import into organelle,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,SLC30A7,1
GO:0070778,L-aspartate transmembrane transport,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,SLC1A3,1
GO:0071313,cellular response to caffeine,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,TMEM38A,1
GO:0071481,cellular response to X-ray,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,SFRP1,1
GO:0072697,protein localization to cell cortex,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,GPSM2,1
GO:0090178,regulation of establishment of planar polarity involved in neural tube closure,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,SFRP1,1
GO:0090394,negative regulation of excitatory postsynaptic potential,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,NLGN4X,1
GO:0099519,dense core granule cytoskeletal transport,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,SYBU,1
GO:1901950,dense core granule transport,1/157,11/18888,0.0877491348599115,0.428518987100915,0.395945658905883,SYBU,1
GO:0006805,xenobiotic metabolic process,3/157,126/18888,0.0878237749204202,0.428518987100915,0.395945658905883,AADAC/CES3/POR,3
GO:0072089,stem cell proliferation,3/157,126/18888,0.0878237749204202,0.428518987100915,0.395945658905883,BRCA2/CEBPA/RUNX2,3
GO:0032535,regulation of cellular component size,6/157,370/18888,0.0888470111331514,0.428518987100915,0.395945658905883,C15orf62/FCHSD2/LIMK1/OLFM1/SEMA4A/SEMA6D,6
GO:0003012,muscle system process,7/157,459/18888,0.0889240217647733,0.428518987100915,0.395945658905883,ADRA2A/CLIC2/GTF2IRD1/MYL3/TACR2/TMEM38A/TNNI2,7
GO:0001706,endoderm formation,2/157,60/18888,0.0889349955956834,0.428518987100915,0.395945658905883,NOG/POU5F1,2
GO:0006940,regulation of smooth muscle contraction,2/157,60/18888,0.0889349955956834,0.428518987100915,0.395945658905883,ADRA2A/TACR2,2
GO:0043030,regulation of macrophage activation,2/157,60/18888,0.0889349955956834,0.428518987100915,0.395945658905883,CEBPA/IL1RL1,2
GO:0046686,response to cadmium ion,2/157,60/18888,0.0889349955956834,0.428518987100915,0.395945658905883,HAAO/MT1F,2
GO:0003206,cardiac chamber morphogenesis,3/157,127/18888,0.089425995214808,0.428518987100915,0.395945658905883,MYL3/NOG/NSD2,3
GO:0003231,cardiac ventricle development,3/157,127/18888,0.089425995214808,0.428518987100915,0.395945658905883,MYL3/NOG/NSD2,3
GO:0010975,regulation of neuron projection development,7/157,460/18888,0.0897011500812083,0.428518987100915,0.395945658905883,LIMK1/PPP2R5B/RTCA/SEMA4A/SEMA6D/SFRP1/SNAP25,7
GO:0120032,regulation of plasma membrane bounded cell projection assembly,4/157,204/18888,0.0906684232534232,0.428518987100915,0.395945658905883,C15orf62/MIEN1/PIK3R1/WDR44,4
GO:0001738,morphogenesis of a polarized epithelium,2/157,61/18888,0.0914662629420469,0.428518987100915,0.395945658905883,PKHD1/SFRP1,2
GO:0002820,negative regulation of adaptive immune response,2/157,61/18888,0.0914662629420469,0.428518987100915,0.395945658905883,IL1RL1/KLRC1,2
GO:0016447,somatic recombination of immunoglobulin gene segments,2/157,61/18888,0.0914662629420469,0.428518987100915,0.395945658905883,EXO1/NSD2,2
GO:0032233,positive regulation of actin filament bundle assembly,2/157,61/18888,0.0914662629420469,0.428518987100915,0.395945658905883,LIMK1/SFRP1,2
GO:0055008,cardiac muscle tissue morphogenesis,2/157,61/18888,0.0914662629420469,0.428518987100915,0.395945658905883,MYL3/NOG,2
GO:0006066,alcohol metabolic process,6/157,373/18888,0.0914827041289839,0.428518987100915,0.395945658905883,CEBPA/CEL/CUBN/CYP7B1/RDH16/SULT2B1,6
GO:0090287,regulation of cellular response to growth factor stimulus,6/157,373/18888,0.0914827041289839,0.428518987100915,0.395945658905883,GREM2/NOG/ONECUT2/PPP2R5B/RUNX2/SFRP1,6
GO:1903532,positive regulation of secretion by cell,5/157,288/18888,0.0927177415921735,0.428518987100915,0.395945658905883,GPR68/MYOM1/SNAP25/SYBU/TACR2,5
GO:0060491,regulation of cell projection assembly,4/157,206/18888,0.0931521481386055,0.428518987100915,0.395945658905883,C15orf62/MIEN1/PIK3R1/WDR44,4
GO:0045931,positive regulation of mitotic cell cycle,3/157,130/18888,0.0943058547155935,0.428518987100915,0.395945658905883,BRCA2/ESPL1/HSPA2,3
GO:0001547,antral ovarian follicle growth,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,BMPR1B,1
GO:0006534,cysteine metabolic process,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,CBS,1
GO:0010749,regulation of nitric oxide mediated signal transduction,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,CBS,1
GO:0014051,gamma-aminobutyric acid secretion,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,SV2A,1
GO:0014831,gastro-intestinal system smooth muscle contraction,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,TACR2,1
GO:0015801,aromatic amino acid transport,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,SLC36A4,1
GO:0030157,pancreatic juice secretion,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,CEL,1
GO:0031223,auditory behavior,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,SLC1A3,1
GO:0032276,regulation of gonadotropin secretion,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,TACR2,1
GO:0035524,proline transmembrane transport,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,SLC36A4,1
GO:0035933,glucocorticoid secretion,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,POMC,1
GO:0042045,epithelial fluid transport,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,CLDN18,1
GO:0042487,regulation of odontogenesis of dentin-containing tooth,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,RUNX2,1
GO:0042797,tRNA transcription by RNA polymerase III,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,POLR3D,1
GO:0045161,neuronal ion channel clustering,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,GLDN,1
GO:0051657,maintenance of organelle location,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,GPSM2,1
GO:0060442,branching involved in prostate gland morphogenesis,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,SFRP1,1
GO:0062042,regulation of cardiac epithelial to mesenchymal transition,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,NOG,1
GO:0070673,response to interleukin-18,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,PIK3R1,1
GO:0090084,negative regulation of inclusion body assembly,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,HSPA2,1
GO:0090177,establishment of planar polarity involved in neural tube closure,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,SFRP1,1
GO:1900121,negative regulation of receptor binding,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,NOG,1
GO:1902093,positive regulation of flagellated sperm motility,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,TACR2,1
GO:2000155,positive regulation of cilium-dependent cell motility,1/157,12/18888,0.0953363248703467,0.428518987100915,0.395945658905883,TACR2,1
GO:0007416,synapse assembly,4/157,208/18888,0.0956681046616414,0.428518987100915,0.395945658905883,ADGRB1/NLGN4X/SEMA4A/SNAP25,4
GO:0016064,immunoglobulin mediated immune response,4/157,208/18888,0.0956681046616414,0.428518987100915,0.395945658905883,CLU/EXO1/IL13RA2/NSD2,4
GO:0015695,organic cation transport,2/157,63/18888,0.0965912818387917,0.428518987100915,0.395945658905883,ADRA2A/TACR2,2
GO:0050909,sensory perception of taste,2/157,63/18888,0.0965912818387917,0.428518987100915,0.395945658905883,CST2/PIGR,2
GO:0051965,positive regulation of synapse assembly,2/157,63/18888,0.0965912818387917,0.428518987100915,0.395945658905883,ADGRB1/SEMA4A,2
GO:0030301,cholesterol transport,3/157,132/18888,0.0976189844347586,0.428518987100915,0.395945658905883,ABCA8/CEL/CLU,3
GO:0021545,cranial nerve development,2/157,64/18888,0.0991840034611498,0.428518987100915,0.395945658905883,EGR2/SLC1A3,2
GO:0030888,regulation of B cell proliferation,2/157,64/18888,0.0991840034611498,0.428518987100915,0.395945658905883,CD22/TNFRSF13C,2
GO:0034142,toll-like receptor 4 signaling pathway,2/157,64/18888,0.0991840034611498,0.428518987100915,0.395945658905883,PIK3R1/TNIP3,2
GO:0070050,neuron cellular homeostasis,2/157,64/18888,0.0991840034611498,0.428518987100915,0.395945658905883,CALB2/HAAO,2
GO:0043271,negative regulation of monoatomic ion transport,3/157,133/18888,0.0992931803106529,0.428518987100915,0.395945658905883,ADRA2A/CLIC2/MAOB,3
GO:0019724,B cell mediated immunity,4/157,212/18888,0.100795462824723,0.428518987100915,0.395945658905883,CLU/EXO1/IL13RA2/NSD2,4
GO:0007389,pattern specification process,7/157,474/18888,0.100984504333443,0.428518987100915,0.395945658905883,BMPR1B/EGR2/GREM2/HOXD9/NOG/SFRP1/TULP3,7
GO:0030225,macrophage differentiation,2/157,65/18888,0.101796191615026,0.428518987100915,0.395945658905883,CEBPA/IL1RL1,2
GO:0044091,membrane biogenesis,2/157,65/18888,0.101796191615026,0.428518987100915,0.395945658905883,NLGN4X/SERINC1,2
GO:1905330,regulation of morphogenesis of an epithelium,2/157,65/18888,0.101796191615026,0.428518987100915,0.395945658905883,NOG/SFRP1,2
GO:0048562,embryonic organ morphogenesis,5/157,297/18888,0.10224055772462,0.428518987100915,0.395945658905883,FRZB/HOXD9/NOG/RUNX2/TULP3,5
GO:0032970,regulation of actin filament-based process,6/157,385/18888,0.102446168783682,0.428518987100915,0.395945658905883,C15orf62/FCHSD2/FZD10/LIMK1/PIK3R1/SFRP1,6
GO:0072175,epithelial tube formation,3/157,135/18888,0.102676268254523,0.428518987100915,0.395945658905883,NOG/SFRP1/TULP3,3
GO:0003353,positive regulation of cilium movement,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,TACR2,1
GO:0006563,L-serine metabolic process,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,CBS,1
GO:0006586,indolalkylamine metabolic process,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,HAAO,1
GO:0009068,aspartate family amino acid catabolic process,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,ASRGL1,1
GO:0009071,serine family amino acid catabolic process,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,CBS,1
GO:0009304,tRNA transcription,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,POLR3D,1
GO:0010225,response to UV-C,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,BRCA2,1
GO:0010896,regulation of triglyceride catabolic process,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,AADAC,1
GO:0014061,regulation of norepinephrine secretion,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,ADRA2A,1
GO:0015824,proline transport,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,SLC36A4,1
GO:0016446,somatic hypermutation of immunoglobulin genes,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,EXO1,1
GO:0019627,urea metabolic process,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,CEBPA,1
GO:0031272,regulation of pseudopodium assembly,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,C15orf62,1
GO:0031274,positive regulation of pseudopodium assembly,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,C15orf62,1
GO:0033604,negative regulation of catecholamine secretion,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,ADRA2A,1
GO:0036006,cellular response to macrophage colony-stimulating factor stimulus,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,PDE1B,1
GO:0042492,gamma-delta T cell differentiation,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,KLRC1,1
GO:0043301,negative regulation of leukocyte degranulation,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,IL13RA2,1
GO:0043650,dicarboxylic acid biosynthetic process,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,HAAO,1
GO:0045986,negative regulation of smooth muscle contraction,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,ADRA2A,1
GO:0051280,negative regulation of release of sequestered calcium ion into cytosol,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,CLIC2,1
GO:0061430,bone trabecula morphogenesis,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,SFRP1,1
GO:0061517,macrophage proliferation,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,CLU,1
GO:0070914,UV-damage excision repair,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,H2AC25,1
GO:0071941,nitrogen cycle metabolic process,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,CEBPA,1
GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,PIK3R1,1
GO:1900115,extracellular regulation of signal transduction,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,GREM2,1
GO:1900116,extracellular negative regulation of signal transduction,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,GREM2,1
GO:1905907,negative regulation of amyloid fibril formation,1/157,13/18888,0.10286081083111,0.428518987100915,0.395945658905883,CLU,1
GO:0016445,somatic diversification of immunoglobulins,2/157,66/18888,0.104427348767908,0.428518987100915,0.395945658905883,EXO1/NSD2,2
GO:0050771,negative regulation of axonogenesis,2/157,66/18888,0.104427348767908,0.428518987100915,0.395945658905883,SEMA4A/SEMA6D,2
GO:0050994,regulation of lipid catabolic process,2/157,66/18888,0.104427348767908,0.428518987100915,0.395945658905883,AADAC/ADRA2A,2
GO:0051898,negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,2/157,66/18888,0.104427348767908,0.428518987100915,0.395945658905883,PIK3IP1/PKHD1,2
GO:1901888,regulation of cell junction assembly,4/157,215/18888,0.104723221787428,0.428518987100915,0.395945658905883,ADGRB1/SEMA4A/SFRP1/SNAP25,4
GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,6/157,388/18888,0.105290997349926,0.428518987100915,0.395945658905883,BMPR1B/GREM2/NOG/ONECUT2/RUNX2/SFRP1,6
GO:0002064,epithelial cell development,4/157,216/18888,0.106047917404503,0.428518987100915,0.395945658905883,CEBPA/FRZB/ONECUT2/PKHD1,4
GO:0090288,negative regulation of cellular response to growth factor stimulus,3/157,137/18888,0.10610485721899,0.428518987100915,0.395945658905883,GREM2/NOG/SFRP1,3
GO:0008652,amino acid biosynthetic process,2/157,67/18888,0.107076984217265,0.428518987100915,0.395945658905883,CBS/SLC1A3,2
GO:0045143,homologous chromosome segregation,2/157,67/18888,0.107076984217265,0.428518987100915,0.395945658905883,ESPL1/SHOC1,2
GO:0034728,nucleosome organization,3/157,138/18888,0.107835927579224,0.428518987100915,0.395945658905883,H2AC25/H2BC4/H2BC8,3
GO:1903829,positive regulation of protein localization,7/157,483/18888,0.108631843827357,0.428518987100915,0.395945658905883,GPR68/GPSM2/MYOM1/PIK3R1/SNAP25/SYBU/ZFAND1,7
GO:0045637,regulation of myeloid cell differentiation,4/157,218/18888,0.108720215646038,0.428518987100915,0.395945658905883,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:1903046,meiotic cell cycle process,4/157,218/18888,0.108720215646038,0.428518987100915,0.395945658905883,BRCA2/ESPL1/HSPA2/SHOC1,4
GO:1902903,regulation of supramolecular fiber organization,6/157,392/18888,0.109147895349948,0.428518987100915,0.395945658905883,C15orf62/CLU/FCHSD2/LIMK1/PIK3R1/SFRP1,6
GO:1903131,mononuclear cell differentiation,7/157,484/18888,0.109500340204285,0.428518987100915,0.395945658905883,GPR68/KLRC1/PDE1B/PIK3R1/RUNX2/SEMA4A/SFRP1,7
GO:0002704,negative regulation of leukocyte mediated immunity,2/157,68/18888,0.109744614012599,0.428518987100915,0.395945658905883,IL13RA2/KLRC1,2
GO:0045668,negative regulation of osteoblast differentiation,2/157,68/18888,0.109744614012599,0.428518987100915,0.395945658905883,NOG/SFRP1,2
GO:0051926,negative regulation of calcium ion transport,2/157,68/18888,0.109744614012599,0.428518987100915,0.395945658905883,ADRA2A/CLIC2,2
GO:0150116,regulation of cell-substrate junction organization,2/157,68/18888,0.109744614012599,0.428518987100915,0.395945658905883,PIK3R1/SFRP1,2
GO:0009952,anterior/posterior pattern specification,4/157,219/18888,0.110067731066269,0.428518987100915,0.395945658905883,HOXD9/NOG/SFRP1/TULP3,4
GO:0000722,telomere maintenance via recombination,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,BRCA2,1
GO:0001833,inner cell mass cell proliferation,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,BRCA2,1
GO:0002566,somatic diversification of immune receptors via somatic mutation,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,EXO1,1
GO:0007638,mechanosensory behavior,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,SLC1A3,1
GO:0009950,dorsal/ventral axis specification,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,SFRP1,1
GO:0014733,regulation of skeletal muscle adaptation,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,GTF2IRD1,1
GO:0042541,hemoglobin biosynthetic process,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,SLC25A37,1
GO:0045842,positive regulation of mitotic metaphase/anaphase transition,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,ESPL1,1
GO:0048243,norepinephrine secretion,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,ADRA2A,1
GO:0050667,homocysteine metabolic process,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,CBS,1
GO:0051127,positive regulation of actin nucleation,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,FCHSD2,1
GO:0061469,regulation of type B pancreatic cell proliferation,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,SFRP1,1
GO:0070365,hepatocyte differentiation,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,FRZB,1
GO:0071285,cellular response to lithium ion,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,CEBPA,1
GO:0071415,cellular response to purine-containing compound,1/157,14/18888,0.110323107662872,0.428518987100915,0.395945658905883,TMEM38A,1
GO:0008360,regulation of cell shape,3/157,140/18888,0.111331042259866,0.428518987100915,0.395945658905883,C15orf62/FGD5/SEMA4A,3
GO:0043467,regulation of generation of precursor metabolites and energy,3/157,140/18888,0.111331042259866,0.428518987100915,0.395945658905883,NOS2/POMC/PPP1R3F,3
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,2/157,69/18888,0.112429760878297,0.428518987100915,0.395945658905883,KLRC1/NOS2,2
GO:0019731,antibacterial humoral response,2/157,69/18888,0.112429760878297,0.428518987100915,0.395945658905883,H2BC4/H2BC8,2
GO:0010810,regulation of cell-substrate adhesion,4/157,221/18888,0.112785273270731,0.428518987100915,0.395945658905883,ONECUT2/PIK3R1/PKHD1/SFRP1,4
GO:0099003,vesicle-mediated transport in synapse,4/157,221/18888,0.112785273270731,0.428518987100915,0.395945658905883,NLGN4X/RIMS1/SNAP25/SV2A,4
GO:0048608,reproductive structure development,5/157,307/18888,0.11337179876083,0.428518987100915,0.395945658905883,BMPR1B/BRCA2/CYP7B1/NOG/SFRP1,5
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,2/157,70/18888,0.115131954137297,0.428518987100915,0.395945658905883,EXO1/NSD2,2
GO:0016444,somatic cell DNA recombination,2/157,70/18888,0.115131954137297,0.428518987100915,0.395945658905883,EXO1/NSD2,2
GO:0043627,response to estrogen,2/157,70/18888,0.115131954137297,0.428518987100915,0.395945658905883,CLDN18/SFRP1,2
GO:0050922,negative regulation of chemotaxis,2/157,70/18888,0.115131954137297,0.428518987100915,0.395945658905883,SEMA4A/SEMA6D,2
GO:0071479,cellular response to ionizing radiation,2/157,70/18888,0.115131954137297,0.428518987100915,0.395945658905883,BRCA2/SFRP1,2
GO:0001889,liver development,3/157,143/18888,0.116654404440931,0.428518987100915,0.395945658905883,CEBPA/FRZB/ONECUT2,3
GO:0002440,production of molecular mediator of immune response,5/157,310/18888,0.116821229891455,0.428518987100915,0.395945658905883,CD22/EXO1/IGKV2D-28/IL13RA2/NSD2,5
GO:0050808,synapse organization,7/157,493/18888,0.117483977324704,0.428518987100915,0.395945658905883,ADGRB1/CNKSR2/NEFH/NLGN4X/SEMA4A/SNAP25/SYBU,7
GO:0001325,formation of extrachromosomal circular DNA,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,EXO1,1
GO:0001711,endodermal cell fate commitment,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,POU5F1,1
GO:0006271,DNA strand elongation involved in DNA replication,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,MCM4,1
GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,BRCA2,1
GO:0014029,neural crest formation,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,SFRP1,1
GO:0016558,protein import into peroxisome matrix,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,PEX12,1
GO:0030174,regulation of DNA-templated DNA replication initiation,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,MCM4,1
GO:0031000,response to caffeine,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,TMEM38A,1
GO:0033147,negative regulation of intracellular estrogen receptor signaling pathway,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,CYP7B1,1
GO:0033599,regulation of mammary gland epithelial cell proliferation,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,BRCA2,1
GO:0033689,negative regulation of osteoblast proliferation,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,SFRP1,1
GO:0042249,establishment of planar polarity of embryonic epithelium,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,SFRP1,1
GO:0043652,engulfment of apoptotic cell,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,ADGRB1,1
GO:0048681,negative regulation of axon regeneration,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,RTCA,1
GO:0051284,positive regulation of sequestering of calcium ion,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,CLIC2,1
GO:0051444,negative regulation of ubiquitin-protein transferase activity,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,LIMK1,1
GO:0060413,atrial septum morphogenesis,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,NSD2,1
GO:0060572,morphogenesis of an epithelial bud,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,NOG,1
GO:0060766,negative regulation of androgen receptor signaling pathway,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,SFRP1,1
GO:0061684,chaperone-mediated autophagy,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,CLU,1
GO:0072498,embryonic skeletal joint development,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,NOG,1
GO:0090656,t-circle formation,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,EXO1,1
GO:0090737,telomere maintenance via telomere trimming,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,EXO1,1
GO:0099509,regulation of presynaptic cytosolic calcium ion concentration,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,CALB2,1
GO:1901741,positive regulation of myoblast fusion,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,ADGRB1,1
GO:1902101,positive regulation of metaphase/anaphase transition of cell cycle,1/157,15/18888,0.117723726084877,0.428518987100915,0.395945658905883,ESPL1,1
GO:0003208,cardiac ventricle morphogenesis,2/157,71/18888,0.117850729635541,0.428518987100915,0.395945658905883,MYL3/NOG,2
GO:0019933,cAMP-mediated signaling,2/157,71/18888,0.117850729635541,0.428518987100915,0.395945658905883,PDE1B/POMC,2
GO:0061458,reproductive system development,5/157,311/18888,0.117982123401899,0.428518987100915,0.395945658905883,BMPR1B/BRCA2/CYP7B1/NOG/SFRP1,5
GO:0046887,positive regulation of hormone secretion,3/157,144/18888,0.118449908294492,0.428518987100915,0.395945658905883,GPR68/SNAP25/SYBU,3
GO:0051047,positive regulation of secretion,5/157,312/18888,0.119148520182902,0.428518987100915,0.395945658905883,GPR68/MYOM1/SNAP25/SYBU/TACR2,5
GO:0015918,sterol transport,3/157,145/18888,0.120255741370777,0.428518987100915,0.395945658905883,ABCA8/CEL/CLU,3
GO:0071333,cellular response to glucose stimulus,3/157,145/18888,0.120255741370777,0.428518987100915,0.395945658905883,ADRA2A/GPR68/SYBU,3
GO:0090090,negative regulation of canonical Wnt signaling pathway,3/157,145/18888,0.120255741370777,0.428518987100915,0.395945658905883,FRZB/NOG/SFRP1,3
GO:0032413,negative regulation of ion transmembrane transporter activity,2/157,72/18888,0.120585629667216,0.428518987100915,0.395945658905883,ADRA2A/CLIC2,2
GO:0060411,cardiac septum morphogenesis,2/157,72/18888,0.120585629667216,0.428518987100915,0.395945658905883,NOG/NSD2,2
GO:0140895,cell surface toll-like receptor signaling pathway,2/157,72/18888,0.120585629667216,0.428518987100915,0.395945658905883,PIK3R1/TNIP3,2
GO:0010977,negative regulation of neuron projection development,3/157,146/18888,0.12207178588865,0.428518987100915,0.395945658905883,RTCA/SEMA4A/SEMA6D,3
GO:0030177,positive regulation of Wnt signaling pathway,3/157,146/18888,0.12207178588865,0.428518987100915,0.395945658905883,PLEKHA4/SFRP1/TMEM198,3
GO:0045598,regulation of fat cell differentiation,3/157,146/18888,0.12207178588865,0.428518987100915,0.395945658905883,CEBPA/FRZB/SFRP1,3
GO:0061008,hepaticobiliary system development,3/157,146/18888,0.12207178588865,0.428518987100915,0.395945658905883,CEBPA/FRZB/ONECUT2,3
GO:0006801,superoxide metabolic process,2/157,73/18888,0.123336202900784,0.428518987100915,0.395945658905883,CBS/NOS2,2
GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,2/157,73/18888,0.123336202900784,0.428518987100915,0.395945658905883,CYP7B1/SFRP1,2
GO:0045109,intermediate filament organization,2/157,73/18888,0.123336202900784,0.428518987100915,0.395945658905883,NEFH/TCHH,2
GO:0170041,non-proteinogenic amino acid metabolic process,2/157,73/18888,0.123336202900784,0.428518987100915,0.395945658905883,CBS/SLC1A3,2
GO:0000463,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,BOP1,1
GO:0002756,MyD88-independent toll-like receptor signaling pathway,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,TNIP3,1
GO:0003188,heart valve formation,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,OLFM1,1
GO:0006369,termination of RNA polymerase II transcription,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,TTF2,1
GO:0010226,response to lithium ion,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,CEBPA,1
GO:0010273,detoxification of copper ion,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,MT1F,1
GO:0017014,protein nitrosylation,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,NOS2,1
GO:0018119,peptidyl-cysteine S-nitrosylation,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,NOS2,1
GO:0021904,dorsal/ventral neural tube patterning,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,TULP3,1
GO:0030299,intestinal cholesterol absorption,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,CEL,1
GO:0030810,positive regulation of nucleotide biosynthetic process,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,NOS2,1
GO:0031269,pseudopodium assembly,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,C15orf62,1
GO:0042772,"DNA damage response, signal transduction resulting in transcription",1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,BRCA2,1
GO:0045779,negative regulation of bone resorption,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,CLDN18,1
GO:0048712,negative regulation of astrocyte differentiation,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,NOG,1
GO:0050665,hydrogen peroxide biosynthetic process,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,MAOB,1
GO:0051044,positive regulation of membrane protein ectodomain proteolysis,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,ADRA2A,1
GO:0060044,negative regulation of cardiac muscle cell proliferation,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,NOG,1
GO:0070571,negative regulation of neuron projection regeneration,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,RTCA,1
GO:0071380,cellular response to prostaglandin E stimulus,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,SFRP1,1
GO:0072378,"blood coagulation, fibrin clot formation",1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,F8,1
GO:0098969,neurotransmitter receptor transport to postsynaptic membrane,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,SNAP25,1
GO:1900373,positive regulation of purine nucleotide biosynthetic process,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,NOS2,1
GO:1904948,midbrain dopaminergic neuron differentiation,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,SFRP1,1
GO:1990169,stress response to copper ion,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,MT1F,1
GO:2000846,regulation of corticosteroid hormone secretion,1/157,16/18888,0.125063172648999,0.428518987100915,0.395945658905883,POMC,1
GO:0071331,cellular response to hexose stimulus,3/157,148/18888,0.125734037059392,0.428518987100915,0.395945658905883,ADRA2A/GPR68/SYBU,3
GO:0003281,ventricular septum development,2/157,74/18888,0.126102004305767,0.428518987100915,0.395945658905883,NOG/NSD2,2
GO:0042273,ribosomal large subunit biogenesis,2/157,74/18888,0.126102004305767,0.428518987100915,0.395945658905883,BOP1/HEATR3,2
GO:0050709,negative regulation of protein secretion,2/157,74/18888,0.126102004305767,0.428518987100915,0.395945658905883,ADRA2A/SFRP1,2
GO:0060415,muscle tissue morphogenesis,2/157,74/18888,0.126102004305767,0.428518987100915,0.395945658905883,MYL3/NOG,2
GO:0070373,negative regulation of ERK1 and ERK2 cascade,2/157,74/18888,0.126102004305767,0.428518987100915,0.395945658905883,CNKSR3/SYNJ2BP,2
GO:1902475,L-alpha-amino acid transmembrane transport,2/157,74/18888,0.126102004305767,0.428518987100915,0.395945658905883,SLC1A3/SLC36A4,2
GO:1904377,positive regulation of protein localization to cell periphery,2/157,74/18888,0.126102004305767,0.428518987100915,0.395945658905883,GPSM2/PIK3R1,2
GO:0035148,tube formation,3/157,149/18888,0.12758000715422,0.428518987100915,0.395945658905883,NOG/SFRP1/TULP3,3
GO:0050768,negative regulation of neurogenesis,3/157,149/18888,0.12758000715422,0.428518987100915,0.395945658905883,NOG/SEMA4A/SEMA6D,3
GO:0005977,glycogen metabolic process,2/157,75/18888,0.128882595080308,0.428518987100915,0.395945658905883,POMC/PPP1R3F,2
GO:0051298,centrosome duplication,2/157,75/18888,0.128882595080308,0.428518987100915,0.395945658905883,BRCA2/PKHD1,2
GO:0061077,chaperone-mediated protein folding,2/157,75/18888,0.128882595080308,0.428518987100915,0.395945658905883,CLU/HSPA2,2
GO:1901019,regulation of calcium ion transmembrane transporter activity,2/157,75/18888,0.128882595080308,0.428518987100915,0.395945658905883,ADRA2A/CLIC2,2
GO:0002705,positive regulation of leukocyte mediated immunity,3/157,150/18888,0.129435715619793,0.428518987100915,0.395945658905883,KLRC1/NOS2/NSD2,3
GO:0016331,morphogenesis of embryonic epithelium,3/157,150/18888,0.129435715619793,0.428518987100915,0.395945658905883,NOG/SFRP1/TULP3,3
GO:0071326,cellular response to monosaccharide stimulus,3/157,150/18888,0.129435715619793,0.428518987100915,0.395945658905883,ADRA2A/GPR68/SYBU,3
GO:0002200,somatic diversification of immune receptors,2/157,76/18888,0.131677542579488,0.428518987100915,0.395945658905883,EXO1/NSD2,2
GO:0031343,positive regulation of cell killing,2/157,76/18888,0.131677542579488,0.428518987100915,0.395945658905883,KLRC1/NOS2,2
GO:0000097,sulfur amino acid biosynthetic process,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,CBS,1
GO:0000479,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,BOP1,1
GO:0000712,resolution of meiotic recombination intermediates,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,SHOC1,1
GO:0001956,positive regulation of neurotransmitter secretion,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,TACR2,1
GO:0002076,osteoblast development,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,RUNX2,1
GO:0006570,tyrosine metabolic process,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,FAH,1
GO:0007063,regulation of sister chromatid cohesion,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,ESPL1,1
GO:0021783,preganglionic parasympathetic fiber development,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,EGR2,1
GO:0030322,stabilization of membrane potential,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,KCNK12,1
GO:0031268,pseudopodium organization,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,C15orf62,1
GO:0031643,positive regulation of myelination,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,EGR2,1
GO:0032310,prostaglandin secretion,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,NOS2,1
GO:0034035,purine ribonucleoside bisphosphate metabolic process,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,SULT2B1,1
GO:0035821,modulation of process of another organism,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,NOS2,1
GO:0036005,response to macrophage colony-stimulating factor,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,PDE1B,1
GO:0043129,surfactant homeostasis,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,SFTPD,1
GO:0048532,anatomical structure arrangement,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,EGR2,1
GO:0050427,3'-phosphoadenosine 5'-phosphosulfate metabolic process,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,SULT2B1,1
GO:0050872,white fat cell differentiation,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,CEBPA,1
GO:0051412,response to corticosterone,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,MAOB,1
GO:0051788,response to misfolded protein,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,CLU,1
GO:0060080,inhibitory postsynaptic potential,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,RIMS1,1
GO:0061548,ganglion development,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,TULP3,1
GO:0071816,tail-anchored membrane protein insertion into ER membrane,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,MMGT1,1
GO:0097428,protein maturation by iron-sulfur cluster transfer,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,YAE1,1
GO:0098712,L-glutamate import across plasma membrane,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,SLC1A3,1
GO:0098877,neurotransmitter receptor transport to plasma membrane,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,SNAP25,1
GO:0170043,non-proteinogenic amino acid biosynthetic process,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,SLC1A3,1
GO:1902033,regulation of hematopoietic stem cell proliferation,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,CEBPA,1
GO:1903540,establishment of protein localization to postsynaptic membrane,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,SNAP25,1
GO:1903830,magnesium ion transmembrane transport,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,MMGT1,1
GO:1904889,regulation of excitatory synapse assembly,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,SEMA4A,1
GO:1905906,regulation of amyloid fibril formation,1/157,17/18888,0.132341949773528,0.428518987100915,0.395945658905883,CLU,1
GO:0035966,response to topologically incorrect protein,3/157,152/18888,0.133175872992738,0.430643477154087,0.397908658537784,CLU/HSPA2/PIK3R1,3
GO:0006809,nitric oxide biosynthetic process,2/157,77/18888,0.134486420244389,0.432571194995896,0.399689843348809,CLU/NOS2,2
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,2/157,77/18888,0.134486420244389,0.432571194995896,0.399689843348809,CEBPA/CLU,2
GO:0044042,glucan metabolic process,2/157,77/18888,0.134486420244389,0.432571194995896,0.399689843348809,POMC/PPP1R3F,2
GO:0055117,regulation of cardiac muscle contraction,2/157,77/18888,0.134486420244389,0.432571194995896,0.399689843348809,CLIC2/TMEM38A,2
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,6/157,417/18888,0.134858133207776,0.433191510118345,0.400263006002695,BMPR1B/GREM2/NOG/ONECUT2/RUNX2/SFRP1,6
GO:0016525,negative regulation of angiogenesis,3/157,153/18888,0.135060084321683,0.433265595002804,0.400331459418472,ADGRB1/SEMA4A/SYNJ2BP,3
GO:0009411,response to UV,3/157,154/18888,0.136953558906236,0.436712746887764,0.40351658041783,BRCA2/H2AC25/PIK3R1,3
GO:0031397,negative regulation of protein ubiquitination,2/157,78/18888,0.137308807531895,0.436712746887764,0.40351658041783,ADGRB1/LIMK1,2
GO:0051961,negative regulation of nervous system development,3/157,155/18888,0.138856177807091,0.436712746887764,0.40351658041783,NOG/SEMA4A/SEMA6D,3
GO:2000181,negative regulation of blood vessel morphogenesis,3/157,155/18888,0.138856177807091,0.436712746887764,0.40351658041783,ADGRB1/SEMA4A/SYNJ2BP,3
GO:0006825,copper ion transport,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,MMGT1,1
GO:0015693,magnesium ion transport,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,MMGT1,1
GO:0019896,axonal transport of mitochondrion,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,SYBU,1
GO:0020027,hemoglobin metabolic process,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,SLC25A37,1
GO:0032274,gonadotropin secretion,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,TACR2,1
GO:0032328,alanine transport,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,SLC36A4,1
GO:0042053,regulation of dopamine metabolic process,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,MAOB,1
GO:0042069,regulation of catecholamine metabolic process,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,MAOB,1
GO:0042481,regulation of odontogenesis,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,RUNX2,1
GO:0043117,positive regulation of vascular permeability,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,TACR2,1
GO:0043217,myelin maintenance,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,CLU,1
GO:0070200,establishment of protein localization to telomere,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,BRCA2,1
GO:0071243,cellular response to arsenic-containing substance,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,ZFAND1,1
GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,NOG,1
GO:1901970,positive regulation of mitotic sister chromatid separation,1/157,18/18888,0.139560555776684,0.436712746887764,0.40351658041783,ESPL1,1
GO:0002752,cell surface pattern recognition receptor signaling pathway,2/157,79/18888,0.140144289845239,0.436846164742817,0.403639856683571,PIK3R1/TNIP3,2
GO:0032508,DNA duplex unwinding,2/157,79/18888,0.140144289845239,0.436846164742817,0.403639856683571,GINS2/MCM4,2
GO:0045685,regulation of glial cell differentiation,2/157,79/18888,0.140144289845239,0.436846164742817,0.403639856683571,EGR2/NOG,2
GO:0050770,regulation of axonogenesis,3/157,156/18888,0.140767822060982,0.438225790529176,0.404914611962722,LIMK1/SEMA4A/SEMA6D,3
GO:0042742,defense response to bacterium,5/157,330/18888,0.141056881531052,0.43835358054925,0.405032688186234,ADGRB1/H2BC4/H2BC8/NOS2/SFTPD,5
GO:0002274,myeloid leukocyte activation,4/157,241/18888,0.141532824107974,0.43835358054925,0.405032688186234,CEBPA/CLU/IL13RA2/IL1RL1,4
GO:0007160,cell-matrix adhesion,4/157,241/18888,0.141532824107974,0.43835358054925,0.405032688186234,ONECUT2/PIK3R1/PKHD1/SFRP1,4
GO:0071356,cellular response to tumor necrosis factor,4/157,241/18888,0.141532824107974,0.43835358054925,0.405032688186234,CEBPA/CLDN18/SFRP1/TNFRSF13C,4
GO:1901343,negative regulation of vasculature development,3/157,157/18888,0.142688372700075,0.441368120919007,0.407818082086926,ADGRB1/SEMA4A/SYNJ2BP,3
GO:0002429,immune response-activating cell surface receptor signaling pathway,5/157,332/18888,0.143594353041294,0.443603983502567,0.409883988407344,CD22/KLRC1/LIMK1/PIK3R1/TNIP3,5
GO:0006865,amino acid transport,3/157,158/18888,0.144617710770971,0.443638692199357,0.409916058766497,SLC1A3/SLC36A4/SV2A,3
GO:0021915,neural tube development,3/157,158/18888,0.144617710770971,0.443638692199357,0.409916058766497,NOG/SFRP1/TULP3,3
GO:0048644,muscle organ morphogenesis,2/157,81/18888,0.145852910482414,0.443638692199357,0.409916058766497,MYL3/NOG,2
GO:0000212,meiotic spindle organization,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,ESPL1,1
GO:0001502,cartilage condensation,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,BMPR1B,1
GO:0006337,nucleosome disassembly,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,H2AC25,1
GO:0006684,sphingomyelin metabolic process,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,ABCA8,1
GO:0008356,asymmetric cell division,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,POU5F1,1
GO:0030903,notochord development,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,NOG,1
GO:0035930,corticosteroid hormone secretion,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,POMC,1
GO:0043950,positive regulation of cAMP-mediated signaling,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,POMC,1
GO:0048486,parasympathetic nervous system development,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,EGR2,1
GO:0071625,vocalization behavior,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,NLGN4X,1
GO:0072376,protein activation cascade,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,F8,1
GO:0170044,non-proteinogenic amino acid catabolic process,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,CBS,1
GO:1902074,response to salt,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,RUNX2,1
GO:1903428,positive regulation of reactive oxygen species biosynthetic process,1/157,19/18888,0.146719484909862,0.443638692199357,0.409916058766497,ADGRB1,1
GO:0006261,DNA-templated DNA replication,3/157,160/18888,0.148502273577947,0.443901239684807,0.410158649037289,BRCA2/GINS2/MCM4,3
GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,2/157,82/18888,0.148725248729433,0.443901239684807,0.410158649037289,H2BC4/H2BC8,2
GO:0140029,exocytic process,2/157,82/18888,0.148725248729433,0.443901239684807,0.410158649037289,SNAP25/SV2A,2
GO:0002703,regulation of leukocyte mediated immunity,4/157,246/18888,0.149138760825897,0.443901239684807,0.410158649037289,IL13RA2/KLRC1/NOS2/NSD2,4
GO:0022604,regulation of cell morphogenesis,4/157,246/18888,0.149138760825897,0.443901239684807,0.410158649037289,C15orf62/FGD5/RIMS1/SEMA4A,4
GO:0040013,negative regulation of locomotion,6/157,431/18888,0.150408655917651,0.443901239684807,0.410158649037289,ADGRB1/NOG/SEMA4A/SEMA6D/SFRP1/SYNJ2BP,6
GO:0071322,cellular response to carbohydrate stimulus,3/157,161/18888,0.150457260644847,0.443901239684807,0.410158649037289,ADRA2A/GPR68/SYBU,3
GO:0050871,positive regulation of B cell activation,2/157,83/18888,0.15160908171477,0.443901239684807,0.410158649037289,NSD2/TNFRSF13C,2
GO:0051279,regulation of release of sequestered calcium ion into cytosol,2/157,83/18888,0.15160908171477,0.443901239684807,0.410158649037289,CLIC2/TMEM38A,2
GO:0045444,fat cell differentiation,4/157,248/18888,0.152224847301685,0.443901239684807,0.410158649037289,CEBPA/EGR2/FRZB/SFRP1,4
GO:0120254,olefinic compound metabolic process,3/157,162/18888,0.152420559840458,0.443901239684807,0.410158649037289,CEL/HSD17B1/RDH16,3
GO:0050803,regulation of synapse structure or activity,4/157,249/18888,0.153777045920034,0.443901239684807,0.410158649037289,ADGRB1/SEMA4A/SNAP25/SYBU,4
GO:0060047,heart contraction,4/157,249/18888,0.153777045920034,0.443901239684807,0.410158649037289,CLIC2/MYL3/TMEM38A/TNNI2,4
GO:0002029,desensitization of G protein-coupled receptor signaling pathway,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,GRK3,1
GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,PEX12,1
GO:0007413,axonal fasciculation,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,NCAM2,1
GO:0009070,serine family amino acid biosynthetic process,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,CBS,1
GO:0015810,aspartate transmembrane transport,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,SLC1A3,1
GO:0015812,gamma-aminobutyric acid transport,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,SV2A,1
GO:0032098,regulation of appetite,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,POMC,1
GO:0032634,interleukin-5 production,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,IL1RL1,1
GO:0032674,regulation of interleukin-5 production,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,IL1RL1,1
GO:0038092,nodal signaling pathway,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,NOG,1
GO:0043691,reverse cholesterol transport,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,CLU,1
GO:0044241,lipid digestion,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,CEL,1
GO:0045655,regulation of monocyte differentiation,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,GPR68,1
GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,KLRC1,1
GO:0072079,nephron tubule formation,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,NOG,1
GO:0072662,protein localization to peroxisome,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,PEX12,1
GO:0072663,establishment of protein localization to peroxisome,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,PEX12,1
GO:0090201,negative regulation of release of cytochrome c from mitochondria,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,CLU,1
GO:0090308,regulation of DNA methylation-dependent heterochromatin formation,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,SAMD1,1
GO:0098856,intestinal lipid absorption,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,CEL,1
GO:0099188,postsynaptic cytoskeleton organization,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,NEFH,1
GO:0106030,neuron projection fasciculation,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,NCAM2,1
GO:1900221,regulation of amyloid-beta clearance,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,CLU,1
GO:1901739,regulation of myoblast fusion,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,ADGRB1,1
GO:1902004,positive regulation of amyloid-beta formation,1/157,20/18888,0.153819227390605,0.443901239684807,0.410158649037289,CLU,1
GO:0030307,positive regulation of cell growth,3/157,163/18888,0.154392052554821,0.443901239684807,0.410158649037289,LIMK1/RIMS1/SFRP1,3
GO:0001523,retinoid metabolic process,2/157,84/18888,0.154504023556685,0.443901239684807,0.410158649037289,CEL/RDH16,2
GO:0046209,nitric oxide metabolic process,2/157,84/18888,0.154504023556685,0.443901239684807,0.410158649037289,CLU/NOS2,2
GO:1905897,regulation of response to endoplasmic reticulum stress,2/157,84/18888,0.154504023556685,0.443901239684807,0.410158649037289,CLU/PIK3R1,2
GO:1902850,microtubule cytoskeleton organization involved in mitosis,3/157,164/18888,0.156371620298262,0.448734673415154,0.414624675422929,ESPL1/GPSM2/PKHD1,3
GO:0030111,regulation of Wnt signaling pathway,5/157,342/18888,0.156574907865502,0.448786303964788,0.41467238134171,FRZB/NOG/PLEKHA4/SFRP1/TMEM198,5
GO:0007492,endoderm development,2/157,85/18888,0.157409693918048,0.44958287578952,0.415408402767838,NOG/POU5F1,2
GO:0032392,DNA geometric change,2/157,85/18888,0.157409693918048,0.44958287578952,0.415408402767838,GINS2/MCM4,2
GO:2001057,reactive nitrogen species metabolic process,2/157,85/18888,0.157409693918048,0.44958287578952,0.415408402767838,CLU/NOS2,2
GO:0060537,muscle tissue development,6/157,438/18888,0.158475981764133,0.45209520357212,0.417729759135263,EGR2/HOXD9/HSD17B1/MYL3/MYOM1/NOG,6
GO:0008654,phospholipid biosynthetic process,4/157,253/18888,0.160045628958821,0.452501245728624,0.418104936511388,ABCA8/MTMR7/PIK3R1/SERINC1,4
GO:0002716,negative regulation of natural killer cell mediated immunity,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,KLRC1,1
GO:0022401,negative adaptation of signaling pathway,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,GRK3,1
GO:0032986,protein-DNA complex disassembly,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,H2AC25,1
GO:0042474,middle ear morphogenesis,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,NOG,1
GO:0045056,transcytosis,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,PIGR,1
GO:0050849,negative regulation of calcium-mediated signaling,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,CD22,1
GO:0071379,cellular response to prostaglandin stimulus,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,SFRP1,1
GO:0090189,regulation of branching involved in ureteric bud morphogenesis,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,NOG,1
GO:0097501,stress response to metal ion,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,MT1F,1
GO:1901317,regulation of flagellated sperm motility,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,TACR2,1
GO:2000001,regulation of DNA damage checkpoint,1/157,21/18888,0.16086026943532,0.452501245728624,0.418104936511388,BRCA2,1
GO:0006665,sphingolipid metabolic process,3/157,167/18888,0.162357590951279,0.456183393600926,0.421507190575674,ABCA8/CEL/SERINC1,3
GO:0002312,B cell activation involved in immune response,2/157,87/18888,0.1632517261872,0.456576998643646,0.421870876229472,EXO1/NSD2,2
GO:0008543,fibroblast growth factor receptor signaling pathway,2/157,87/18888,0.1632517261872,0.456576998643646,0.421870876229472,NOG/RUNX2,2
GO:0015844,monoamine transport,2/157,87/18888,0.1632517261872,0.456576998643646,0.421870876229472,ADRA2A/MAOB,2
GO:0034103,regulation of tissue remodeling,2/157,87/18888,0.1632517261872,0.456576998643646,0.421870876229472,CLDN18/SFRP1,2
GO:0003205,cardiac chamber development,3/157,168/18888,0.164368276884494,0.458640514532539,0.423777536570984,MYL3/NOG/NSD2,3
GO:1903169,regulation of calcium ion transmembrane transport,3/157,168/18888,0.164368276884494,0.458640514532539,0.423777536570984,ADRA2A/CLIC2/TMEM38A,3
GO:0006887,exocytosis,5/157,348/18888,0.164589413815108,0.458729068193545,0.42385935893758,ADRA2A/IL13RA2/RIMS1/SNAP25/SV2A,5
GO:0001832,blastocyst growth,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,BRCA2,1
GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,LIMK1,1
GO:0003228,atrial cardiac muscle tissue development,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,NOG,1
GO:0006883,intracellular sodium ion homeostasis,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,SLC1A3,1
GO:0015919,peroxisomal membrane transport,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,PEX12,1
GO:0032148,activation of protein kinase B activity,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,ADRA2A,1
GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,LIMK1,1
GO:0042953,lipoprotein transport,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,CUBN,1
GO:0043249,erythrocyte maturation,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,HEATR3,1
GO:0043574,peroxisomal transport,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,PEX12,1
GO:0051923,sulfation,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,SULT2B1,1
GO:0061687,detoxification of inorganic compound,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,MT1F,1
GO:0071305,cellular response to vitamin D,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,SFRP1,1
GO:0090208,positive regulation of triglyceride metabolic process,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,AADAC,1
GO:1902018,negative regulation of cilium assembly,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,WDR44,1
GO:2000831,regulation of steroid hormone secretion,1/157,22/18888,0.167843093291718,0.458765118528732,0.423892668952185,POMC,1
GO:0006959,humoral immune response,4/157,258/18888,0.168011833251439,0.458765118528732,0.423892668952185,CLU/EXO1/H2BC4/H2BC8,4
GO:0032886,regulation of microtubule-based process,4/157,258/18888,0.168011833251439,0.458765118528732,0.423892668952185,GPSM2/NEFH/PKHD1/TACR2,4
GO:0006112,energy reserve metabolic process,2/157,89/18888,0.16913224428256,0.459751173571672,0.424803770269622,POMC/PPP1R3F,2
GO:0016101,diterpenoid metabolic process,2/157,89/18888,0.16913224428256,0.459751173571672,0.424803770269622,CEL/RDH16,2
GO:0050829,defense response to Gram-negative bacterium,2/157,89/18888,0.16913224428256,0.459751173571672,0.424803770269622,ADGRB1/NOS2,2
GO:0072384,organelle transport along microtubule,2/157,89/18888,0.16913224428256,0.459751173571672,0.424803770269622,NEFH/SYBU,2
GO:0003015,heart process,4/157,260/18888,0.1712375096604,0.461335387872978,0.426267562526816,CLIC2/MYL3/TMEM38A/TNNI2,4
GO:0034644,cellular response to UV,2/157,90/18888,0.172086041767019,0.461335387872978,0.426267562526816,H2AC25/PIK3R1,2
GO:0046849,bone remodeling,2/157,90/18888,0.172086041767019,0.461335387872978,0.426267562526816,CLDN18/SFRP1,2
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,2/157,90/18888,0.172086041767019,0.461335387872978,0.426267562526816,ADGRB1/LIMK1,2
GO:1903522,regulation of blood circulation,4/157,262/18888,0.174484924158434,0.461335387872978,0.426267562526816,ADRA2A/CLIC2/MYL3/TMEM38A,4
GO:0050680,negative regulation of epithelial cell proliferation,3/157,173/18888,0.174531635470165,0.461335387872978,0.426267562526816,BRCA2/SFRP1/SYNJ2BP,3
GO:0002223,stimulatory C-type lectin receptor signaling pathway,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,KLRC1,1
GO:0003283,atrial septum development,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,NSD2,1
GO:0006658,phosphatidylserine metabolic process,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,SERINC1,1
GO:0006837,serotonin transport,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,MAOB,1
GO:0015874,norepinephrine transport,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,ADRA2A,1
GO:0016338,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,CLDN18,1
GO:0021533,cell differentiation in hindbrain,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,NOG,1
GO:0031629,synaptic vesicle fusion to presynaptic active zone membrane,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,SNAP25,1
GO:0035493,SNARE complex assembly,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,SNAP25,1
GO:0044872,lipoprotein localization,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,CUBN,1
GO:0045063,T-helper 1 cell differentiation,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,SEMA4A,1
GO:0045932,negative regulation of muscle contraction,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,ADRA2A,1
GO:0051131,chaperone-mediated protein complex assembly,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,CLU,1
GO:0051590,positive regulation of neurotransmitter transport,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,TACR2,1
GO:0060143,positive regulation of syncytium formation by plasma membrane fusion,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,ADGRB1,1
GO:0097164,ammonium ion metabolic process,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,PDE1B,1
GO:0098743,cell aggregation,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,BMPR1B,1
GO:1990840,response to lectin,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,KLRC1,1
GO:1990858,cellular response to lectin,1/157,23/18888,0.174768177271003,0.461335387872978,0.426267562526816,KLRC1,1
GO:0030901,midbrain development,2/157,91/18888,0.17504839861902,0.461335387872978,0.426267562526816,MAOB/SFRP1,2
GO:0032273,positive regulation of protein polymerization,2/157,91/18888,0.17504839861902,0.461335387872978,0.426267562526816,C15orf62/FCHSD2,2
GO:0033273,response to vitamin,2/157,91/18888,0.17504839861902,0.461335387872978,0.426267562526816,CBS/SFRP1,2
GO:0034612,response to tumor necrosis factor,4/157,263/18888,0.176116645168793,0.463646211520453,0.428402731840794,CEBPA/CLDN18/SFRP1/TNFRSF13C,4
GO:0034329,cell junction assembly,6/157,453/18888,0.176382318217684,0.46384144921089,0.428583128785411,ADGRB1/CLDN18/NLGN4X/SEMA4A/SFRP1/SNAP25,6
GO:0072594,establishment of protein localization to organelle,6/157,454/18888,0.177604897269513,0.466019472223174,0.430595592136324,BRCA2/CLU/HEATR3/LAMP5/PEX12/PIK3R1,6
GO:0071103,DNA conformation change,2/157,92/18888,0.178018971544715,0.466019472223174,0.430595592136324,GINS2/MCM4,2
GO:1904063,negative regulation of cation transmembrane transport,2/157,92/18888,0.178018971544715,0.466019472223174,0.430595592136324,ADRA2A/CLIC2,2
GO:0048568,embryonic organ development,6/157,455/18888,0.17883096464976,0.466019472223174,0.430595592136324,CEBPA/FRZB/HOXD9/NOG/RUNX2/TULP3,6
GO:0000724,double-strand break repair via homologous recombination,3/157,176/18888,0.180713388013941,0.466019472223174,0.430595592136324,BRCA2/GINS2/MCM4,3
GO:0015807,L-amino acid transport,2/157,93/18888,0.180997422297345,0.466019472223174,0.430595592136324,SLC1A3/SLC36A4,2
GO:0045132,meiotic chromosome segregation,2/157,93/18888,0.180997422297345,0.466019472223174,0.430595592136324,ESPL1/SHOC1,2
GO:0050886,endocrine process,2/157,93/18888,0.180997422297345,0.466019472223174,0.430595592136324,POMC/TACR2,2
GO:0031346,positive regulation of cell projection organization,5/157,360/18888,0.181096737461044,0.466019472223174,0.430595592136324,C15orf62/LIMK1/MIEN1/PIK3R1/PPP2R5B,5
GO:0000027,ribosomal large subunit assembly,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,BOP1,1
GO:0007130,synaptonemal complex assembly,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,SHOC1,1
GO:0014821,phasic smooth muscle contraction,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,TACR2,1
GO:0023058,adaptation of signaling pathway,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,GRK3,1
GO:0031145,anaphase-promoting complex-dependent catabolic process,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,ANAPC13,1
GO:0032528,microvillus organization,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,GLDN,1
GO:0034695,response to prostaglandin E,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,SFRP1,1
GO:0050855,regulation of B cell receptor signaling pathway,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,CD22,1
GO:0060571,morphogenesis of an epithelial fold,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,NOG,1
GO:0071294,cellular response to zinc ion,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,MT1F,1
GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,ADRA2A,1
GO:0090103,cochlea morphogenesis,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,FRZB,1
GO:0099500,vesicle fusion to plasma membrane,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,SNAP25,1
GO:1903861,positive regulation of dendrite extension,1/157,24/18888,0.1816359957798,0.466019472223174,0.430595592136324,RIMS1,1
GO:0030178,negative regulation of Wnt signaling pathway,3/157,177/18888,0.182787231527497,0.468476904507512,0.432866225817276,FRZB/NOG/SFRP1,3
GO:0042176,regulation of protein catabolic process,5/157,362/18888,0.183907029636981,0.469555150127201,0.433862509961506,ADGRB1/ADRA2A/CEBPA/CLU/NOS2,5
GO:0043648,dicarboxylic acid metabolic process,2/157,94/18888,0.183983417617966,0.469555150127201,0.433862509961506,HAAO/ME3,2
GO:0045104,intermediate filament cytoskeleton organization,2/157,94/18888,0.183983417617966,0.469555150127201,0.433862509961506,NEFH/TCHH,2
GO:1901874,negative regulation of post-translational protein modification,2/157,94/18888,0.183983417617966,0.469555150127201,0.433862509961506,ADGRB1/LIMK1,2
GO:0003007,heart morphogenesis,4/157,269/18888,0.186015668217335,0.471506901725317,0.435665901633284,MYL3/NOG/NSD2/OLFM1,4
GO:1903034,regulation of response to wounding,3/157,179/18888,0.186954115621481,0.471506901725317,0.435665901633284,ADRA2A/PROS1/RTCA,3
GO:0043279,response to alkaloid,2/157,95/18888,0.186976629176802,0.471506901725317,0.435665901633284,SLC1A3/TMEM38A,2
GO:0045103,intermediate filament-based process,2/157,95/18888,0.186976629176802,0.471506901725317,0.435665901633284,NEFH/TCHH,2
GO:0060395,SMAD protein signal transduction,2/157,95/18888,0.186976629176802,0.471506901725317,0.435665901633284,NOG/RUNX2,2
GO:0090316,positive regulation of intracellular protein transport,2/157,95/18888,0.186976629176802,0.471506901725317,0.435665901633284,PIK3R1/ZFAND1,2
GO:0051051,negative regulation of transport,6/157,462/18888,0.187509359319009,0.471506901725317,0.435665901633284,ADRA2A/CLIC2/IL13RA2/MAOB/SFRP1/TACR2,6
GO:0000466,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,BOP1,1
GO:0002070,epithelial cell maturation,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,CEBPA,1
GO:0006312,mitotic recombination,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,BRCA2,1
GO:0016973,poly(A)+ mRNA export from nucleus,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,DDX19A,1
GO:0031445,regulation of heterochromatin formation,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,SAMD1,1
GO:0043501,skeletal muscle adaptation,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,GTF2IRD1,1
GO:0046514,ceramide catabolic process,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,CEL,1
GO:0048011,neurotrophin TRK receptor signaling pathway,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,PPP2R5B,1
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,CLIC2,1
GO:0060396,growth hormone receptor signaling pathway,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,PIK3R1,1
GO:0120261,regulation of heterochromatin organization,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,SAMD1,1
GO:1902993,positive regulation of amyloid precursor protein catabolic process,1/157,25/18888,0.188447019351819,0.471506901725317,0.435665901633284,CLU,1
GO:0035265,organ growth,3/157,180/18888,0.189046926713556,0.472519769350087,0.436601777408094,CLDN18/NLGN4X/NOG,3
GO:0001910,regulation of leukocyte mediated cytotoxicity,2/157,96/18888,0.189976733515216,0.473378239273512,0.437394991827323,KLRC1/NOS2,2
GO:0032410,negative regulation of transporter activity,2/157,96/18888,0.189976733515216,0.473378239273512,0.437394991827323,ADRA2A/CLIC2,2
GO:0072091,regulation of stem cell proliferation,2/157,96/18888,0.189976733515216,0.473378239273512,0.437394991827323,CEBPA/RUNX2,2
GO:0000725,recombinational repair,3/157,181/18888,0.191145831424281,0.474201156422467,0.438155355971213,BRCA2/GINS2/MCM4,3
GO:0016055,Wnt signaling pathway,6/157,466/18888,0.192541949635752,0.474201156422467,0.438155355971213,FRZB/FZD10/NOG/PLEKHA4/SFRP1/TMEM198,6
GO:0019827,stem cell population maintenance,3/157,182/18888,0.193250715897291,0.474201156422467,0.438155355971213,NOG/POU5F1/SFRP1,3
GO:0007015,actin filament organization,6/157,467/18888,0.193808236024738,0.474201156422467,0.438155355971213,C15orf62/FCHSD2/LIMK1/PHACTR1/PIK3R1/SFRP1,6
GO:0051960,regulation of nervous system development,6/157,468/18888,0.195077734514558,0.474201156422467,0.438155355971213,ADGRB1/EGR2/LIMK1/NOG/SEMA4A/SEMA6D,6
GO:0198738,cell-cell signaling by wnt,6/157,468/18888,0.195077734514558,0.474201156422467,0.438155355971213,FRZB/FZD10/NOG/PLEKHA4/SFRP1/TMEM198,6
GO:0001911,negative regulation of leukocyte mediated cytotoxicity,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,KLRC1,1
GO:0002026,regulation of the force of heart contraction,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,MYL3,1
GO:0003181,atrioventricular valve morphogenesis,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,OLFM1,1
GO:0009435,NAD biosynthetic process,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,HAAO,1
GO:0022010,central nervous system myelination,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,CLU,1
GO:0032291,axon ensheathment in central nervous system,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,CLU,1
GO:0033598,mammary gland epithelial cell proliferation,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,BRCA2,1
GO:0034643,"establishment of mitochondrion localization, microtubule-mediated",1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,SYBU,1
GO:0035988,chondrocyte proliferation,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,BMPR1B,1
GO:0046629,gamma-delta T cell activation,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,KLRC1,1
GO:0047497,mitochondrion transport along microtubule,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,SYBU,1
GO:0051894,positive regulation of focal adhesion assembly,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,SFRP1,1
GO:0060343,trabecula formation,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,SFRP1,1
GO:0070102,interleukin-6-mediated signaling pathway,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,CEBPA,1
GO:0071280,cellular response to copper ion,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,MT1F,1
GO:0071378,cellular response to growth hormone stimulus,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,PIK3R1,1
GO:0071467,cellular response to pH,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,GPR68,1
GO:0098719,sodium ion import across plasma membrane,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,SLC9A3,1
GO:0099637,neurotransmitter receptor transport,1/157,26/18888,0.195201714679273,0.474201156422467,0.438155355971213,SNAP25,1
GO:0003018,vascular process in circulatory system,4/157,275/18888,0.196092325752336,0.47471192795131,0.438627301849053,ADRA2A/CBS/SLC1A3/TACR2,4
GO:0002443,leukocyte mediated immunity,6/157,469/18888,0.196350423251107,0.47471192795131,0.438627301849053,CLU/EXO1/IL13RA2/KLRC1/NOS2/NSD2,6
GO:0043269,regulation of monoatomic ion transport,6/157,470/18888,0.1976262803012,0.47471192795131,0.438627301849053,ADRA2A/CLIC2/CNKSR3/MAOB/TACR2/TMEM38A,6
GO:0002449,lymphocyte mediated immunity,5/157,372/18888,0.198196143734741,0.47471192795131,0.438627301849053,CLU/EXO1/IL13RA2/KLRC1/NSD2,5
GO:0001657,ureteric bud development,2/157,99/18888,0.199015240487205,0.47471192795131,0.438627301849053,NOG/SFRP1,2
GO:1901992,positive regulation of mitotic cell cycle phase transition,2/157,99/18888,0.199015240487205,0.47471192795131,0.438627301849053,ESPL1/HSPA2,2
GO:0006694,steroid biosynthetic process,3/157,185/18888,0.199600115007918,0.47471192795131,0.438627301849053,CYP7B1/HSD17B1/HSD17B2,3
GO:0044282,small molecule catabolic process,5/157,373/18888,0.199646054598949,0.47471192795131,0.438627301849053,ASRGL1/CBS/FAH/HAAO/NOS2,5
GO:0006260,DNA replication,4/157,278/18888,0.201193485451801,0.47471192795131,0.438627301849053,ADRA2A/BRCA2/GINS2/MCM4,4
GO:0098727,maintenance of cell number,3/157,186/18888,0.201727787613417,0.47471192795131,0.438627301849053,NOG/POU5F1/SFRP1,3
GO:0007274,neuromuscular synaptic transmission,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,FCHSD2,1
GO:0010875,positive regulation of cholesterol efflux,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,ABCA8,1
GO:0035929,steroid hormone secretion,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,POMC,1
GO:0042026,protein refolding,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,HSPA2,1
GO:0042730,fibrinolysis,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,PROS1,1
GO:0050996,positive regulation of lipid catabolic process,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,AADAC,1
GO:0051043,regulation of membrane protein ectodomain proteolysis,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,ADRA2A,1
GO:0099170,postsynaptic modulation of chemical synaptic transmission,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,NEFH,1
GO:0150146,cell junction disassembly,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,PIK3R1,1
GO:1902894,negative regulation of miRNA transcription,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,POU5F1,1
GO:1903859,regulation of dendrite extension,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,RIMS1,1
GO:1904862,inhibitory synapse assembly,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,SEMA4A,1
GO:2001032,regulation of double-strand break repair via nonhomologous end joining,1/157,27/18888,0.201900544644036,0.47471192795131,0.438627301849053,NSD2,1
GO:0006721,terpenoid metabolic process,2/157,100/18888,0.202039776783589,0.47471192795131,0.438627301849053,CEL/RDH16,2
GO:0007029,endoplasmic reticulum organization,2/157,100/18888,0.202039776783589,0.47471192795131,0.438627301849053,MMGT1/TMEM38A,2
GO:0019935,cyclic-nucleotide-mediated signaling,2/157,100/18888,0.202039776783589,0.47471192795131,0.438627301849053,PDE1B/POMC,2
GO:0034766,negative regulation of monoatomic ion transmembrane transport,2/157,100/18888,0.202039776783589,0.47471192795131,0.438627301849053,ADRA2A/CLIC2,2
GO:0072163,mesonephric epithelium development,2/157,100/18888,0.202039776783589,0.47471192795131,0.438627301849053,NOG/SFRP1,2
GO:0072164,mesonephric tubule development,2/157,100/18888,0.202039776783589,0.47471192795131,0.438627301849053,NOG/SFRP1,2
GO:1903035,negative regulation of response to wounding,2/157,100/18888,0.202039776783589,0.47471192795131,0.438627301849053,PROS1/RTCA,2
GO:0001837,epithelial to mesenchymal transition,3/157,187/18888,0.203860876522921,0.47471192795131,0.438627301849053,NOG/OLFM1/SFRP1,3
GO:0002700,regulation of production of molecular mediator of immune response,3/157,187/18888,0.203860876522921,0.47471192795131,0.438627301849053,CD22/IL13RA2/NSD2,3
GO:0005976,polysaccharide metabolic process,2/157,101/18888,0.205069659645125,0.47471192795131,0.438627301849053,POMC/PPP1R3F,2
GO:0010596,negative regulation of endothelial cell migration,2/157,101/18888,0.205069659645125,0.47471192795131,0.438627301849053,ADGRB1/SYNJ2BP,2
GO:0120162,positive regulation of cold-induced thermogenesis,2/157,101/18888,0.205069659645125,0.47471192795131,0.438627301849053,DIO2/TRPM8,2
GO:0017157,regulation of exocytosis,3/157,188/18888,0.205999270278669,0.47471192795131,0.438627301849053,ADRA2A/IL13RA2/RIMS1,3
GO:0048771,tissue remodeling,3/157,188/18888,0.205999270278669,0.47471192795131,0.438627301849053,CBS/CLDN18/SFRP1,3
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,2/157,102/18888,0.208104593655393,0.47471192795131,0.438627301849053,CEBPA/CLU,2
GO:0032640,tumor necrosis factor production,3/157,189/18888,0.208142857856064,0.47471192795131,0.438627301849053,CLU/PIK3R1/POMC,3
GO:0032680,regulation of tumor necrosis factor production,3/157,189/18888,0.208142857856064,0.47471192795131,0.438627301849053,CLU/PIK3R1/POMC,3
GO:0061138,morphogenesis of a branching epithelium,3/157,189/18888,0.208142857856064,0.47471192795131,0.438627301849053,NOG/PKHD1/SFRP1,3
GO:0000470,maturation of LSU-rRNA,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,BOP1,1
GO:0003272,endocardial cushion formation,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,NOG,1
GO:0010592,positive regulation of lamellipodium assembly,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,PIK3R1,1
GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,HSPA2,1
GO:0015732,prostaglandin transport,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,NOS2,1
GO:0015740,C4-dicarboxylate transport,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,SLC1A3,1
GO:0019359,nicotinamide nucleotide biosynthetic process,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,HAAO,1
GO:0019363,pyridine nucleotide biosynthetic process,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,HAAO,1
GO:0019433,triglyceride catabolic process,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,AADAC,1
GO:0032703,negative regulation of interleukin-2 production,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,SFTPD,1
GO:0032770,positive regulation of monooxygenase activity,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,POR,1
GO:0043304,regulation of mast cell degranulation,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,IL13RA2,1
GO:0044342,type B pancreatic cell proliferation,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,SFRP1,1
GO:0045606,positive regulation of epidermal cell differentiation,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,SULT2B1,1
GO:0045686,negative regulation of glial cell differentiation,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,NOG,1
GO:0045830,positive regulation of isotype switching,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,NSD2,1
GO:0048499,synaptic vesicle membrane organization,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,SNAP25,1
GO:0050995,negative regulation of lipid catabolic process,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,ADRA2A,1
GO:0051953,negative regulation of amine transport,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,ADRA2A,1
GO:0055022,negative regulation of cardiac muscle tissue growth,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,NOG,1
GO:0061117,negative regulation of heart growth,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,NOG,1
GO:0070199,establishment of protein localization to chromosome,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,BRCA2,1
GO:0071577,zinc ion transmembrane transport,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,SLC30A7,1
GO:0120255,olefinic compound biosynthetic process,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,HSD17B1,1
GO:2000629,negative regulation of miRNA metabolic process,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,POU5F1,1
GO:2000647,negative regulation of stem cell proliferation,1/157,28/18888,0.208543968348553,0.47471192795131,0.438627301849053,CEBPA,1
GO:0035282,segmentation,2/157,103/18888,0.211144287879774,0.478028231611763,0.441691520886005,EGR2/SFRP1,2
GO:0150115,cell-substrate junction organization,2/157,103/18888,0.211144287879774,0.478028231611763,0.441691520886005,PIK3R1/SFRP1,2
GO:0030336,negative regulation of cell migration,5/157,381/18888,0.211375177850776,0.478028231611763,0.441691520886005,ADGRB1/NOG/SEMA6D/SFRP1/SYNJ2BP,5
GO:0006575,cellular modified amino acid metabolic process,3/157,191/18888,0.212445172596216,0.478028231611763,0.441691520886005,CPQ/DIO2/SERINC1,3
GO:0001823,mesonephros development,2/157,104/18888,0.214188455812168,0.478028231611763,0.441691520886005,NOG/SFRP1,2
GO:0003333,amino acid transmembrane transport,2/157,104/18888,0.214188455812168,0.478028231611763,0.441691520886005,SLC1A3/SLC36A4,2
GO:0022600,digestive system process,2/157,104/18888,0.214188455812168,0.478028231611763,0.441691520886005,ADRA2A/CEL,2
GO:0042100,B cell proliferation,2/157,104/18888,0.214188455812168,0.478028231611763,0.441691520886005,CD22/TNFRSF13C,2
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3/157,192/18888,0.214603679954255,0.478028231611763,0.441691520886005,IL1RL1/KLRC1/NSD2,3
GO:0002710,negative regulation of T cell mediated immunity,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,KLRC1,1
GO:0003171,atrioventricular valve development,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,OLFM1,1
GO:0003401,axis elongation,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,SFRP1,1
GO:0006829,zinc ion transport,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,SLC30A7,1
GO:0006910,"phagocytosis, recognition",1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,ADGRB1,1
GO:0015813,L-glutamate transmembrane transport,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,SLC1A3,1
GO:0031342,negative regulation of cell killing,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,KLRC1,1
GO:0033137,negative regulation of peptidyl-serine phosphorylation,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,CNKSR3,1
GO:0045672,positive regulation of osteoclast differentiation,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,GPR68,1
GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,ADRA2A,1
GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,KLRC1,1
GO:0060142,regulation of syncytium formation by plasma membrane fusion,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,ADGRB1,1
GO:0060765,regulation of androgen receptor signaling pathway,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,SFRP1,1
GO:1902430,negative regulation of amyloid-beta formation,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,CLU,1
GO:1903671,negative regulation of sprouting angiogenesis,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,SYNJ2BP,1
GO:1905820,positive regulation of chromosome separation,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,ESPL1,1
GO:2000273,positive regulation of signaling receptor activity,1/157,29/18888,0.2151324411465,0.478028231611763,0.441691520886005,ADRA2A,1
GO:0021549,cerebellum development,2/157,105/18888,0.217236815322279,0.482010784108888,0.445371344697942,CBS/NLGN4X,2
GO:0002697,regulation of immune effector process,5/157,385/18888,0.217322781274528,0.482010784108888,0.445371344697942,CD22/IL13RA2/KLRC1/NOS2/NSD2,5
GO:0071706,tumor necrosis factor superfamily cytokine production,3/157,194/18888,0.218934848626158,0.483236774382073,0.446504142872914,CLU/PIK3R1/POMC,3
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,3/157,194/18888,0.218934848626158,0.483236774382073,0.446504142872914,CLU/PIK3R1/POMC,3
GO:0045165,cell fate commitment,4/157,289/18888,0.22022724371323,0.483236774382073,0.446504142872914,ONECUT2/POU5F1/RUNX2/SFRP1,4
GO:0032526,response to retinoic acid,2/157,106/18888,0.220289088603461,0.483236774382073,0.446504142872914,FZD10/HSD17B2,2
GO:0034308,primary alcohol metabolic process,2/157,106/18888,0.220289088603461,0.483236774382073,0.446504142872914,CEL/RDH16,2
GO:0005979,regulation of glycogen biosynthetic process,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,PPP1R3F,1
GO:0006353,DNA-templated transcription termination,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,TTF2,1
GO:0007271,"synaptic transmission, cholinergic",1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,TACR2,1
GO:0008209,androgen metabolic process,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,HSD17B2,1
GO:0010962,regulation of glucan biosynthetic process,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,PPP1R3F,1
GO:0038094,Fc-gamma receptor signaling pathway,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,LIMK1,1
GO:0045987,positive regulation of smooth muscle contraction,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,TACR2,1
GO:0046856,phosphatidylinositol dephosphorylation,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,MTMR7,1
GO:0060037,pharyngeal system development,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,NOG,1
GO:0060295,regulation of cilium movement involved in cell motility,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,TACR2,1
GO:0071295,cellular response to vitamin,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,SFRP1,1
GO:1900101,regulation of endoplasmic reticulum unfolded protein response,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,PIK3R1,1
GO:1902019,regulation of cilium-dependent cell motility,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,TACR2,1
GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1/157,30/18888,0.221666414673197,0.483236774382073,0.446504142872914,CLU,1
GO:0051650,establishment of vesicle localization,3/157,196/18888,0.223284166791221,0.48558491484502,0.448673792411888,SNAP25/SYBU/WDR11,3
GO:0099173,postsynapse organization,3/157,196/18888,0.223284166791221,0.48558491484502,0.448673792411888,CNKSR2/NEFH/NLGN4X,3
GO:0060079,excitatory postsynaptic potential,2/157,107/18888,0.22334500212112,0.48558491484502,0.448673792411888,NLGN4X/RIMS1,2
GO:0030100,regulation of endocytosis,4/157,291/18888,0.223739659109778,0.485989822263095,0.449047921305289,CD22/CLU/SFTPD/SYNJ2BP,4
GO:0003279,cardiac septum development,2/157,108/18888,0.226404286561663,0.485989822263095,0.449047921305289,NOG/NSD2,2
GO:0006939,smooth muscle contraction,2/157,108/18888,0.226404286561663,0.485989822263095,0.449047921305289,ADRA2A/TACR2,2
GO:0002431,Fc receptor mediated stimulatory signaling pathway,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,LIMK1,1
GO:0002825,regulation of T-helper 1 type immune response,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,IL1RL1,1
GO:0010765,positive regulation of sodium ion transport,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,CNKSR3,1
GO:0010996,response to auditory stimulus,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,SLC1A3,1
GO:0021602,cranial nerve morphogenesis,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,EGR2,1
GO:0030808,regulation of nucleotide biosynthetic process,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,NOS2,1
GO:0033238,regulation of amine metabolic process,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,MAOB,1
GO:0033688,regulation of osteoblast proliferation,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,SFRP1,1
GO:0034063,stress granule assembly,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,GRB7,1
GO:0034315,regulation of Arp2/3 complex-mediated actin nucleation,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,FCHSD2,1
GO:0045048,protein insertion into ER membrane,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,MMGT1,1
GO:0060325,face morphogenesis,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,NOG,1
GO:0065002,intracellular protein transmembrane transport,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,PEX12,1
GO:0070198,"protein localization to chromosome, telomeric region",1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,BRCA2,1
GO:0070979,protein K11-linked ubiquitination,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,ANAPC13,1
GO:0072525,pyridine-containing compound biosynthetic process,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,HAAO,1
GO:0099590,neurotransmitter receptor internalization,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,SNAP25,1
GO:1900371,regulation of purine nucleotide biosynthetic process,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,NOS2,1
GO:1901186,positive regulation of ERBB signaling pathway,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,ADRA2A,1
GO:1902751,positive regulation of cell cycle G2/M phase transition,1/157,31/18888,0.22814633687578,0.485989822263095,0.449047921305289,HSPA2,1
GO:0051962,positive regulation of nervous system development,4/157,294/18888,0.229035882762768,0.486662251458841,0.44966923664718,ADGRB1/EGR2/LIMK1/SEMA4A,4
GO:0050767,regulation of neurogenesis,5/157,393/18888,0.229373161855028,0.486662251458841,0.44966923664718,EGR2/LIMK1/NOG/SEMA4A/SEMA6D,5
GO:0032760,positive regulation of tumor necrosis factor production,2/157,109/18888,0.229466676781997,0.486662251458841,0.44966923664718,CLU/PIK3R1,2
GO:1901800,positive regulation of proteasomal protein catabolic process,2/157,109/18888,0.229466676781997,0.486662251458841,0.44966923664718,CEBPA/CLU,2
GO:1902476,chloride transmembrane transport,2/157,109/18888,0.229466676781997,0.486662251458841,0.44966923664718,CLIC2/SLC1A3,2
GO:0007369,gastrulation,3/157,200/18888,0.23203381945964,0.489771520041753,0.452542158115854,NOG/POU5F1/SFRP1,3
GO:0071248,cellular response to metal ion,3/157,200/18888,0.23203381945964,0.489771520041753,0.452542158115854,CEBPA/HSD17B1/MT1F,3
GO:0031341,regulation of cell killing,2/157,110/18888,0.232531911759563,0.489771520041753,0.452542158115854,KLRC1/NOS2,2
GO:0048477,oogenesis,2/157,110/18888,0.232531911759563,0.489771520041753,0.452542158115854,BMPR1B/BRCA2,2
GO:2000146,negative regulation of cell motility,5/157,396/18888,0.233942562536417,0.489771520041753,0.452542158115854,ADGRB1/NOG/SEMA6D/SFRP1/SYNJ2BP,5
GO:0021532,neural tube patterning,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,TULP3,1
GO:0034694,response to prostaglandin,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,SFRP1,1
GO:0045684,positive regulation of epidermis development,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,SULT2B1,1
GO:0046685,response to arsenic-containing substance,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,ZFAND1,1
GO:0048679,regulation of axon regeneration,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,RTCA,1
GO:0048710,regulation of astrocyte differentiation,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,NOG,1
GO:0051085,chaperone cofactor-dependent protein refolding,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,HSPA2,1
GO:0061384,heart trabecula morphogenesis,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,NOG,1
GO:0090169,regulation of spindle assembly,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,GPSM2,1
GO:0099022,vesicle tethering,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,WDR11,1
GO:0140058,neuron projection arborization,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,PHACTR1,1
GO:1902992,negative regulation of amyloid precursor protein catabolic process,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,CLU,1
GO:2000463,positive regulation of excitatory postsynaptic potential,1/157,32/18888,0.234572652043119,0.489771520041753,0.452542158115854,RIMS1,1
GO:0007626,locomotory behavior,3/157,202/18888,0.236432458289122,0.493229469402459,0.455737255834511,HOXD9/PDE1B/SNAP25,3
GO:0001819,positive regulation of cytokine production,6/157,500/18888,0.237263640233167,0.494537466992023,0.456945827643548,ADRA2A/CLU/IL1RL1/NOS2/PIK3R1/POLR3D,6
GO:0009749,response to glucose,3/157,203/18888,0.238637364028256,0.496185977006961,0.458469028257117,ADRA2A/GPR68/SYBU,3
GO:0098739,import across plasma membrane,3/157,203/18888,0.238637364028256,0.496185977006961,0.458469028257117,SLC1A3/SLC36A4/SLC9A3,3
GO:0014013,regulation of gliogenesis,2/157,112/18888,0.238669892202775,0.496185977006961,0.458469028257117,EGR2/NOG,2
GO:0001556,oocyte maturation,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,BRCA2,1
GO:0001975,response to amphetamine,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,PDE1B,1
GO:0006622,protein targeting to lysosome,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,CLU,1
GO:0021591,ventricular system development,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,SEMA6D,1
GO:0043949,regulation of cAMP-mediated signaling,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,POMC,1
GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,CD22,1
GO:0050869,negative regulation of B cell activation,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,SFRP1,1
GO:0051497,negative regulation of stress fiber assembly,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,PIK3R1,1
GO:0051654,establishment of mitochondrion localization,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,SYBU,1
GO:0060351,cartilage development involved in endochondral bone morphogenesis,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,CBS,1
GO:0060795,cell fate commitment involved in formation of primary germ layer,1/157,33/18888,0.240945800835505,0.496185977006961,0.458469028257117,POU5F1,1
GO:0002366,leukocyte activation involved in immune response,4/157,301/18888,0.241514721588972,0.496185977006961,0.458469028257117,EXO1/IL13RA2/NSD2/SEMA4A,4
GO:0001701,in utero embryonic development,5/157,401/18888,0.241615773657251,0.496185977006961,0.458469028257117,BRCA2/CEBPA/HSD17B2/NOG/POU5F1,5
GO:0060840,artery development,2/157,113/18888,0.241742135783738,0.496185977006961,0.458469028257117,EGR2/NOG,2
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,2/157,113/18888,0.241742135783738,0.496185977006961,0.458469028257117,CLU/PIK3R1,2
GO:0045732,positive regulation of protein catabolic process,3/157,205/18888,0.243057830206509,0.498464068382866,0.460573953401701,ADRA2A/CEBPA/CLU,3
GO:0042177,negative regulation of protein catabolic process,2/157,114/18888,0.244816220256328,0.50115379548179,0.46305922430105,ADGRB1/NOS2,2
GO:0001763,morphogenesis of a branching structure,3/157,206/18888,0.245273185113917,0.50115379548179,0.46305922430105,NOG/PKHD1/SFRP1,3
GO:0000096,sulfur amino acid metabolic process,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,CBS,1
GO:0002717,positive regulation of natural killer cell mediated immunity,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,KLRC1,1
GO:0003382,epithelial cell morphogenesis,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,PKHD1,1
GO:0009954,proximal/distal pattern formation,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,HOXD9,1
GO:0030212,hyaluronan metabolic process,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,ITIH3,1
GO:0034383,low-density lipoprotein particle clearance,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,CES3,1
GO:0060074,synapse maturation,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,SYBU,1
GO:0070570,regulation of neuron projection regeneration,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,RTCA,1
GO:0071875,adrenergic receptor signaling pathway,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,ADRA2A,1
GO:0090075,relaxation of muscle,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,TNNI2,1
GO:0090183,regulation of kidney development,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,NOG,1
GO:1904861,excitatory synapse assembly,1/157,34/18888,0.247266220314095,0.50115379548179,0.46305922430105,SEMA4A,1
GO:0002819,regulation of adaptive immune response,3/157,207/18888,0.247491818473708,0.501163766799322,0.463068437661506,IL1RL1/KLRC1/NSD2,3
GO:0022037,metencephalon development,2/157,115/18888,0.247891904469689,0.501163766799322,0.463068437661506,CBS/NLGN4X,2
GO:0099565,"chemical synaptic transmission, postsynaptic",2/157,115/18888,0.247891904469689,0.501163766799322,0.463068437661506,NLGN4X/RIMS1,2
GO:0002263,cell activation involved in immune response,4/157,305/18888,0.248715828573545,0.502410122439639,0.464220053156014,EXO1/IL13RA2/NSD2/SEMA4A,4
GO:0008016,regulation of heart contraction,3/157,208/18888,0.249713628919738,0.503585686297757,0.465306258016008,CLIC2/MYL3/TMEM38A,3
GO:0009746,response to hexose,3/157,208/18888,0.249713628919738,0.503585686297757,0.465306258016008,ADRA2A/GPR68/SYBU,3
GO:0002062,chondrocyte differentiation,2/157,116/18888,0.250968951104742,0.505696172691918,0.467256318459306,BMPR1B/RUNX2,2
GO:0006298,mismatch repair,1/157,35/18888,0.25353434397012,0.50809425325568,0.469472111965569,EXO1,1
GO:0006346,DNA methylation-dependent heterochromatin formation,1/157,35/18888,0.25353434397012,0.50809425325568,0.469472111965569,SAMD1,1
GO:0033146,regulation of intracellular estrogen receptor signaling pathway,1/157,35/18888,0.25353434397012,0.50809425325568,0.469472111965569,CYP7B1,1
GO:0035640,exploration behavior,1/157,35/18888,0.25353434397012,0.50809425325568,0.469472111965569,NOG,1
GO:0045577,regulation of B cell differentiation,1/157,35/18888,0.25353434397012,0.50809425325568,0.469472111965569,SFRP1,1
GO:0048147,negative regulation of fibroblast proliferation,1/157,35/18888,0.25353434397012,0.50809425325568,0.469472111965569,SFRP1,1
GO:0001824,blastocyst development,2/157,117/18888,0.25404712662784,0.50809425325568,0.469472111965569,BRCA2/POU5F1,2
GO:0033209,tumor necrosis factor-mediated signaling pathway,2/157,117/18888,0.25404712662784,0.50809425325568,0.469472111965569,CLDN18/TNFRSF13C,2
GO:1901989,positive regulation of cell cycle phase transition,2/157,117/18888,0.25404712662784,0.50809425325568,0.469472111965569,ESPL1/HSPA2,2
GO:0043270,positive regulation of monoatomic ion transport,3/157,211/18888,0.256397117675087,0.512137877808576,0.47320836551829,ADRA2A/CNKSR3/TACR2,3
GO:0006334,nucleosome assembly,2/157,118/18888,0.257126201244934,0.512137877808576,0.47320836551829,H2BC4/H2BC8,2
GO:0010633,negative regulation of epithelial cell migration,2/157,118/18888,0.257126201244934,0.512137877808576,0.47320836551829,ADGRB1/SYNJ2BP,2
GO:0050830,defense response to Gram-positive bacterium,2/157,118/18888,0.257126201244934,0.512137877808576,0.47320836551829,H2BC4/H2BC8,2
GO:0051224,negative regulation of protein transport,2/157,118/18888,0.257126201244934,0.512137877808576,0.47320836551829,ADRA2A/SFRP1,2
GO:0030217,T cell differentiation,4/157,310/18888,0.257782534708714,0.512726941685271,0.473752652450296,KLRC1/PIK3R1/RUNX2/SEMA4A,4
GO:0002285,lymphocyte activation involved in immune response,3/157,212/18888,0.258630634251887,0.512726941685271,0.473752652450296,EXO1/NSD2/SEMA4A,3
GO:0000460,maturation of 5.8S rRNA,1/157,36/18888,0.259750601753851,0.512726941685271,0.473752652450296,BOP1,1
GO:0009069,serine family amino acid metabolic process,1/157,36/18888,0.259750601753851,0.512726941685271,0.473752652450296,CBS,1
GO:0032232,negative regulation of actin filament bundle assembly,1/157,36/18888,0.259750601753851,0.512726941685271,0.473752652450296,PIK3R1,1
GO:0033687,osteoblast proliferation,1/157,36/18888,0.259750601753851,0.512726941685271,0.473752652450296,SFRP1,1
GO:0034143,regulation of toll-like receptor 4 signaling pathway,1/157,36/18888,0.259750601753851,0.512726941685271,0.473752652450296,PIK3R1,1
GO:0035137,hindlimb morphogenesis,1/157,36/18888,0.259750601753851,0.512726941685271,0.473752652450296,HOXD9,1
GO:0060218,hematopoietic stem cell differentiation,1/157,36/18888,0.259750601753851,0.512726941685271,0.473752652450296,SFRP1,1
GO:1902745,positive regulation of lamellipodium organization,1/157,36/18888,0.259750601753851,0.512726941685271,0.473752652450296,PIK3R1,1
GO:1905332,positive regulation of morphogenesis of an epithelium,1/157,36/18888,0.259750601753851,0.512726941685271,0.473752652450296,NOG,1
GO:0045216,cell-cell junction organization,3/157,213/18888,0.260866829709138,0.514510962178772,0.475401062884988,CLDN18/NLGN4X/PKHD1,3
GO:0006302,double-strand break repair,4/157,312/18888,0.261428136078787,0.515198491117024,0.476036330181578,BRCA2/GINS2/MCM4/NSD2,4
GO:2000241,regulation of reproductive process,3/157,214/18888,0.263105606161318,0.51523771799224,0.476072575275546,ANAPC13/SFRP1/TACR2,3
GO:0034284,response to monosaccharide,3/157,215/18888,0.265346866317552,0.51523771799224,0.476072575275546,ADRA2A/GPR68/SYBU,3
GO:0051648,vesicle localization,3/157,215/18888,0.265346866317552,0.51523771799224,0.476072575275546,SNAP25/SYBU/WDR11,3
GO:0006270,DNA replication initiation,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,MCM4,1
GO:0007031,peroxisome organization,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,PEX12,1
GO:0022616,DNA strand elongation,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,MCM4,1
GO:0031076,embryonic camera-type eye development,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,TULP3,1
GO:0033280,response to vitamin D,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,SFRP1,1
GO:0045191,regulation of isotype switching,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,NSD2,1
GO:0045773,positive regulation of axon extension,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,LIMK1,1
GO:0045880,positive regulation of smoothened signaling pathway,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,SFRP1,1
GO:0046326,positive regulation of glucose import,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,PIK3R1,1
GO:0046621,negative regulation of organ growth,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,NOG,1
GO:0046677,response to antibiotic,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,SLC1A3,1
GO:0051084,'de novo' post-translational protein folding,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,HSPA2,1
GO:0060323,head morphogenesis,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,NOG,1
GO:0060392,negative regulation of SMAD protein signal transduction,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,NOG,1
GO:0071276,cellular response to cadmium ion,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,MT1F,1
GO:0097484,dendrite extension,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,RIMS1,1
GO:1902275,regulation of chromatin organization,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,SAMD1,1
GO:1905898,positive regulation of response to endoplasmic reticulum stress,1/157,37/18888,0.265915420103344,0.51523771799224,0.476072575275546,PIK3R1,1
GO:1903828,negative regulation of protein localization,3/157,216/18888,0.267590513485341,0.518068923790165,0.478688570549738,ADRA2A/CLDN18/SFRP1,3
GO:0045471,response to ethanol,2/157,122/18888,0.269447023132229,0.518783287888555,0.479348633165747,CLDN18/MAOB,2
GO:0006643,membrane lipid metabolic process,3/157,217/18888,0.269836451574127,0.518783287888555,0.479348633165747,ABCA8/CEL/SERINC1,3
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,4/157,317/18888,0.270585642356429,0.518783287888555,0.479348633165747,GREM2/NOG/ONECUT2/SFRP1,4
GO:0006699,bile acid biosynthetic process,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,CYP7B1,1
GO:0031281,positive regulation of cyclase activity,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,NOS2,1
GO:0031952,regulation of protein autophosphorylation,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,PPP2R5B,1
GO:0032885,regulation of polysaccharide biosynthetic process,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,PPP1R3F,1
GO:0043001,Golgi to plasma membrane protein transport,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,PHAF1,1
GO:0044743,protein transmembrane import into intracellular organelle,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,PEX12,1
GO:0045981,positive regulation of nucleotide metabolic process,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,NOS2,1
GO:0046461,neutral lipid catabolic process,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,AADAC,1
GO:0046464,acylglycerol catabolic process,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,AADAC,1
GO:0046688,response to copper ion,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,MT1F,1
GO:0051438,regulation of ubiquitin-protein transferase activity,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,LIMK1,1
GO:0070316,regulation of G0 to G1 transition,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,PPP2R5B,1
GO:0071392,cellular response to estradiol stimulus,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,SFRP1,1
GO:1900181,negative regulation of protein localization to nucleus,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,CLDN18,1
GO:1900544,positive regulation of purine nucleotide metabolic process,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,NOS2,1
GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1/157,38/18888,0.272029221972942,0.518783287888555,0.479348633165747,CLU,1
GO:0030518,intracellular steroid hormone receptor signaling pathway,2/157,123/18888,0.272527274047208,0.518915925898064,0.479471188864915,CYP7B1/SFRP1,2
GO:0071482,cellular response to light stimulus,2/157,123/18888,0.272527274047208,0.518915925898064,0.479471188864915,H2AC25/PIK3R1,2
GO:0006821,chloride transport,2/157,124/18888,0.275607121317769,0.522528982047069,0.482809603125763,CLIC2/SLC1A3,2
GO:1903706,regulation of hemopoiesis,5/157,424/18888,0.277723937789117,0.522528982047069,0.482809603125763,CEBPA/CLDN18/GPR68/PIK3R1/SFRP1,5
GO:0007340,acrosome reaction,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,RIMS1,1
GO:0007616,long-term memory,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,SNAP25,1
GO:0010737,protein kinase A signaling,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,MYOM1,1
GO:0014912,negative regulation of smooth muscle cell migration,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,SEMA6D,1
GO:0017158,regulation of calcium ion-dependent exocytosis,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,ADRA2A,1
GO:0030149,sphingolipid catabolic process,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,CEL,1
GO:0032373,positive regulation of sterol transport,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,ABCA8,1
GO:0032376,positive regulation of cholesterol transport,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,ABCA8,1
GO:0038179,neurotrophin signaling pathway,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,PPP2R5B,1
GO:0042044,fluid transport,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,CLDN18,1
GO:0051349,positive regulation of lyase activity,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,NOS2,1
GO:0051938,L-glutamate import,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,SLC1A3,1
GO:0051954,positive regulation of amine transport,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,TACR2,1
GO:0060416,response to growth hormone,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,PIK3R1,1
GO:0097242,amyloid-beta clearance,1/157,39/18888,0.278092426861549,0.522528982047069,0.482809603125763,CLU,1
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,2/157,125/18888,0.27868636008426,0.522833744480308,0.483091199428543,CEBPA/CLU,2
GO:0072676,lymphocyte migration,2/157,125/18888,0.27868636008426,0.522833744480308,0.483091199428543,CYP7B1/GPR15,2
GO:0043583,ear development,3/157,223/18888,0.283354885049977,0.528497236510092,0.488324188283044,CEBPA/FRZB/NOG,3
GO:0001953,negative regulation of cell-matrix adhesion,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,PIK3R1,1
GO:0030279,negative regulation of ossification,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,SFRP1,1
GO:0032728,positive regulation of interferon-beta production,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,POLR3D,1
GO:0042307,positive regulation of protein import into nucleus,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,PIK3R1,1
GO:0045023,G0 to G1 transition,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,PPP2R5B,1
GO:0045429,positive regulation of nitric oxide biosynthetic process,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,CLU,1
GO:0048246,macrophage chemotaxis,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,SFTPD,1
GO:0051125,regulation of actin nucleation,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,FCHSD2,1
GO:0051385,response to mineralocorticoid,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,MAOB,1
GO:0071354,cellular response to interleukin-6,1/157,40/18888,0.284105450840685,0.528497236510092,0.488324188283044,CEBPA,1
GO:0030282,bone mineralization,2/157,127/18888,0.284842209575824,0.528649679381338,0.488465043402462,BMPR1B/RUNX2,2
GO:0031623,receptor internalization,2/157,127/18888,0.284842209575824,0.528649679381338,0.488465043402462,GRK3/SNAP25,2
GO:0042471,ear morphogenesis,2/157,127/18888,0.284842209575824,0.528649679381338,0.488465043402462,FRZB/NOG,2
GO:0002708,positive regulation of lymphocyte mediated immunity,2/157,128/18888,0.2879184273667,0.531552846193742,0.491147529665737,KLRC1/NSD2,2
GO:0001941,postsynaptic membrane organization,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,NLGN4X,1
GO:0003203,endocardial cushion morphogenesis,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,NOG,1
GO:0003352,regulation of cilium movement,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,TACR2,1
GO:0006458,'de novo' protein folding,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,HSPA2,1
GO:0009268,response to pH,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,GPR68,1
GO:0010591,regulation of lamellipodium assembly,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,PIK3R1,1
GO:0030851,granulocyte differentiation,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,CEBPA,1
GO:0032781,positive regulation of ATP-dependent activity,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,MYL3,1
GO:0032814,regulation of natural killer cell activation,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,KLRC1,1
GO:0045454,cell redox homeostasis,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,NOS2,1
GO:0071542,dopaminergic neuron differentiation,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,SFRP1,1
GO:0090077,foam cell differentiation,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,SAMD1,1
GO:0099068,postsynapse assembly,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,NLGN4X,1
GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,WDR44,1
GO:1904407,positive regulation of nitric oxide metabolic process,1/157,41/18888,0.290068706582303,0.531552846193742,0.491147529665737,CLU,1
GO:0007596,blood coagulation,3/157,226/18888,0.290137432976105,0.531552846193742,0.491147529665737,ADRA2A/F8/PROS1,3
GO:0030098,lymphocyte differentiation,5/157,432/18888,0.290544461599279,0.531896210123547,0.491464793221201,KLRC1/PIK3R1/RUNX2/SEMA4A/SFRP1,5
GO:1902105,regulation of leukocyte differentiation,4/157,328/18888,0.290922710565745,0.531913700530852,0.491480954117342,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0051209,release of sequestered calcium ion into cytosol,2/157,129/18888,0.290993250703294,0.531913700530852,0.491480954117342,CLIC2/TMEM38A,2
GO:0043393,regulation of protein binding,2/157,130/18888,0.294066491265602,0.536317049582295,0.495549588166352,GREM2/NOG,2
GO:0051283,negative regulation of sequestering of calcium ion,2/157,130/18888,0.294066491265602,0.536317049582295,0.495549588166352,CLIC2/TMEM38A,2
GO:0098661,inorganic anion transmembrane transport,2/157,130/18888,0.294066491265602,0.536317049582295,0.495549588166352,CLIC2/SLC1A3,2
GO:0051651,maintenance of location in cell,3/157,228/18888,0.29466610149399,0.536579240570232,0.495791849038338,CLIC2/GPSM2/TMEM38A,3
GO:0002714,positive regulation of B cell mediated immunity,1/157,42/18888,0.295982603386387,0.536579240570232,0.495791849038338,NSD2,1
GO:0002891,positive regulation of immunoglobulin mediated immune response,1/157,42/18888,0.295982603386387,0.536579240570232,0.495791849038338,NSD2,1
GO:0006904,vesicle docking involved in exocytosis,1/157,42/18888,0.295982603386387,0.536579240570232,0.495791849038338,SNAP25,1
GO:0006958,"complement activation, classical pathway",1/157,42/18888,0.295982603386387,0.536579240570232,0.495791849038338,CLU,1
GO:0021983,pituitary gland development,1/157,42/18888,0.295982603386387,0.536579240570232,0.495791849038338,NOG,1
GO:0060236,regulation of mitotic spindle organization,1/157,42/18888,0.295982603386387,0.536579240570232,0.495791849038338,GPSM2,1
GO:1990000,amyloid fibril formation,1/157,42/18888,0.295982603386387,0.536579240570232,0.495791849038338,CLU,1
GO:0071241,cellular response to inorganic substance,3/157,229/18888,0.296932258898106,0.537065782548594,0.496241407144296,CEBPA/HSD17B1/MT1F,3
GO:0001704,formation of primary germ layer,2/157,131/18888,0.297137963920362,0.537065782548594,0.496241407144296,NOG/POU5F1,2
GO:0006661,phosphatidylinositol biosynthetic process,2/157,131/18888,0.297137963920362,0.537065782548594,0.496241407144296,MTMR7/PIK3R1,2
GO:1903052,positive regulation of proteolysis involved in protein catabolic process,2/157,131/18888,0.297137963920362,0.537065782548594,0.496241407144296,CEBPA/CLU,2
GO:0045787,positive regulation of cell cycle,4/157,332/18888,0.298372456418175,0.538894921286219,0.497931506216916,BRCA2/ESPL1/GPSM2/HSPA2,4
GO:0097191,extrinsic apoptotic signaling pathway,3/157,230/18888,0.299199514178008,0.539986008449431,0.498939655770998,BMPR1B/PIK3R1/SFRP1,3
GO:0019730,antimicrobial humoral response,2/157,132/18888,0.300207486681678,0.540001367898704,0.498953847691184,H2BC4/H2BC8,2
GO:0051282,regulation of sequestering of calcium ion,2/157,132/18888,0.300207486681678,0.540001367898704,0.498953847691184,CLIC2/TMEM38A,2
GO:0006913,nucleocytoplasmic transport,4/157,333/18888,0.300238741034622,0.540001367898704,0.498953847691184,DDX19A/EGR2/HEATR3/PIK3R1,4
GO:0051169,nuclear transport,4/157,333/18888,0.300238741034622,0.540001367898704,0.498953847691184,DDX19A/EGR2/HEATR3/PIK3R1,4
GO:0050817,coagulation,3/157,231/18888,0.30146777996373,0.540001367898704,0.498953847691184,ADRA2A/F8/PROS1,3
GO:0032768,regulation of monooxygenase activity,1/157,43/18888,0.30184754720833,0.540001367898704,0.498953847691184,POR,1
GO:0045124,regulation of bone resorption,1/157,43/18888,0.30184754720833,0.540001367898704,0.498953847691184,CLDN18,1
GO:0046839,phospholipid dephosphorylation,1/157,43/18888,0.30184754720833,0.540001367898704,0.498953847691184,MTMR7,1
GO:0048821,erythrocyte development,1/157,43/18888,0.30184754720833,0.540001367898704,0.498953847691184,HEATR3,1
GO:0051353,positive regulation of oxidoreductase activity,1/157,43/18888,0.30184754720833,0.540001367898704,0.498953847691184,POR,1
GO:0051955,regulation of amino acid transport,1/157,43/18888,0.30184754720833,0.540001367898704,0.498953847691184,SV2A,1
GO:0046394,carboxylic acid biosynthetic process,4/157,334/18888,0.302106463048201,0.540001367898704,0.498953847691184,CBS/CYP7B1/HAAO/SLC1A3,4
GO:0070588,calcium ion transmembrane transport,4/157,334/18888,0.302106463048201,0.540001367898704,0.498953847691184,ADRA2A/CLIC2/TMEM38A/TRPM8,4
GO:0048565,digestive tract development,2/157,133/18888,0.303274880672076,0.540850788523378,0.499738700682647,CLDN18/SFRP1,2
GO:1904950,negative regulation of establishment of protein localization,2/157,133/18888,0.303274880672076,0.540850788523378,0.499738700682647,ADRA2A/SFRP1,2
GO:0060562,epithelial tube morphogenesis,4/157,335/18888,0.30397557185444,0.540850788523378,0.499738700682647,NOG/PKHD1/SFRP1/TULP3,4
GO:0007599,hemostasis,3/157,233/18888,0.306006996766637,0.540850788523378,0.499738700682647,ADRA2A/F8/PROS1,3
GO:0008406,gonad development,3/157,233/18888,0.306006996766637,0.540850788523378,0.499738700682647,BMPR1B/BRCA2/SFRP1,3
GO:0007622,rhythmic behavior,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,EGR2,1
GO:0010828,positive regulation of glucose transmembrane transport,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,PIK3R1,1
GO:0021762,substantia nigra development,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,MAOB,1
GO:0030501,positive regulation of bone mineralization,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,BMPR1B,1
GO:0030890,positive regulation of B cell proliferation,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,TNFRSF13C,1
GO:0031018,endocrine pancreas development,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,ONECUT2,1
GO:0032689,negative regulation of type II interferon production,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,IL1RL1,1
GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,BRCA2,1
GO:0043268,positive regulation of potassium ion transport,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,ADRA2A,1
GO:0045840,positive regulation of mitotic nuclear division,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,ESPL1,1
GO:0046717,acid secretion,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,SV2A,1
GO:0051602,response to electrical stimulus,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,TACR2,1
GO:0070741,response to interleukin-6,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,CEBPA,1
GO:0090199,regulation of release of cytochrome c from mitochondria,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,CLU,1
GO:1901976,regulation of cell cycle checkpoint,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,BRCA2,1
GO:1903539,protein localization to postsynaptic membrane,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,SNAP25,1
GO:2000300,regulation of synaptic vesicle exocytosis,1/157,44/18888,0.307663940686085,0.540850788523378,0.499738700682647,RIMS1,1
GO:0016053,organic acid biosynthetic process,4/157,337/18888,0.307717748383656,0.540850788523378,0.499738700682647,CBS/CYP7B1/HAAO/SLC1A3,4
GO:0010594,regulation of endothelial cell migration,3/157,234/18888,0.308277776241892,0.541442185683729,0.500285143536707,ADGRB1/SEMA4A/SYNJ2BP,3
GO:0006720,isoprenoid metabolic process,2/157,135/18888,0.309402582141554,0.542567810286021,0.50132520521017,CEL/RDH16,2
GO:0030879,mammary gland development,2/157,135/18888,0.309402582141554,0.542567810286021,0.50132520521017,BRCA2/HOXD9,2
GO:0015980,energy derivation by oxidation of organic compounds,4/157,338/18888,0.309590715860975,0.542567810286021,0.50132520521017,ME3/NOS2/POMC/PPP1R3F,4
GO:0007586,digestion,2/157,136/18888,0.312462547063123,0.542625266355055,0.50137829382887,ADRA2A/CEL,2
GO:0030833,regulation of actin filament polymerization,2/157,136/18888,0.312462547063123,0.542625266355055,0.50137829382887,C15orf62/FCHSD2,2
GO:0051208,sequestering of calcium ion,2/157,136/18888,0.312462547063123,0.542625266355055,0.50137829382887,CLIC2/TMEM38A,2
GO:0008038,neuron recognition,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,NCAM2,1
GO:0009066,aspartate family amino acid metabolic process,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,ASRGL1,1
GO:0014014,negative regulation of gliogenesis,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,NOG,1
GO:0018198,peptidyl-cysteine modification,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,NOS2,1
GO:0021587,cerebellum morphogenesis,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,CBS,1
GO:0030574,collagen catabolic process,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,PEPD,1
GO:0031641,regulation of myelination,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,EGR2,1
GO:0032309,icosanoid secretion,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,NOS2,1
GO:0032941,secretion by tissue,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,CEL,1
GO:0043300,regulation of leukocyte degranulation,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,IL13RA2,1
GO:0046466,membrane lipid catabolic process,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,CEL,1
GO:0062237,protein localization to postsynapse,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,SNAP25,1
GO:1903426,regulation of reactive oxygen species biosynthetic process,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,ADGRB1,1
GO:1903573,negative regulation of response to endoplasmic reticulum stress,1/157,45/18888,0.313432183167103,0.542625266355055,0.50137829382887,CLU,1
GO:0006909,phagocytosis,3/157,237/18888,0.315093783200897,0.544357583464987,0.502978931047226,ADGRB1/LIMK1/SFTPD,3
GO:0050670,regulation of lymphocyte proliferation,3/157,237/18888,0.315093783200897,0.544357583464987,0.502978931047226,CD22/SFTPD/TNFRSF13C,3
GO:0035270,endocrine system development,2/157,137/18888,0.315519698023777,0.544357583464987,0.502978931047226,NOG/ONECUT2,2
GO:1904375,regulation of protein localization to cell periphery,2/157,137/18888,0.315519698023777,0.544357583464987,0.502978931047226,GPSM2/PIK3R1,2
GO:0045137,development of primary sexual characteristics,3/157,238/18888,0.317366729965744,0.544357583464987,0.502978931047226,BMPR1B/BRCA2/SFRP1,3
GO:0051098,regulation of binding,3/157,238/18888,0.317366729965744,0.544357583464987,0.502978931047226,CLIC2/GREM2/NOG,3
GO:0006986,response to unfolded protein,2/157,138/18888,0.31857387111855,0.544357583464987,0.502978931047226,HSPA2/PIK3R1,2
GO:0010212,response to ionizing radiation,2/157,138/18888,0.31857387111855,0.544357583464987,0.502978931047226,BRCA2/SFRP1,2
GO:0061041,regulation of wound healing,2/157,138/18888,0.31857387111855,0.544357583464987,0.502978931047226,ADRA2A/PROS1,2
GO:0003009,skeletal muscle contraction,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,TNNI2,1
GO:0005978,glycogen biosynthetic process,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,PPP1R3F,1
GO:0009250,glucan biosynthetic process,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,PPP1R3F,1
GO:0034314,Arp2/3 complex-mediated actin nucleation,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,FCHSD2,1
GO:0045687,positive regulation of glial cell differentiation,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,EGR2,1
GO:0047496,vesicle transport along microtubule,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,SYBU,1
GO:0048483,autonomic nervous system development,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,EGR2,1
GO:0051205,protein insertion into membrane,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,MMGT1,1
GO:0090207,regulation of triglyceride metabolic process,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,AADAC,1
GO:0090224,regulation of spindle organization,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,GPSM2,1
GO:0140467,integrated stress response signaling,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,CEBPA,1
GO:0170036,import into the mitochondrion,1/157,46/18888,0.319152670735046,0.544357583464987,0.502978931047226,SLC25A37,1
GO:0009743,response to carbohydrate,3/157,239/18888,0.319640011367184,0.544805142527319,0.503392469474154,ADRA2A/GPR68/SYBU,3
GO:0007098,centrosome cycle,2/157,139/18888,0.321624905325938,0.54741779388575,0.505806523447826,BRCA2/PKHD1,2
GO:0043401,steroid hormone mediated signaling pathway,2/157,139/18888,0.321624905325938,0.54741779388575,0.505806523447826,CYP7B1/SFRP1,2
GO:0032944,regulation of mononuclear cell proliferation,3/157,241/18888,0.324187252399568,0.548242563403704,0.506568599155232,CD22/SFTPD/TNFRSF13C,3
GO:0032388,positive regulation of intracellular transport,2/157,140/18888,0.324672642471823,0.548242563403704,0.506568599155232,PIK3R1/ZFAND1,2
GO:0001881,receptor recycling,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,PEX12,1
GO:0006509,membrane protein ectodomain proteolysis,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,ADRA2A,1
GO:0006513,protein monoubiquitination,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,PEX12,1
GO:0006953,acute-phase response,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,F8,1
GO:0010824,regulation of centrosome duplication,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,PKHD1,1
GO:0014003,oligodendrocyte development,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,CLU,1
GO:0045933,positive regulation of muscle contraction,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,TACR2,1
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,SFRP1,1
GO:0055078,sodium ion homeostasis,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,SLC1A3,1
GO:1900271,regulation of long-term synaptic potentiation,1/157,47/18888,0.324825796236298,0.548242563403704,0.506568599155232,CALB2,1
GO:0070828,heterochromatin organization,2/157,141/18888,0.327716927193793,0.548563825373359,0.50686544080306,H2AC25/SAMD1,2
GO:0032496,response to lipopolysaccharide,4/157,348/18888,0.328377516224312,0.548563825373359,0.50686544080306,DIO2/MAOB/NOS2/TNIP3,4
GO:0050807,regulation of synapse organization,3/157,243/18888,0.328734861413161,0.548563825373359,0.50686544080306,ADGRB1/SEMA4A/SNAP25,3
GO:0006869,lipid transport,5/157,456/18888,0.329575774679694,0.548563825373359,0.50686544080306,ABCA8/CEL/CLU/NOS2/POMC,5
GO:0032102,negative regulation of response to external stimulus,5/157,456/18888,0.329575774679694,0.548563825373359,0.50686544080306,KLRC1/PROS1/RTCA/SEMA4A/SEMA6D,5
GO:0001774,microglial cell activation,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,CLU,1
GO:0006623,protein targeting to vacuole,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,CLU,1
GO:0007520,myoblast fusion,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,ADGRB1,1
GO:0021575,hindbrain morphogenesis,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,CBS,1
GO:0031295,T cell costimulation,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,TNFRSF13C,1
GO:0031670,cellular response to nutrient,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,SFRP1,1
GO:0042311,vasodilation,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,ADRA2A,1
GO:0042596,fear response,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,ADRA2A,1
GO:0043277,apoptotic cell clearance,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,ADGRB1,1
GO:0044273,sulfur compound catabolic process,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,CBS,1
GO:0045776,negative regulation of blood pressure,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,NOS2,1
GO:0060043,regulation of cardiac muscle cell proliferation,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,NOG,1
GO:0072583,clathrin-dependent endocytosis,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,FCHSD2,1
GO:0090329,regulation of DNA-templated DNA replication,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,MCM4,1
GO:0140718,facultative heterochromatin formation,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,SAMD1,1
GO:1902003,regulation of amyloid-beta formation,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,CLU,1
GO:1902116,negative regulation of organelle assembly,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,WDR44,1
GO:2001222,regulation of neuron migration,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,PHACTR1,1
GO:2001258,negative regulation of cation channel activity,1/157,48/18888,0.330451949306247,0.548563825373359,0.50686544080306,CLIC2,1
GO:2001235,positive regulation of apoptotic signaling pathway,2/157,143/18888,0.333794531763509,0.552707545604398,0.510694181387696,BMPR1B/SFRP1,2
GO:0070661,leukocyte proliferation,4/157,352/18888,0.335914522801478,0.552707545604398,0.510694181387696,CD22/CLU/SFTPD/TNFRSF13C,4
GO:0006911,"phagocytosis, engulfment",1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,ADGRB1,1
GO:0014037,Schwann cell differentiation,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,EGR2,1
GO:0014075,response to amine,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,PDE1B,1
GO:0030195,negative regulation of blood coagulation,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,PROS1,1
GO:0031294,lymphocyte costimulation,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,TNFRSF13C,1
GO:0031297,replication fork processing,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,BRCA2,1
GO:0042181,ketone biosynthetic process,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,HSD17B1,1
GO:0042269,regulation of natural killer cell mediated cytotoxicity,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,KLRC1,1
GO:0042551,neuron maturation,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,GLDN,1
GO:0048546,digestive tract morphogenesis,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,SFRP1,1
GO:0099054,presynapse assembly,1/157,49/18888,0.336031516395362,0.552707545604398,0.510694181387696,NLGN4X,1
GO:0001909,leukocyte mediated cytotoxicity,2/157,144/18888,0.33682755462927,0.552707545604398,0.510694181387696,KLRC1/NOS2,2
GO:0030534,adult behavior,2/157,144/18888,0.33682755462927,0.552707545604398,0.510694181387696,HOXD9/NLGN4X,2
GO:0034763,negative regulation of transmembrane transport,2/157,144/18888,0.33682755462927,0.552707545604398,0.510694181387696,ADRA2A/CLIC2,2
GO:1900180,regulation of protein localization to nucleus,2/157,144/18888,0.33682755462927,0.552707545604398,0.510694181387696,CLDN18/PIK3R1,2
GO:0045765,regulation of angiogenesis,4/157,353/18888,0.337800168245718,0.553600138092523,0.511518924588076,ADGRB1/SEMA4A/SFRP1/SYNJ2BP,4
GO:0051924,regulation of calcium ion transport,3/157,247/18888,0.33782865569808,0.553600138092523,0.511518924588076,ADRA2A/CLIC2/TMEM38A,3
GO:0055123,digestive system development,2/157,145/18888,0.33985653103848,0.555587737599487,0.513355439235304,CLDN18/SFRP1,2
GO:0001914,regulation of T cell mediated cytotoxicity,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,KLRC1,1
GO:0014911,positive regulation of smooth muscle cell migration,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,SEMA6D,1
GO:0022602,ovulation cycle process,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,BMPR1B,1
GO:0030521,androgen receptor signaling pathway,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,SFRP1,1
GO:0032924,activin receptor signaling pathway,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,NOG,1
GO:0033120,positive regulation of RNA splicing,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,PIK3R1,1
GO:0043114,regulation of vascular permeability,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,TACR2,1
GO:0043457,regulation of cellular respiration,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,NOS2,1
GO:0090102,cochlea development,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,FRZB,1
GO:1900047,negative regulation of hemostasis,1/157,50/18888,0.341564880795061,0.555587737599487,0.513355439235304,PROS1,1
GO:0098656,monoatomic anion transmembrane transport,2/157,146/18888,0.342881319165561,0.556980922212601,0.514642722684163,CLIC2/SLC1A3,2
GO:0098781,ncRNA transcription,2/157,146/18888,0.342881319165561,0.556980922212601,0.514642722684163,POLR3D/POU5F1,2
GO:1990778,protein localization to cell periphery,4/157,356/18888,0.343459702609826,0.55754651455831,0.51516532224389,GPSM2/PHAF1/PIK3R1/SNAP25,4
GO:0001974,blood vessel remodeling,1/157,51/18888,0.347052422663368,0.559921296749728,0.51735958837408,CBS,1
GO:0002269,leukocyte activation involved in inflammatory response,1/157,51/18888,0.347052422663368,0.559921296749728,0.51735958837408,CLU,1
GO:0008089,anterograde axonal transport,1/157,51/18888,0.347052422663368,0.559921296749728,0.51735958837408,SYBU,1
GO:0008206,bile acid metabolic process,1/157,51/18888,0.347052422663368,0.559921296749728,0.51735958837408,CYP7B1,1
GO:0035987,endodermal cell differentiation,1/157,51/18888,0.347052422663368,0.559921296749728,0.51735958837408,POU5F1,1
GO:0042220,response to cocaine,1/157,51/18888,0.347052422663368,0.559921296749728,0.51735958837408,SLC1A3,1
GO:0045214,sarcomere organization,1/157,51/18888,0.347052422663368,0.559921296749728,0.51735958837408,MYOM1,1
GO:0050885,neuromuscular process controlling balance,1/157,51/18888,0.347052422663368,0.559921296749728,0.51735958837408,SLC1A3,1
GO:0051180,vitamin transport,1/157,51/18888,0.347052422663368,0.559921296749728,0.51735958837408,CUBN,1
GO:0046942,carboxylic acid transport,4/157,358/18888,0.347234429280797,0.559921296749728,0.51735958837408,NOS2/SLC1A3/SLC36A4/SV2A,4
GO:0060078,regulation of postsynaptic membrane potential,2/157,148/18888,0.348917776266383,0.561574129125742,0.51888678278992,NLGN4X/RIMS1,2
GO:0015849,organic acid transport,4/157,359/18888,0.34912216657165,0.561574129125742,0.51888678278992,NOS2/SLC1A3/SLC36A4/SV2A,4
GO:0031589,cell-substrate adhesion,4/157,359/18888,0.34912216657165,0.561574129125742,0.51888678278992,ONECUT2/PIK3R1/PKHD1/SFRP1,4
GO:0032984,protein-containing complex disassembly,3/157,252/18888,0.349186886235907,0.561574129125742,0.51888678278992,H2AC25/PEX12/ZFAND1,3
GO:0008277,regulation of G protein-coupled receptor signaling pathway,2/157,149/18888,0.351929174485596,0.563525891181507,0.520690184124422,GRK3/TULP3,2
GO:0033157,regulation of intracellular protein transport,2/157,149/18888,0.351929174485596,0.563525891181507,0.520690184124422,PIK3R1/ZFAND1,2
GO:0003197,endocardial cushion development,1/157,52/18888,0.352494519050364,0.563525891181507,0.520690184124422,NOG,1
GO:0010332,response to gamma radiation,1/157,52/18888,0.352494519050364,0.563525891181507,0.520690184124422,BRCA2,1
GO:0010823,negative regulation of mitochondrion organization,1/157,52/18888,0.352494519050364,0.563525891181507,0.520690184124422,CLU,1
GO:0035176,social behavior,1/157,52/18888,0.352494519050364,0.563525891181507,0.520690184124422,NLGN4X,1
GO:0043303,mast cell degranulation,1/157,52/18888,0.352494519050364,0.563525891181507,0.520690184124422,IL13RA2,1
GO:0051646,mitochondrion localization,1/157,52/18888,0.352494519050364,0.563525891181507,0.520690184124422,SYBU,1
GO:0060324,face development,1/157,52/18888,0.352494519050364,0.563525891181507,0.520690184124422,NOG,1
GO:0002696,positive regulation of leukocyte activation,4/157,362/18888,0.354786331849389,0.566307385625444,0.523260246790254,CEBPA/IL1RL1/NSD2/TNFRSF13C,4
GO:1901342,regulation of vasculature development,4/157,362/18888,0.354786331849389,0.566307385625444,0.523260246790254,ADGRB1/SEMA4A/SFRP1/SYNJ2BP,4
GO:0001890,placenta development,2/157,150/18888,0.354935842848648,0.566307385625444,0.523260246790254,CEBPA/HSD17B2,2
GO:0002639,positive regulation of immunoglobulin production,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,NSD2,1
GO:0002715,regulation of natural killer cell mediated immunity,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,KLRC1,1
GO:0007129,homologous chromosome pairing at meiosis,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,SHOC1,1
GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,ALCAM,1
GO:0045778,positive regulation of ossification,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,BMPR1B,1
GO:0048009,insulin-like growth factor receptor signaling pathway,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,PIK3R1,1
GO:0048260,positive regulation of receptor-mediated endocytosis,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,CLU,1
GO:0050433,regulation of catecholamine secretion,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,ADRA2A,1
GO:0050819,negative regulation of coagulation,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,PROS1,1
GO:1902743,regulation of lamellipodium organization,1/157,53/18888,0.357891543923432,0.566617642944482,0.523546920292046,PIK3R1,1
GO:0098876,vesicle-mediated transport to the plasma membrane,2/157,151/18888,0.35793765223165,0.566617642944482,0.523546920292046,PHAF1/SNAP25,2
GO:0120161,regulation of cold-induced thermogenesis,2/157,151/18888,0.35793765223165,0.566617642944482,0.523546920292046,DIO2/TRPM8,2
GO:0010639,negative regulation of organelle organization,4/157,365/18888,0.360450989132868,0.568331168450734,0.525130194326681,CLU/ESPL1/PIK3R1/WDR44,4
GO:0045089,positive regulation of innate immune response,4/157,365/18888,0.360450989132868,0.568331168450734,0.525130194326681,KLRC1/PIK3R1/POLR3D/TNIP3,4
GO:0002699,positive regulation of immune effector process,3/157,257/18888,0.36052643583694,0.568331168450734,0.525130194326681,KLRC1/NOS2/NSD2,3
GO:0031023,microtubule organizing center organization,2/157,152/18888,0.360934475954836,0.568331168450734,0.525130194326681,BRCA2/PKHD1,2
GO:0035296,regulation of tube diameter,2/157,152/18888,0.360934475954836,0.568331168450734,0.525130194326681,ADRA2A/CBS,2
GO:0072073,kidney epithelium development,2/157,152/18888,0.360934475954836,0.568331168450734,0.525130194326681,NOG/SFRP1,2
GO:0097746,blood vessel diameter maintenance,2/157,152/18888,0.360934475954836,0.568331168450734,0.525130194326681,ADRA2A/CBS,2
GO:0106106,cold-induced thermogenesis,2/157,152/18888,0.360934475954836,0.568331168450734,0.525130194326681,DIO2/TRPM8,2
GO:0045927,positive regulation of growth,3/157,258/18888,0.362791313514417,0.568331168450734,0.525130194326681,LIMK1/RIMS1/SFRP1,3
GO:0010874,regulation of cholesterol efflux,1/157,54/18888,0.363243868192294,0.568331168450734,0.525130194326681,ABCA8,1
GO:0030520,intracellular estrogen receptor signaling pathway,1/157,54/18888,0.363243868192294,0.568331168450734,0.525130194326681,CYP7B1,1
GO:0031103,axon regeneration,1/157,54/18888,0.363243868192294,0.568331168450734,0.525130194326681,RTCA,1
GO:0031279,regulation of cyclase activity,1/157,54/18888,0.363243868192294,0.568331168450734,0.525130194326681,NOS2,1
GO:0046605,regulation of centrosome cycle,1/157,54/18888,0.363243868192294,0.568331168450734,0.525130194326681,PKHD1,1
GO:0050873,brown fat cell differentiation,1/157,54/18888,0.363243868192294,0.568331168450734,0.525130194326681,CEBPA,1
GO:0051703,biological process involved in intraspecies interaction between organisms,1/157,54/18888,0.363243868192294,0.568331168450734,0.525130194326681,NLGN4X,1
GO:0070169,positive regulation of biomineral tissue development,1/157,54/18888,0.363243868192294,0.568331168450734,0.525130194326681,BMPR1B,1
GO:0099172,presynapse organization,1/157,54/18888,0.363243868192294,0.568331168450734,0.525130194326681,NLGN4X,1
GO:0035150,regulation of tube size,2/157,153/18888,0.363926189751302,0.568664020372679,0.525437744931251,ADRA2A/CBS,2
GO:0050729,positive regulation of inflammatory response,2/157,153/18888,0.363926189751302,0.568664020372679,0.525437744931251,CEBPA/IL1RL1,2
GO:0097305,response to alcohol,3/157,259/18888,0.365055017266768,0.570008048707154,0.526679608653748,CLDN18/MAOB/SFRP1,3
GO:0008064,regulation of actin polymerization or depolymerization,2/157,154/18888,0.366912671736105,0.570008048707154,0.526679608653748,C15orf62/FCHSD2,2
GO:0030010,establishment of cell polarity,2/157,154/18888,0.366912671736105,0.570008048707154,0.526679608653748,GPSM2/PKHD1,2
GO:0042552,myelination,2/157,154/18888,0.366912671736105,0.570008048707154,0.526679608653748,CLU/EGR2,2
GO:0071456,cellular response to hypoxia,2/157,154/18888,0.366912671736105,0.570008048707154,0.526679608653748,CBS/SFRP1,2
GO:0009636,response to toxic substance,3/157,260/18888,0.367317478445053,0.570008048707154,0.526679608653748,CLIC2/MAOB/MT1F,3
GO:0010001,glial cell differentiation,3/157,260/18888,0.367317478445053,0.570008048707154,0.526679608653748,CLU/EGR2/NOG,3
GO:0002237,response to molecule of bacterial origin,4/157,369/18888,0.36800257679247,0.570008048707154,0.526679608653748,DIO2/MAOB/NOS2/TNIP3,4
GO:0001836,release of cytochrome c from mitochondria,1/157,55/18888,0.368551859733858,0.570008048707154,0.526679608653748,CLU,1
GO:0002279,mast cell activation involved in immune response,1/157,55/18888,0.368551859733858,0.570008048707154,0.526679608653748,IL13RA2,1
GO:0002448,mast cell mediated immunity,1/157,55/18888,0.368551859733858,0.570008048707154,0.526679608653748,IL13RA2,1
GO:0030857,negative regulation of epithelial cell differentiation,1/157,55/18888,0.368551859733858,0.570008048707154,0.526679608653748,FRZB,1
GO:0034381,plasma lipoprotein particle clearance,1/157,55/18888,0.368551859733858,0.570008048707154,0.526679608653748,CES3,1
GO:0042743,hydrogen peroxide metabolic process,1/157,55/18888,0.368551859733858,0.570008048707154,0.526679608653748,MAOB,1
GO:0060425,lung morphogenesis,1/157,55/18888,0.368551859733858,0.570008048707154,0.526679608653748,NOG,1
GO:1902991,regulation of amyloid precursor protein catabolic process,1/157,55/18888,0.368551859733858,0.570008048707154,0.526679608653748,CLU,1
GO:0050878,regulation of body fluid levels,4/157,370/18888,0.369889954562774,0.57062598048022,0.527250569125537,ADRA2A/CEL/F8/PROS1,4
GO:0008037,cell recognition,2/157,155/18888,0.3698938023757,0.57062598048022,0.527250569125537,ADGRB1/NCAM2,2
GO:0030183,B cell differentiation,2/157,155/18888,0.3698938023757,0.57062598048022,0.527250569125537,PIK3R1/SFRP1,2
GO:0045807,positive regulation of endocytosis,2/157,155/18888,0.3698938023757,0.57062598048022,0.527250569125537,CLU/SFTPD,2
GO:0007272,ensheathment of neurons,2/157,156/18888,0.372869464457709,0.573389531118182,0.529804051961083,CLU/EGR2,2
GO:0008366,axon ensheathment,2/157,156/18888,0.372869464457709,0.573389531118182,0.529804051961083,CLU/EGR2,2
GO:0032368,regulation of lipid transport,2/157,156/18888,0.372869464457709,0.573389531118182,0.529804051961083,ABCA8/POMC,2
GO:0046718,symbiont entry into host cell,2/157,156/18888,0.372869464457709,0.573389531118182,0.529804051961083,ANPEP/GPR15,2
GO:0001954,positive regulation of cell-matrix adhesion,1/157,56/18888,0.373815883416849,0.573389531118182,0.529804051961083,SFRP1,1
GO:0014888,striated muscle adaptation,1/157,56/18888,0.373815883416849,0.573389531118182,0.529804051961083,GTF2IRD1,1
GO:0034205,amyloid-beta formation,1/157,56/18888,0.373815883416849,0.573389531118182,0.529804051961083,CLU,1
GO:0170038,proteinogenic amino acid biosynthetic process,1/157,56/18888,0.373815883416849,0.573389531118182,0.529804051961083,CBS,1
GO:2000648,positive regulation of stem cell proliferation,1/157,56/18888,0.373815883416849,0.573389531118182,0.529804051961083,RUNX2,1
GO:0090068,positive regulation of cell cycle process,3/157,263/18888,0.37409672964385,0.573457138732534,0.529866520468238,ESPL1/GPSM2/HSPA2,3
GO:0030832,regulation of actin filament length,2/157,157/18888,0.375839543061034,0.575036875106648,0.531326175182204,C15orf62/FCHSD2,2
GO:0048754,branching morphogenesis of an epithelial tube,2/157,157/18888,0.375839543061034,0.575036875106648,0.531326175182204,NOG/PKHD1,2
GO:2001236,regulation of extrinsic apoptotic signaling pathway,2/157,157/18888,0.375839543061034,0.575036875106648,0.531326175182204,BMPR1B/SFRP1,2
GO:0000723,telomere maintenance,2/157,158/18888,0.378803925526291,0.575925923041276,0.532147643263832,BRCA2/EXO1,2
GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2/157,158/18888,0.378803925526291,0.575925923041276,0.532147643263832,ADGRB1/ADRA2A,2
GO:0098754,detoxification,2/157,158/18888,0.378803925526291,0.575925923041276,0.532147643263832,CLIC2/MT1F,2
GO:1905039,carboxylic acid transmembrane transport,2/157,158/18888,0.378803925526291,0.575925923041276,0.532147643263832,SLC1A3/SLC36A4,2
GO:0001541,ovarian follicle development,1/157,57/18888,0.379036301126257,0.575925923041276,0.532147643263832,BMPR1B,1
GO:0002707,negative regulation of lymphocyte mediated immunity,1/157,57/18888,0.379036301126257,0.575925923041276,0.532147643263832,KLRC1,1
GO:0002886,regulation of myeloid leukocyte mediated immunity,1/157,57/18888,0.379036301126257,0.575925923041276,0.532147643263832,IL13RA2,1
GO:0006893,Golgi to plasma membrane transport,1/157,57/18888,0.379036301126257,0.575925923041276,0.532147643263832,PHAF1,1
GO:0045005,DNA-templated DNA replication maintenance of fidelity,1/157,57/18888,0.379036301126257,0.575925923041276,0.532147643263832,BRCA2,1
GO:0061900,glial cell activation,1/157,57/18888,0.379036301126257,0.575925923041276,0.532147643263832,CLU,1
GO:0170034,L-amino acid biosynthetic process,1/157,57/18888,0.379036301126257,0.575925923041276,0.532147643263832,CBS,1
GO:1903825,organic acid transmembrane transport,2/157,159/18888,0.381762501426584,0.579704563294788,0.535639054963153,SLC1A3/SLC36A4,2
GO:0032386,regulation of intracellular transport,3/157,267/18888,0.383114282274764,0.58087704661017,0.536722413443966,NEFH/PIK3R1/ZFAND1,3
GO:0070663,regulation of leukocyte proliferation,3/157,267/18888,0.383114282274764,0.58087704661017,0.536722413443966,CD22/SFTPD/TNFRSF13C,3
GO:0042306,regulation of protein import into nucleus,1/157,58/18888,0.384213471787569,0.58087704661017,0.536722413443966,PIK3R1,1
GO:0045010,actin nucleation,1/157,58/18888,0.384213471787569,0.58087704661017,0.536722413443966,FCHSD2,1
GO:0051339,regulation of lyase activity,1/157,58/18888,0.384213471787569,0.58087704661017,0.536722413443966,NOS2,1
GO:0072132,mesenchyme morphogenesis,1/157,58/18888,0.384213471787569,0.58087704661017,0.536722413443966,NOG,1
GO:0099024,plasma membrane invagination,1/157,58/18888,0.384213471787569,0.58087704661017,0.536722413443966,ADGRB1,1
GO:0006606,protein import into nucleus,2/157,161/18888,0.387661802813985,0.583178883035612,0.538849278688213,HEATR3/PIK3R1,2
GO:0036294,cellular response to decreased oxygen levels,2/157,161/18888,0.387661802813985,0.583178883035612,0.538849278688213,CBS/SFRP1,2
GO:0050867,positive regulation of cell activation,4/157,380/18888,0.388740692612396,0.583178883035612,0.538849278688213,CEBPA/IL1RL1/NSD2/TNFRSF13C,4
GO:0007062,sister chromatid cohesion,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,ESPL1,1
GO:0010718,positive regulation of epithelial to mesenchymal transition,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,OLFM1,1
GO:0010965,regulation of mitotic sister chromatid separation,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,ESPL1,1
GO:0032608,interferon-beta production,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,POLR3D,1
GO:0032648,regulation of interferon-beta production,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,POLR3D,1
GO:0045604,regulation of epidermal cell differentiation,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,SULT2B1,1
GO:0045620,negative regulation of lymphocyte differentiation,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,SFRP1,1
GO:0050432,catecholamine secretion,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,ADRA2A,1
GO:0050881,musculoskeletal movement,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,TNNI2,1
GO:0051480,regulation of cytosolic calcium ion concentration,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,CALB2,1
GO:0060135,maternal process involved in female pregnancy,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,CBS,1
GO:0060612,adipose tissue development,1/157,59/18888,0.389347751390827,0.583178883035612,0.538849278688213,HSD17B1,1
GO:0007292,female gamete generation,2/157,163/18888,0.393536607367257,0.585734182759691,0.541210340539399,BMPR1B/BRCA2,2
GO:0044409,symbiont entry into host,2/157,163/18888,0.393536607367257,0.585734182759691,0.541210340539399,ANPEP/GPR15,2
GO:0006644,phospholipid metabolic process,4/157,383/18888,0.394384002627714,0.585734182759691,0.541210340539399,ABCA8/MTMR7/PIK3R1/SERINC1,4
GO:0001658,branching involved in ureteric bud morphogenesis,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,NOG,1
GO:0001913,T cell mediated cytotoxicity,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,KLRC1,1
GO:0007131,reciprocal meiotic recombination,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,SHOC1,1
GO:0014009,glial cell proliferation,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,CLU,1
GO:0043113,receptor clustering,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,PIGR,1
GO:0046324,regulation of glucose import,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,PIK3R1,1
GO:0060038,cardiac muscle cell proliferation,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,NOG,1
GO:0061462,protein localization to lysosome,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,CLU,1
GO:0099518,vesicle cytoskeletal trafficking,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,SYBU,1
GO:0140527,reciprocal homologous recombination,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,SHOC1,1
GO:1905517,macrophage migration,1/157,60/18888,0.394439493014474,0.585734182759691,0.541210340539399,SFTPD,1
GO:0007584,response to nutrient,2/157,164/18888,0.396464570170578,0.587344816099531,0.542698543625365,CBS/SFRP1,2
GO:0046488,phosphatidylinositol metabolic process,2/157,164/18888,0.396464570170578,0.587344816099531,0.542698543625365,MTMR7/PIK3R1,2
GO:0060271,cilium assembly,4/157,385/18888,0.398142152023975,0.587344816099531,0.542698543625365,ONECUT2/PKHD1/WDR11/WDR44,4
GO:0001667,ameboidal-type cell migration,5/157,498/18888,0.398832709587429,0.587344816099531,0.542698543625365,ADGRB1/NRTN/SEMA4A/SEMA6D/SYNJ2BP,5
GO:0050905,neuromuscular process,2/157,165/18888,0.39938610913319,0.587344816099531,0.542698543625365,SLC1A3/TNNI2,2
GO:0051250,negative regulation of lymphocyte activation,2/157,165/18888,0.39938610913319,0.587344816099531,0.542698543625365,SFRP1/SFTPD,2
GO:0003179,heart valve morphogenesis,1/157,61/18888,0.399489046849014,0.587344816099531,0.542698543625365,OLFM1,1
GO:0006383,transcription by RNA polymerase III,1/157,61/18888,0.399489046849014,0.587344816099531,0.542698543625365,POLR3D,1
GO:0031102,neuron projection regeneration,1/157,61/18888,0.399489046849014,0.587344816099531,0.542698543625365,RTCA,1
GO:0042908,xenobiotic transport,1/157,61/18888,0.399489046849014,0.587344816099531,0.542698543625365,ABCA8,1
GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,1/157,61/18888,0.399489046849014,0.587344816099531,0.542698543625365,GRK3,1
GO:0048599,oocyte development,1/157,61/18888,0.399489046849014,0.587344816099531,0.542698543625365,BRCA2,1
GO:0050879,multicellular organismal movement,1/157,61/18888,0.399489046849014,0.587344816099531,0.542698543625365,TNNI2,1
GO:0051785,positive regulation of nuclear division,1/157,61/18888,0.399489046849014,0.587344816099531,0.542698543625365,ESPL1,1
GO:0071709,membrane assembly,1/157,61/18888,0.399489046849014,0.587344816099531,0.542698543625365,NLGN4X,1
GO:0002757,immune response-activating signaling pathway,5/157,500/18888,0.4021304612426,0.587344816099531,0.542698543625365,CD22/KLRC1/LIMK1/PIK3R1/TNIP3,5
GO:0007264,small GTPase-mediated signal transduction,5/157,500/18888,0.4021304612426,0.587344816099531,0.542698543625365,ADRA2A/C15orf62/FGD5/LIMK1/SYNJ2BP,5
GO:0007338,single fertilization,2/157,166/18888,0.402301128663926,0.587344816099531,0.542698543625365,HOXD9/RIMS1,2
GO:0051170,import into nucleus,2/157,166/18888,0.402301128663926,0.587344816099531,0.542698543625365,HEATR3/PIK3R1,2
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,2/157,166/18888,0.402301128663926,0.587344816099531,0.542698543625365,CEBPA/CLU,2
GO:0000768,syncytium formation by plasma membrane fusion,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,ADGRB1,1
GO:0002712,regulation of B cell mediated immunity,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,NSD2,1
GO:0002763,positive regulation of myeloid leukocyte differentiation,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,GPR68,1
GO:0002889,regulation of immunoglobulin mediated immune response,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,NSD2,1
GO:0006611,protein export from nucleus,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,EGR2,1
GO:0006767,water-soluble vitamin metabolic process,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,CUBN,1
GO:0033013,tetrapyrrole metabolic process,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,CUBN,1
GO:0033619,membrane protein proteolysis,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,ADRA2A,1
GO:0034113,heterotypic cell-cell adhesion,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,GLDN,1
GO:0042255,ribosome assembly,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,BOP1,1
GO:0046824,positive regulation of nucleocytoplasmic transport,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,PIK3R1,1
GO:0051306,mitotic sister chromatid separation,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,ESPL1,1
GO:0071715,icosanoid transport,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,NOS2,1
GO:0097120,receptor localization to synapse,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,SNAP25,1
GO:0140253,cell-cell fusion,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,ADGRB1,1
GO:1903078,positive regulation of protein localization to plasma membrane,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,PIK3R1,1
GO:1903670,regulation of sprouting angiogenesis,1/157,62/18888,0.404496760220486,0.587344816099531,0.542698543625365,SYNJ2BP,1
GO:0030041,actin filament polymerization,2/157,167/18888,0.405209535181655,0.587957983566144,0.543265101943423,C15orf62/FCHSD2,2
GO:0090150,establishment of protein localization to membrane,3/157,277/18888,0.405525766251157,0.587957983566144,0.543265101943423,MMGT1/PHAF1/SNAP25,3
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,4/157,389/18888,0.405647312361283,0.587957983566144,0.543265101943423,ANAPC13/CEBPA/CLU/PEX12,4
GO:0002833,positive regulation of response to biotic stimulus,4/157,390/18888,0.407521058658113,0.589607212711342,0.544788967023475,KLRC1/PIK3R1/POLR3D/TNIP3,4
GO:0002758,innate immune response-activating signaling pathway,3/157,278/18888,0.40775484567806,0.589607212711342,0.544788967023475,KLRC1/PIK3R1/TNIP3,3
GO:0032623,interleukin-2 production,1/157,63/18888,0.40946297761374,0.589607212711342,0.544788967023475,SFTPD,1
GO:0032663,regulation of interleukin-2 production,1/157,63/18888,0.40946297761374,0.589607212711342,0.544788967023475,SFTPD,1
GO:0032757,positive regulation of interleukin-8 production,1/157,63/18888,0.40946297761374,0.589607212711342,0.544788967023475,NOS2,1
GO:0033059,cellular pigmentation,1/157,63/18888,0.40946297761374,0.589607212711342,0.544788967023475,POMC,1
GO:0045428,regulation of nitric oxide biosynthetic process,1/157,63/18888,0.40946297761374,0.589607212711342,0.544788967023475,CLU,1
GO:0051893,regulation of focal adhesion assembly,1/157,63/18888,0.40946297761374,0.589607212711342,0.544788967023475,SFRP1,1
GO:0061951,establishment of protein localization to plasma membrane,1/157,63/18888,0.40946297761374,0.589607212711342,0.544788967023475,PHAF1,1
GO:0090109,regulation of cell-substrate junction assembly,1/157,63/18888,0.40946297761374,0.589607212711342,0.544788967023475,SFRP1,1
GO:2000117,negative regulation of cysteine-type endopeptidase activity,1/157,63/18888,0.40946297761374,0.589607212711342,0.544788967023475,CST2,1
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,3/157,279/18888,0.409981498286717,0.590003083095918,0.545154745822036,ALCAM/CLDN18/PCDH9,3
GO:0015698,inorganic anion transport,2/157,169/18888,0.411006144745456,0.590075211958206,0.54522139190019,CLIC2/SLC1A3,2
GO:0048639,positive regulation of developmental growth,2/157,169/18888,0.411006144745456,0.590075211958206,0.54522139190019,LIMK1/RIMS1,2
GO:1902904,negative regulation of supramolecular fiber organization,2/157,169/18888,0.411006144745456,0.590075211958206,0.54522139190019,CLU/PIK3R1,2
GO:1990845,adaptive thermogenesis,2/157,169/18888,0.411006144745456,0.590075211958206,0.54522139190019,DIO2/TRPM8,2
GO:0043409,negative regulation of MAPK cascade,2/157,170/18888,0.413894170443052,0.592302124871988,0.547279028848645,CNKSR3/SYNJ2BP,2
GO:0019674,NAD metabolic process,1/157,64/18888,0.414388040695527,0.592302124871988,0.547279028848645,HAAO,1
GO:0043124,negative regulation of canonical NF-kappaB signal transduction,1/157,64/18888,0.414388040695527,0.592302124871988,0.547279028848645,TNIP3,1
GO:0048247,lymphocyte chemotaxis,1/157,64/18888,0.414388040695527,0.592302124871988,0.547279028848645,CYP7B1,1
GO:0048278,vesicle docking,1/157,64/18888,0.414388040695527,0.592302124871988,0.547279028848645,SNAP25,1
GO:0010959,regulation of metal ion transport,4/157,394/18888,0.415004741640287,0.592302124871988,0.547279028848645,ADRA2A/CLIC2/CNKSR3/TMEM38A,4
GO:0006820,monoatomic anion transport,2/157,171/18888,0.416775228379297,0.592302124871988,0.547279028848645,CLIC2/SLC1A3,2
GO:0030856,regulation of epithelial cell differentiation,2/157,171/18888,0.416775228379297,0.592302124871988,0.547279028848645,FRZB/SULT2B1,2
GO:0051168,nuclear export,2/157,171/18888,0.416775228379297,0.592302124871988,0.547279028848645,DDX19A/EGR2,2
GO:0050900,leukocyte migration,4/157,396/18888,0.418739285785588,0.592302124871988,0.547279028848645,CYP7B1/GPR15/PIK3R1/SFTPD,4
GO:2001233,regulation of apoptotic signaling pathway,4/157,396/18888,0.418739285785588,0.592302124871988,0.547279028848645,BMPR1B/CLU/NOG/SFRP1,4
GO:0009994,oocyte differentiation,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,BRCA2,1
GO:0010324,membrane invagination,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,ADGRB1,1
GO:0010812,negative regulation of cell-substrate adhesion,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,PIK3R1,1
GO:0030166,proteoglycan biosynthetic process,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,BMPR1B,1
GO:0035904,aorta development,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,EGR2,1
GO:0042058,regulation of epidermal growth factor receptor signaling pathway,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,ADRA2A,1
GO:0043462,regulation of ATP-dependent activity,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,MYL3,1
GO:0045682,regulation of epidermis development,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,SULT2B1,1
GO:0046503,glycerolipid catabolic process,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,AADAC,1
GO:0050435,amyloid-beta metabolic process,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,CLU,1
GO:0070192,chromosome organization involved in meiotic cell cycle,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,SHOC1,1
GO:0072666,establishment of protein localization to vacuole,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,CLU,1
GO:0080164,regulation of nitric oxide metabolic process,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,CLU,1
GO:0090303,positive regulation of wound healing,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,ADRA2A,1
GO:0098930,axonal transport,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,SYBU,1
GO:1904036,negative regulation of epithelial cell apoptotic process,1/157,65/18888,0.419272288337409,0.592302124871988,0.547279028848645,PKHD1,1
GO:0009266,response to temperature stimulus,2/157,172/18888,0.419649234632672,0.592302124871988,0.547279028848645,HSPA2/TRPM8,2
GO:0010970,transport along microtubule,2/157,172/18888,0.419649234632672,0.592302124871988,0.547279028848645,NEFH/SYBU,2
GO:0000271,polysaccharide biosynthetic process,1/157,66/18888,0.424116056638479,0.596174747056527,0.550857278561509,PPP1R3F,1
GO:0001756,somitogenesis,1/157,66/18888,0.424116056638479,0.596174747056527,0.550857278561509,SFRP1,1
GO:0006949,syncytium formation,1/157,66/18888,0.424116056638479,0.596174747056527,0.550857278561509,ADGRB1,1
GO:0015800,acidic amino acid transport,1/157,66/18888,0.424116056638479,0.596174747056527,0.550857278561509,SLC1A3,1
GO:0045453,bone resorption,1/157,66/18888,0.424116056638479,0.596174747056527,0.550857278561509,CLDN18,1
GO:0046854,phosphatidylinositol phosphate biosynthetic process,1/157,66/18888,0.424116056638479,0.596174747056527,0.550857278561509,PIK3R1,1
GO:0071806,protein transmembrane transport,1/157,66/18888,0.424116056638479,0.596174747056527,0.550857278561509,PEX12,1
GO:0043542,endothelial cell migration,3/157,286/18888,0.425495477553132,0.59776684839541,0.552328358333105,ADGRB1/SEMA4A/SYNJ2BP,3
GO:0046486,glycerolipid metabolic process,4/157,400/18888,0.42619233350921,0.598398743048874,0.552912220314618,AADAC/MTMR7/PIK3R1/SERINC1,4
GO:0006903,vesicle targeting,1/157,67/18888,0.428919678947891,0.600140648418136,0.554521716952912,WDR11,1
GO:0006956,complement activation,1/157,67/18888,0.428919678947891,0.600140648418136,0.554521716952912,CLU,1
GO:0048857,neural nucleus development,1/157,67/18888,0.428919678947891,0.600140648418136,0.554521716952912,MAOB,1
GO:0055021,regulation of cardiac muscle tissue growth,1/157,67/18888,0.428919678947891,0.600140648418136,0.554521716952912,NOG,1
GO:0060675,ureteric bud morphogenesis,1/157,67/18888,0.428919678947891,0.600140648418136,0.554521716952912,NOG,1
GO:0061180,mammary gland epithelium development,1/157,67/18888,0.428919678947891,0.600140648418136,0.554521716952912,BRCA2,1
GO:0007548,sex differentiation,3/157,288/18888,0.429903104048114,0.601169352196611,0.555472225116257,BMPR1B/BRCA2/SFRP1,3
GO:0055088,lipid homeostasis,2/157,176/18888,0.431073128824722,0.602457656095486,0.556662600225565,CEBPA/CYP7B1,2
GO:0006303,double-strand break repair via nonhomologous end joining,1/157,68/18888,0.433683485887224,0.602944160442148,0.557112123560349,NSD2,1
GO:0016925,protein sumoylation,1/157,68/18888,0.433683485887224,0.602944160442148,0.557112123560349,EGR2,1
GO:0035825,homologous recombination,1/157,68/18888,0.433683485887224,0.602944160442148,0.557112123560349,SHOC1,1
GO:0042987,amyloid precursor protein catabolic process,1/157,68/18888,0.433683485887224,0.602944160442148,0.557112123560349,CLU,1
GO:0045576,mast cell activation,1/157,68/18888,0.433683485887224,0.602944160442148,0.557112123560349,IL13RA2,1
GO:0050854,regulation of antigen receptor-mediated signaling pathway,1/157,68/18888,0.433683485887224,0.602944160442148,0.557112123560349,CD22,1
GO:0071300,cellular response to retinoic acid,1/157,68/18888,0.433683485887224,0.602944160442148,0.557112123560349,FZD10,1
GO:0072171,mesonephric tubule morphogenesis,1/157,68/18888,0.433683485887224,0.602944160442148,0.557112123560349,NOG,1
GO:0071453,cellular response to oxygen levels,2/157,177/18888,0.43391068193669,0.602944160442148,0.557112123560349,CBS/SFRP1,2
GO:0072331,signal transduction by p53 class mediator,2/157,177/18888,0.43391068193669,0.602944160442148,0.557112123560349,BOP1/BRCA2,2
GO:0045786,negative regulation of cell cycle,4/157,405/18888,0.435475665245681,0.604771824096926,0.558800859676676,BRCA2/CEBPA/ESPL1/PPP2R5B,4
GO:0021953,central nervous system neuron differentiation,2/157,178/18888,0.436740717954513,0.6060637583405,0.559994589174629,BMPR1B/TULP3,2
GO:0006414,translational elongation,1/157,69/18888,0.438407805372649,0.6060637583405,0.559994589174629,DIO2,1
GO:0019229,regulation of vasoconstriction,1/157,69/18888,0.438407805372649,0.6060637583405,0.559994589174629,ADRA2A,1
GO:0030193,regulation of blood coagulation,1/157,69/18888,0.438407805372649,0.6060637583405,0.559994589174629,PROS1,1
GO:0045911,positive regulation of DNA recombination,1/157,69/18888,0.438407805372649,0.6060637583405,0.559994589174629,NSD2,1
GO:0048645,animal organ formation,1/157,69/18888,0.438407805372649,0.6060637583405,0.559994589174629,NOG,1
GO:0051445,regulation of meiotic cell cycle,1/157,69/18888,0.438407805372649,0.6060637583405,0.559994589174629,ANAPC13,1
GO:1901607,alpha-amino acid biosynthetic process,1/157,69/18888,0.438407805372649,0.6060637583405,0.559994589174629,CBS,1
GO:0031214,biomineral tissue development,2/157,180/18888,0.442377954637658,0.611203312112042,0.564743466274154,BMPR1B/RUNX2,2
GO:2000379,positive regulation of reactive oxygen species metabolic process,1/157,70/18888,0.44309296263693,0.611842163914848,0.565333756566112,ADGRB1,1
GO:0042129,regulation of T cell proliferation,2/157,181/18888,0.445185017466858,0.614380690771926,0.567679320518542,SFTPD/TNFRSF13C,2
GO:0032091,negative regulation of protein binding,1/157,71/18888,0.447739280251235,0.615842958556218,0.569030435868799,NOG,1
GO:0032835,glomerulus development,1/157,71/18888,0.447739280251235,0.615842958556218,0.569030435868799,NOG,1
GO:0048488,synaptic vesicle endocytosis,1/157,71/18888,0.447739280251235,0.615842958556218,0.569030435868799,NLGN4X,1
GO:0070830,bicellular tight junction assembly,1/157,71/18888,0.447739280251235,0.615842958556218,0.569030435868799,CLDN18,1
GO:1900046,regulation of hemostasis,1/157,71/18888,0.447739280251235,0.615842958556218,0.569030435868799,PROS1,1
GO:0006109,regulation of carbohydrate metabolic process,2/157,182/18888,0.447984287484298,0.615842958556218,0.569030435868799,POMC/PPP1R3F,2
GO:0044782,cilium organization,4/157,412/18888,0.448403153831185,0.615842958556218,0.569030435868799,ONECUT2/PKHD1/WDR11/WDR44,4
GO:0140694,non-membrane-bounded organelle assembly,4/157,413/18888,0.450242779465748,0.615842958556218,0.569030435868799,BOP1/GPSM2/GRB7/MYOM1,4
GO:0001659,temperature homeostasis,2/157,183/18888,0.450775699869198,0.615842958556218,0.569030435868799,DIO2/TRPM8,2
GO:0007219,Notch signaling pathway,2/157,183/18888,0.450775699869198,0.615842958556218,0.569030435868799,CEBPA/SYNJ2BP,2
GO:0007565,female pregnancy,2/157,183/18888,0.450775699869198,0.615842958556218,0.569030435868799,ADRA2A/CBS,2
GO:0061025,membrane fusion,2/157,183/18888,0.450775699869198,0.615842958556218,0.569030435868799,RIMS1/SNAP25,2
GO:0002218,activation of innate immune response,3/157,298/18888,0.451755747616888,0.615842958556218,0.569030435868799,KLRC1/PIK3R1/TNIP3,3
GO:0010632,regulation of epithelial cell migration,3/157,298/18888,0.451755747616888,0.615842958556218,0.569030435868799,ADGRB1/SEMA4A/SYNJ2BP,3
GO:0006406,mRNA export from nucleus,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,DDX19A,1
GO:0030032,lamellipodium assembly,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,PIK3R1,1
GO:0032722,positive regulation of chemokine production,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,IL1RL1,1
GO:0042698,ovulation cycle,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,BMPR1B,1
GO:0043112,receptor metabolic process,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,PEX12,1
GO:0050766,positive regulation of phagocytosis,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,SFTPD,1
GO:0051341,regulation of oxidoreductase activity,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,POR,1
GO:0061512,protein localization to cilium,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,TULP3,1
GO:0140238,presynaptic endocytosis,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,NLGN4X,1
GO:1901184,regulation of ERBB signaling pathway,1/157,72/18888,0.452347078146785,0.615842958556218,0.569030435868799,ADRA2A,1
GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,3/157,299/18888,0.453922872104569,0.61764112148161,0.57069191371633,PIK3IP1/PIK3R1/PKHD1,3
GO:0003170,heart valve development,1/157,73/18888,0.456916673636313,0.619279341660408,0.572205606662622,OLFM1,1
GO:0030858,positive regulation of epithelial cell differentiation,1/157,73/18888,0.456916673636313,0.619279341660408,0.572205606662622,SULT2B1,1
GO:0032481,positive regulation of type I interferon production,1/157,73/18888,0.456916673636313,0.619279341660408,0.572205606662622,POLR3D,1
GO:0042130,negative regulation of T cell proliferation,1/157,73/18888,0.456916673636313,0.619279341660408,0.572205606662622,SFTPD,1
GO:0060420,regulation of heart growth,1/157,73/18888,0.456916673636313,0.619279341660408,0.572205606662622,NOG,1
GO:0071260,cellular response to mechanical stimulus,1/157,73/18888,0.456916673636313,0.619279341660408,0.572205606662622,MAP3K14,1
GO:0140962,multicellular organismal-level chemical homeostasis,1/157,73/18888,0.456916673636313,0.619279341660408,0.572205606662622,SFTPD,1
GO:0002706,regulation of lymphocyte mediated immunity,2/157,186/18888,0.459102166875036,0.620770605399895,0.573583513877256,KLRC1/NSD2,2
GO:0051302,regulation of cell division,2/157,186/18888,0.459102166875036,0.620770605399895,0.573583513877256,BRCA2/POU5F1,2
GO:1905952,regulation of lipid localization,2/157,186/18888,0.459102166875036,0.620770605399895,0.573583513877256,ABCA8/POMC,2
GO:0043254,regulation of protein-containing complex assembly,4/157,418/18888,0.459412000835169,0.620770605399895,0.573583513877256,C15orf62/CLU/FCHSD2/PPP2R5B,4
GO:0014015,positive regulation of gliogenesis,1/157,74/18888,0.461448381435361,0.620770605399895,0.573583513877256,EGR2,1
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",1/157,74/18888,0.461448381435361,0.620770605399895,0.573583513877256,BRCA2,1
GO:0033344,cholesterol efflux,1/157,74/18888,0.461448381435361,0.620770605399895,0.573583513877256,ABCA8,1
GO:0042093,T-helper cell differentiation,1/157,74/18888,0.461448381435361,0.620770605399895,0.573583513877256,SEMA4A,1
GO:0050818,regulation of coagulation,1/157,74/18888,0.461448381435361,0.620770605399895,0.573583513877256,PROS1,1
GO:0051937,catecholamine transport,1/157,74/18888,0.461448381435361,0.620770605399895,0.573583513877256,ADRA2A,1
GO:0072678,T cell migration,1/157,74/18888,0.461448381435361,0.620770605399895,0.573583513877256,GPR15,1
GO:1902017,regulation of cilium assembly,1/157,74/18888,0.461448381435361,0.620770605399895,0.573583513877256,WDR44,1
GO:1905818,regulation of chromosome separation,1/157,74/18888,0.461448381435361,0.620770605399895,0.573583513877256,ESPL1,1
GO:0008217,regulation of blood pressure,2/157,187/18888,0.46186153217614,0.620770605399895,0.573583513877256,NOS2/POMC,2
GO:0097553,calcium ion transmembrane import into cytosol,2/157,187/18888,0.46186153217614,0.620770605399895,0.573583513877256,CLIC2/TMEM38A,2
GO:0000910,cytokinesis,2/157,188/18888,0.464612739293317,0.624122049122803,0.576680201849311,BRCA2/ESPL1,2
GO:0060390,regulation of SMAD protein signal transduction,1/157,75/18888,0.465942513683402,0.625214829995125,0.57768991636735,NOG,1
GO:1902893,regulation of miRNA transcription,1/157,75/18888,0.465942513683402,0.625214829995125,0.57768991636735,POU5F1,1
GO:0032200,telomere organization,2/157,189/18888,0.467355732677672,0.626417036273006,0.578800738457304,BRCA2/EXO1,2
GO:0061136,regulation of proteasomal protein catabolic process,2/157,189/18888,0.467355732677672,0.626417036273006,0.578800738457304,CEBPA/CLU,2
GO:0001707,mesoderm formation,1/157,76/18888,0.470399379964788,0.628063560239645,0.580322103989519,NOG,1
GO:0002224,toll-like receptor signaling pathway,1/157,76/18888,0.470399379964788,0.628063560239645,0.580322103989519,TNIP3,1
GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",1/157,76/18888,0.470399379964788,0.628063560239645,0.580322103989519,SEMA4A,1
GO:0008088,axo-dendritic transport,1/157,76/18888,0.470399379964788,0.628063560239645,0.580322103989519,SYBU,1
GO:0030968,endoplasmic reticulum unfolded protein response,1/157,76/18888,0.470399379964788,0.628063560239645,0.580322103989519,PIK3R1,1
GO:0042267,natural killer cell mediated cytotoxicity,1/157,76/18888,0.470399379964788,0.628063560239645,0.580322103989519,KLRC1,1
GO:0061614,miRNA transcription,1/157,76/18888,0.470399379964788,0.628063560239645,0.580322103989519,POU5F1,1
GO:0006650,glycerophospholipid metabolic process,3/157,307/18888,0.471130938805495,0.628693737623641,0.580904379237629,MTMR7/PIK3R1/SERINC1,3
GO:0046651,lymphocyte proliferation,3/157,308/18888,0.473265201880308,0.628765617229153,0.580970795005946,CD22/SFTPD/TNFRSF13C,3
GO:0070372,regulation of ERK1 and ERK2 cascade,3/157,308/18888,0.473265201880308,0.628765617229153,0.580970795005946,CNKSR3/PKHD1/SYNJ2BP,3
GO:0031400,negative regulation of protein modification process,4/157,426/18888,0.473975173765414,0.628765617229153,0.580970795005946,ADGRB1/CNKSR3/LIMK1/SFRP1,4
GO:0001937,negative regulation of endothelial cell proliferation,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,SYNJ2BP,1
GO:0002287,alpha-beta T cell activation involved in immune response,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,SEMA4A,1
GO:0002293,alpha-beta T cell differentiation involved in immune response,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,SEMA4A,1
GO:0007585,respiratory gaseous exchange by respiratory system,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,SFTPD,1
GO:0030239,myofibril assembly,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,MYOM1,1
GO:0031016,pancreas development,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,ONECUT2,1
GO:0032890,regulation of organic acid transport,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,SV2A,1
GO:0035914,skeletal muscle cell differentiation,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,EGR2,1
GO:0061045,negative regulation of wound healing,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,PROS1,1
GO:0072078,nephron tubule morphogenesis,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,NOG,1
GO:0120192,tight junction assembly,1/157,77/18888,0.47481928732953,0.628765617229153,0.580970795005946,CLDN18,1
GO:1904062,regulation of monoatomic cation transmembrane transport,3/157,309/18888,0.475395608965774,0.629025407042541,0.581210837225626,ADRA2A/CLIC2/TMEM38A,3
GO:0002695,negative regulation of leukocyte activation,2/157,192/18888,0.475534896901277,0.629025407042541,0.581210837225626,SFRP1/SFTPD,2
GO:0006816,calcium ion transport,4/157,428/18888,0.477593811016348,0.631119386971344,0.58314564592163,ADRA2A/CLIC2/TMEM38A/TRPM8,4
GO:0010827,regulation of glucose transmembrane transport,1/157,78/18888,0.479202540313915,0.631119386971344,0.58314564592163,PIK3R1,1
GO:0032720,negative regulation of tumor necrosis factor production,1/157,78/18888,0.479202540313915,0.631119386971344,0.58314564592163,POMC,1
GO:0035418,protein localization to synapse,1/157,78/18888,0.479202540313915,0.631119386971344,0.58314564592163,SNAP25,1
GO:0046323,glucose import,1/157,78/18888,0.479202540313915,0.631119386971344,0.58314564592163,PIK3R1,1
GO:0048332,mesoderm morphogenesis,1/157,78/18888,0.479202540313915,0.631119386971344,0.58314564592163,NOG,1
GO:0050772,positive regulation of axonogenesis,1/157,78/18888,0.479202540313915,0.631119386971344,0.58314564592163,LIMK1,1
GO:0050853,B cell receptor signaling pathway,1/157,78/18888,0.479202540313915,0.631119386971344,0.58314564592163,CD22,1
GO:0034504,protein localization to nucleus,3/157,311/18888,0.479644699819204,0.631358403783756,0.5833664941737,CLDN18/HEATR3/PIK3R1,3
GO:0030258,lipid modification,2/157,194/18888,0.480945651294843,0.63237872489317,0.584309256865957,MTMR7/SAMD1,2
GO:0050777,negative regulation of immune response,2/157,194/18888,0.480945651294843,0.63237872489317,0.584309256865957,IL1RL1/KLRC1,2
GO:0042060,wound healing,4/157,430/18888,0.481203133764704,0.63237872489317,0.584309256865957,ADRA2A/F8/NOG/PROS1,4
GO:0002228,natural killer cell mediated immunity,1/157,79/18888,0.483549440960949,0.633400078965613,0.585252974001866,KLRC1,1
GO:0042246,tissue regeneration,1/157,79/18888,0.483549440960949,0.633400078965613,0.585252974001866,CPQ,1
GO:0043297,apical junction assembly,1/157,79/18888,0.483549440960949,0.633400078965613,0.585252974001866,CLDN18,1
GO:0043299,leukocyte degranulation,1/157,79/18888,0.483549440960949,0.633400078965613,0.585252974001866,IL13RA2,1
GO:0055002,striated muscle cell development,1/157,79/18888,0.483549440960949,0.633400078965613,0.585252974001866,MYOM1,1
GO:0072088,nephron epithelium morphogenesis,1/157,79/18888,0.483549440960949,0.633400078965613,0.585252974001866,NOG,1
GO:0001666,response to hypoxia,3/157,313/18888,0.483877905947913,0.633487723354511,0.585333956213521,CBS/NOS2/SFRP1,3
GO:0008154,actin polymerization or depolymerization,2/157,196/18888,0.486322339759265,0.635573075930417,0.587260793353934,C15orf62/FCHSD2,2
GO:0009755,hormone-mediated signaling pathway,2/157,196/18888,0.486322339759265,0.635573075930417,0.587260793353934,CYP7B1/SFRP1,2
GO:0048839,inner ear development,2/157,196/18888,0.486322339759265,0.635573075930417,0.587260793353934,CEBPA/FRZB,2
GO:0002534,cytokine production involved in inflammatory response,1/157,80/18888,0.487860288840641,0.635573075930417,0.587260793353934,NOS2,1
GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,1/157,80/18888,0.487860288840641,0.635573075930417,0.587260793353934,ADRA2A,1
GO:0021536,diencephalon development,1/157,80/18888,0.487860288840641,0.635573075930417,0.587260793353934,NOG,1
GO:1900015,regulation of cytokine production involved in inflammatory response,1/157,80/18888,0.487860288840641,0.635573075930417,0.587260793353934,NOS2,1
GO:1903036,positive regulation of response to wounding,1/157,80/18888,0.487860288840641,0.635573075930417,0.587260793353934,ADRA2A,1
GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,1/157,80/18888,0.487860288840641,0.635573075930417,0.587260793353934,POMC,1
GO:0032943,mononuclear cell proliferation,3/157,315/18888,0.488094930318157,0.635573075930417,0.587260793353934,CD22/SFTPD/TNFRSF13C,3
GO:0002520,immune system development,2/157,197/18888,0.48899779593265,0.636064802228183,0.587715141699821,EXO1/NSD2,2
GO:0007051,spindle organization,2/157,197/18888,0.48899779593265,0.636064802228183,0.587715141699821,ESPL1/GPSM2,2
GO:0010948,negative regulation of cell cycle process,3/157,316/18888,0.490197283790153,0.63706675197853,0.588640929508607,BRCA2/ESPL1/PPP2R5B,3
GO:0031396,regulation of protein ubiquitination,2/157,198/18888,0.49166460227486,0.63706675197853,0.588640929508607,ADGRB1/LIMK1,2
GO:0003151,outflow tract morphogenesis,1/157,81/18888,0.492135381070119,0.63706675197853,0.588640929508607,NOG,1
GO:0008344,adult locomotory behavior,1/157,81/18888,0.492135381070119,0.63706675197853,0.588640929508607,HOXD9,1
GO:0032088,negative regulation of NF-kappaB transcription factor activity,1/157,81/18888,0.492135381070119,0.63706675197853,0.588640929508607,PKHD1,1
GO:0048844,artery morphogenesis,1/157,81/18888,0.492135381070119,0.63706675197853,0.588640929508607,NOG,1
GO:0051304,chromosome separation,1/157,81/18888,0.492135381070119,0.63706675197853,0.588640929508607,ESPL1,1
GO:0061333,renal tubule morphogenesis,1/157,81/18888,0.492135381070119,0.63706675197853,0.588640929508607,NOG,1
GO:0072028,nephron morphogenesis,1/157,81/18888,0.492135381070119,0.63706675197853,0.588640929508607,NOG,1
GO:0030500,regulation of bone mineralization,1/157,82/18888,0.496375012333584,0.640248098877516,0.591580450351428,BMPR1B,1
GO:0032147,activation of protein kinase activity,1/157,82/18888,0.496375012333584,0.640248098877516,0.591580450351428,ADRA2A,1
GO:0036465,synaptic vesicle recycling,1/157,82/18888,0.496375012333584,0.640248098877516,0.591580450351428,NLGN4X,1
GO:0043406,positive regulation of MAP kinase activity,1/157,82/18888,0.496375012333584,0.640248098877516,0.591580450351428,ADRA2A,1
GO:0140056,organelle localization by membrane tethering,1/157,82/18888,0.496375012333584,0.640248098877516,0.591580450351428,SNAP25,1
GO:0001822,kidney development,3/157,319/18888,0.496479287002333,0.640248098877516,0.591580450351428,NOG/PKHD1/SFRP1,3
GO:0097193,intrinsic apoptotic signaling pathway,3/157,319/18888,0.496479287002333,0.640248098877516,0.591580450351428,BRCA2/CLU/PIK3R1,3
GO:0030705,cytoskeleton-dependent intracellular transport,2/157,200/18888,0.496972099871895,0.640248098877516,0.591580450351428,NEFH/SYBU,2
GO:0031099,regeneration,2/157,200/18888,0.496972099871895,0.640248098877516,0.591580450351428,CPQ/RTCA,2
GO:0045088,regulation of innate immune response,4/157,440/18888,0.499102509106571,0.642162864519546,0.593349667507738,KLRC1/PIK3R1/POLR3D/TNIP3,4
GO:0006289,nucleotide-excision repair,1/157,83/18888,0.500579474902107,0.642162864519546,0.593349667507738,BRCA2,1
GO:0031424,keratinization,1/157,83/18888,0.500579474902107,0.642162864519546,0.593349667507738,TCHH,1
GO:0032371,regulation of sterol transport,1/157,83/18888,0.500579474902107,0.642162864519546,0.593349667507738,ABCA8,1
GO:0032374,regulation of cholesterol transport,1/157,83/18888,0.500579474902107,0.642162864519546,0.593349667507738,ABCA8,1
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,1/157,83/18888,0.500579474902107,0.642162864519546,0.593349667507738,BRCA2,1
GO:0120193,tight junction organization,1/157,83/18888,0.500579474902107,0.642162864519546,0.593349667507738,CLDN18,1
GO:0150076,neuroinflammatory response,1/157,83/18888,0.500579474902107,0.642162864519546,0.593349667507738,CLU,1
GO:0051701,biological process involved in interaction with host,2/157,202/18888,0.502244514040437,0.643957762311243,0.595008128416577,ANPEP/GPR15,2
GO:0002028,regulation of sodium ion transport,1/157,84/18888,0.504749058653256,0.645460517454164,0.596396653530163,CNKSR3,1
GO:0014855,striated muscle cell proliferation,1/157,84/18888,0.504749058653256,0.645460517454164,0.596396653530163,NOG,1
GO:0032418,lysosome localization,1/157,84/18888,0.504749058653256,0.645460517454164,0.596396653530163,IL13RA2,1
GO:1902117,positive regulation of organelle assembly,1/157,84/18888,0.504749058653256,0.645460517454164,0.596396653530163,GPSM2,1
GO:1990849,vacuolar localization,1/157,84/18888,0.504749058653256,0.645460517454164,0.596396653530163,IL13RA2,1
GO:0032271,regulation of protein polymerization,2/157,204/18888,0.507481546153761,0.648270202945364,0.598992764336496,C15orf62/FCHSD2,2
GO:0044703,multi-organism reproductive process,2/157,204/18888,0.507481546153761,0.648270202945364,0.598992764336496,ADRA2A/CBS,2
GO:0002292,T cell differentiation involved in immune response,1/157,85/18888,0.50888405109058,0.649376802814218,0.600015247417544,SEMA4A,1
GO:0048041,focal adhesion assembly,1/157,85/18888,0.50888405109058,0.649376802814218,0.600015247417544,SFRP1,1
GO:0000280,nuclear division,4/157,446/18888,0.509716969530537,0.650097156504981,0.600680844334647,BRCA2/ESPL1/HSPA2/SHOC1,4
GO:0071674,mononuclear cell migration,2/157,206/18888,0.512682916905052,0.652962110444562,0.60332802242824,CYP7B1/GPR15,2
GO:0048678,response to axon injury,1/157,86/18888,0.512984737362918,0.652962110444562,0.60332802242824,RTCA,1
GO:0006605,protein targeting,3/157,327/18888,0.513041658206441,0.652962110444562,0.60332802242824,CLU/PEX12/SYNJ2BP,3
GO:0036293,response to decreased oxygen levels,3/157,327/18888,0.513041658206441,0.652962110444562,0.60332802242824,CBS/NOS2/SFRP1,3
GO:0009566,fertilization,2/157,207/18888,0.51527014713365,0.655453937162658,0.60563043609362,HOXD9/RIMS1,2
GO:0010232,vascular transport,1/157,87/18888,0.517051400283567,0.656450575140447,0.606551315897514,SLC1A3,1
GO:0032370,positive regulation of lipid transport,1/157,87/18888,0.517051400283567,0.656450575140447,0.606551315897514,ABCA8,1
GO:0150104,transport across blood-brain barrier,1/157,87/18888,0.517051400283567,0.656450575140447,0.606551315897514,SLC1A3,1
GO:0072001,renal system development,3/157,329/18888,0.517137777608577,0.656450575140447,0.606551315897514,NOG/PKHD1/SFRP1,3
GO:0015711,organic anion transport,4/157,451/18888,0.518485990241043,0.657817217581879,0.607814074744263,NOS2/SLC1A3/SLC36A4/SV2A,4
GO:0000281,mitotic cytokinesis,1/157,88/18888,0.52108432034928,0.659042414561857,0.608946139927206,ESPL1,1
GO:0001892,embryonic placenta development,1/157,88/18888,0.52108432034928,0.659042414561857,0.608946139927206,CEBPA,1
GO:0045824,negative regulation of innate immune response,1/157,88/18888,0.52108432034928,0.659042414561857,0.608946139927206,KLRC1,1
GO:0048708,astrocyte differentiation,1/157,88/18888,0.52108432034928,0.659042414561857,0.608946139927206,NOG,1
GO:0072665,protein localization to vacuole,1/157,88/18888,0.52108432034928,0.659042414561857,0.608946139927206,CLU,1
GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,1/157,88/18888,0.52108432034928,0.659042414561857,0.608946139927206,SNAP25,1
GO:0006470,protein dephosphorylation,2/157,210/18888,0.522977650404662,0.660743362602912,0.610517792556735,MTMR7/PPP2R5B,2
GO:0046474,glycerophospholipid biosynthetic process,2/157,210/18888,0.522977650404662,0.660743362602912,0.610517792556735,MTMR7/PIK3R1,2
GO:0070371,ERK1 and ERK2 cascade,3/157,332/18888,0.52324763396878,0.660743362602912,0.610517792556735,CNKSR3/PKHD1/SYNJ2BP,3
GO:0006029,proteoglycan metabolic process,1/157,89/18888,0.525083775759129,0.661682052491473,0.611385129122027,BMPR1B,1
GO:0042310,vasoconstriction,1/157,89/18888,0.525083775759129,0.661682052491473,0.611385129122027,ADRA2A,1
GO:0050672,negative regulation of lymphocyte proliferation,1/157,89/18888,0.525083775759129,0.661682052491473,0.611385129122027,SFTPD,1
GO:2000243,positive regulation of reproductive process,1/157,89/18888,0.525083775759129,0.661682052491473,0.611385129122027,TACR2,1
GO:0044706,multi-multicellular organism process,2/157,212/18888,0.528070546249484,0.663905989022921,0.613440015934082,ADRA2A/CBS,2
GO:0030071,regulation of mitotic metaphase/anaphase transition,1/157,90/18888,0.529050042433198,0.663905989022921,0.613440015934082,ESPL1,1
GO:0031640,killing of cells of another organism,1/157,90/18888,0.529050042433198,0.663905989022921,0.613440015934082,NOS2,1
GO:0032945,negative regulation of mononuclear cell proliferation,1/157,90/18888,0.529050042433198,0.663905989022921,0.613440015934082,SFTPD,1
GO:0034620,cellular response to unfolded protein,1/157,90/18888,0.529050042433198,0.663905989022921,0.613440015934082,PIK3R1,1
GO:0048145,regulation of fibroblast proliferation,1/157,90/18888,0.529050042433198,0.663905989022921,0.613440015934082,SFRP1,1
GO:0141061,disruption of cell in another organism,1/157,90/18888,0.529050042433198,0.663905989022921,0.613440015934082,NOS2,1
GO:2000628,regulation of miRNA metabolic process,1/157,90/18888,0.529050042433198,0.663905989022921,0.613440015934082,POU5F1,1
GO:0071496,cellular response to external stimulus,3/157,335/18888,0.52931563369251,0.663905989022921,0.613440015934082,CBS/MAP3K14/SFRP1,3
GO:0042098,T cell proliferation,2/157,213/18888,0.530603282899155,0.664488702782706,0.613978435445275,SFTPD/TNFRSF13C,2
GO:0071383,cellular response to steroid hormone stimulus,2/157,213/18888,0.530603282899155,0.664488702782706,0.613978435445275,CYP7B1/SFRP1,2
GO:0099111,microtubule-based transport,2/157,213/18888,0.530603282899155,0.664488702782706,0.613978435445275,NEFH/SYBU,2
GO:0045862,positive regulation of proteolysis,3/157,336/18888,0.531328873482175,0.664719763307623,0.61419193219697,ADRA2A/CEBPA/CLU,3
GO:0014910,regulation of smooth muscle cell migration,1/157,91/18888,0.532983394031133,0.664719763307623,0.61419193219697,SEMA6D,1
GO:0051453,regulation of intracellular pH,1/157,91/18888,0.532983394031133,0.664719763307623,0.61419193219697,SLC9A3,1
GO:0055017,cardiac muscle tissue growth,1/157,91/18888,0.532983394031133,0.664719763307623,0.61419193219697,NOG,1
GO:0097006,regulation of plasma lipoprotein particle levels,1/157,91/18888,0.532983394031133,0.664719763307623,0.61419193219697,CES3,1
GO:0097581,lamellipodium organization,1/157,91/18888,0.532983394031133,0.664719763307623,0.61419193219697,PIK3R1,1
GO:1900542,regulation of purine nucleotide metabolic process,1/157,91/18888,0.532983394031133,0.664719763307623,0.61419193219697,NOS2,1
GO:1903510,mucopolysaccharide metabolic process,1/157,91/18888,0.532983394031133,0.664719763307623,0.61419193219697,ITIH3,1
GO:0051235,maintenance of location,3/157,337/18888,0.533337356641743,0.664818876884355,0.614283511780667,CLIC2/GPSM2/TMEM38A,3
GO:0048545,response to steroid hormone,3/157,338/18888,0.535341057902466,0.666973272757084,0.616274143979122,CYP7B1/MAOB/SFRP1,3
GO:0050866,negative regulation of cell activation,2/157,215/18888,0.535641211892597,0.66700412092744,0.616302647264869,SFRP1/SFTPD,2
GO:0006140,regulation of nucleotide metabolic process,1/157,92/18888,0.536884101970544,0.667865071891453,0.617098154131526,NOS2,1
GO:0022406,membrane docking,1/157,92/18888,0.536884101970544,0.667865071891453,0.617098154131526,SNAP25,1
GO:0009612,response to mechanical stimulus,2/157,216/18888,0.538146358606684,0.669091622456565,0.618231470008543,MAP3K14/SLC1A3,2
GO:0016042,lipid catabolic process,3/157,340/18888,0.539334015873747,0.669239856233215,0.618368435982362,AADAC/ADRA2A/CEL,3
GO:1901654,response to ketone,2/157,217/18888,0.540642264718614,0.669239856233215,0.618368435982362,MAOB/SFRP1,2
GO:0006405,RNA export from nucleus,1/157,93/18888,0.540752435445253,0.669239856233215,0.618368435982362,DDX19A,1
GO:0007589,body fluid secretion,1/157,93/18888,0.540752435445253,0.669239856233215,0.618368435982362,CEL,1
GO:0032465,regulation of cytokinesis,1/157,93/18888,0.540752435445253,0.669239856233215,0.618368435982362,BRCA2,1
GO:0042475,odontogenesis of dentin-containing tooth,1/157,93/18888,0.540752435445253,0.669239856233215,0.618368435982362,RUNX2,1
GO:0141060,disruption of anatomical structure in another organism,1/157,93/18888,0.540752435445253,0.669239856233215,0.618368435982362,NOS2,1
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,1/157,93/18888,0.540752435445253,0.669239856233215,0.618368435982362,ESPL1,1
GO:2001251,negative regulation of chromosome organization,1/157,93/18888,0.540752435445253,0.669239856233215,0.618368435982362,ESPL1,1
GO:0050821,protein stabilization,2/157,218/18888,0.54312890990028,0.671585406321744,0.620535692050949,CLU/PIK3R1,2
GO:0006935,chemotaxis,4/157,466/18888,0.544347944865797,0.671585406321744,0.620535692050949,CYP7B1/SEMA4A/SEMA6D/SFTPD,4
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,1/157,94/18888,0.544588661443396,0.671585406321744,0.620535692050949,ESPL1,1
GO:0043367,"CD4-positive, alpha-beta T cell differentiation",1/157,94/18888,0.544588661443396,0.671585406321744,0.620535692050949,SEMA4A,1
GO:0043502,regulation of muscle adaptation,1/157,94/18888,0.544588661443396,0.671585406321744,0.620535692050949,GTF2IRD1,1
GO:0050848,regulation of calcium-mediated signaling,1/157,94/18888,0.544588661443396,0.671585406321744,0.620535692050949,CD22,1
GO:1900182,positive regulation of protein localization to nucleus,1/157,94/18888,0.544588661443396,0.671585406321744,0.620535692050949,PIK3R1,1
GO:0042330,taxis,4/157,468/18888,0.547743226569762,0.674902415864711,0.62360056331365,CYP7B1/SEMA4A/SEMA6D/SFTPD,4
GO:0030641,regulation of cellular pH,1/157,95/18888,0.548393044765381,0.674902415864711,0.62360056331365,SLC9A3,1
GO:0033555,multicellular organismal response to stress,1/157,95/18888,0.548393044765381,0.674902415864711,0.62360056331365,ADRA2A,1
GO:0046330,positive regulation of JNK cascade,1/157,95/18888,0.548393044765381,0.674902415864711,0.62360056331365,FZD10,1
GO:0032412,regulation of monoatomic ion transmembrane transporter activity,2/157,221/18888,0.550533091017551,0.677192049997211,0.625716153806802,ADRA2A/CLIC2,2
GO:0042063,gliogenesis,3/157,346/18888,0.551195632763709,0.677319037317962,0.625833488347163,CLU/EGR2/NOG,3
GO:0043010,camera-type eye development,3/157,346/18888,0.551195632763709,0.677319037317962,0.625833488347163,BMPR1B/MYOM1/TULP3,3
GO:0007044,cell-substrate junction assembly,1/157,96/18888,0.552165848041698,0.677480083058254,0.62598229239943,SFRP1,1
GO:0042982,amyloid precursor protein metabolic process,1/157,96/18888,0.552165848041698,0.677480083058254,0.62598229239943,CLU,1
GO:1990542,mitochondrial transmembrane transport,1/157,96/18888,0.552165848041698,0.677480083058254,0.62598229239943,SLC25A37,1
GO:1902115,regulation of organelle assembly,2/157,223/18888,0.555422577332089,0.680691383973673,0.628949490342052,GPSM2/WDR44,2
GO:0002275,myeloid cell activation involved in immune response,1/157,97/18888,0.555907331750588,0.680691383973673,0.628949490342052,IL13RA2,1
GO:0044784,metaphase/anaphase transition of cell cycle,1/157,97/18888,0.555907331750588,0.680691383973673,0.628949490342052,ESPL1,1
GO:0140747,regulation of ncRNA transcription,1/157,97/18888,0.555907331750588,0.680691383973673,0.628949490342052,POU5F1,1
GO:0034765,regulation of monoatomic ion transmembrane transport,3/157,349/18888,0.557059378722997,0.681757359912631,0.629934437469796,ADRA2A/CLIC2/TMEM38A,3
GO:0014909,smooth muscle cell migration,1/157,98/18888,0.559617754235563,0.682931610906983,0.6310194292617,SEMA6D,1
GO:0021510,spinal cord development,1/157,98/18888,0.559617754235563,0.682931610906983,0.6310194292617,NOG,1
GO:0030101,natural killer cell activation,1/157,98/18888,0.559617754235563,0.682931610906983,0.6310194292617,KLRC1,1
GO:0060993,kidney morphogenesis,1/157,98/18888,0.559617754235563,0.682931610906983,0.6310194292617,NOG,1
GO:0070664,negative regulation of leukocyte proliferation,1/157,98/18888,0.559617754235563,0.682931610906983,0.6310194292617,SFTPD,1
GO:0006457,protein folding,2/157,225/18888,0.560274612251104,0.682931610906983,0.6310194292617,CLU/HSPA2,2
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,2/157,225/18888,0.560274612251104,0.682931610906983,0.6310194292617,PPP2R5B/SFRP1,2
GO:0071222,cellular response to lipopolysaccharide,2/157,225/18888,0.560274612251104,0.682931610906983,0.6310194292617,NOS2/TNIP3,2
GO:0001906,cell killing,2/157,226/18888,0.562686551351774,0.684205734359378,0.632196701833212,KLRC1/NOS2,2
GO:0007163,establishment or maintenance of cell polarity,2/157,226/18888,0.562686551351774,0.684205734359378,0.632196701833212,GPSM2/PKHD1,2
GO:0002709,regulation of T cell mediated immunity,1/157,99/18888,0.563297371722791,0.684205734359378,0.632196701833212,KLRC1,1
GO:0006835,dicarboxylic acid transport,1/157,99/18888,0.563297371722791,0.684205734359378,0.632196701833212,SLC1A3,1
GO:0009798,axis specification,1/157,99/18888,0.563297371722791,0.684205734359378,0.632196701833212,SFRP1,1
GO:0060419,heart growth,1/157,99/18888,0.563297371722791,0.684205734359378,0.632196701833212,NOG,1
GO:0098869,cellular oxidant detoxification,1/157,99/18888,0.563297371722791,0.684205734359378,0.632196701833212,CLIC2,1
GO:0009895,negative regulation of catabolic process,3/157,353/18888,0.5648069010523,0.685695395663495,0.63357312841957,ADGRB1/ADRA2A/NOS2,3
GO:0070482,response to oxygen levels,3/157,354/18888,0.566731008945068,0.686229022316569,0.634066192118313,CBS/NOS2/SFRP1,3
GO:0006493,protein O-linked glycosylation,1/157,100/18888,0.566946438338338,0.686229022316569,0.634066192118313,GALNT16,1
GO:0008593,regulation of Notch signaling pathway,1/157,100/18888,0.566946438338338,0.686229022316569,0.634066192118313,SYNJ2BP,1
GO:0048661,positive regulation of smooth muscle cell proliferation,1/157,100/18888,0.566946438338338,0.686229022316569,0.634066192118313,PIK3R1,1
GO:0050764,regulation of phagocytosis,1/157,100/18888,0.566946438338338,0.686229022316569,0.634066192118313,SFTPD,1
GO:0072080,nephron tubule development,1/157,100/18888,0.566946438338338,0.686229022316569,0.634066192118313,NOG,1
GO:1903050,regulation of proteolysis involved in protein catabolic process,2/157,228/18888,0.567482212208901,0.686534424560418,0.63434837959731,CEBPA/CLU,2
GO:0022898,regulation of transmembrane transporter activity,2/157,229/18888,0.569865912238071,0.688201657985759,0.635888880384947,ADRA2A/CLIC2,2
GO:0050920,regulation of chemotaxis,2/157,229/18888,0.569865912238071,0.688201657985759,0.635888880384947,SEMA4A/SEMA6D,2
GO:0032755,positive regulation of interleukin-6 production,1/157,101/18888,0.57056520612527,0.688201657985759,0.635888880384947,NOS2,1
GO:0034446,substrate adhesion-dependent cell spreading,1/157,101/18888,0.57056520612527,0.688201657985759,0.635888880384947,PIK3R1,1
GO:0042632,cholesterol homeostasis,1/157,101/18888,0.57056520612527,0.688201657985759,0.635888880384947,CYP7B1,1
GO:0043255,regulation of carbohydrate biosynthetic process,1/157,101/18888,0.57056520612527,0.688201657985759,0.635888880384947,PPP1R3F,1
GO:0022412,cellular process involved in reproduction in multicellular organism,4/157,482/18888,0.571140049115626,0.688552114961696,0.636212697817621,BMPR1B/BRCA2/HSPA2/SFRP1,4
GO:0044242,cellular lipid catabolic process,2/157,230/18888,0.572240178887721,0.68944016187249,0.637033240966975,AADAC/CEL,2
GO:0006892,post-Golgi vesicle-mediated transport,1/157,102/18888,0.574153925060616,0.68944016187249,0.637033240966975,PHAF1,1
GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,1/157,102/18888,0.574153925060616,0.68944016187249,0.637033240966975,ADRA2A,1
GO:0032677,regulation of interleukin-8 production,1/157,102/18888,0.574153925060616,0.68944016187249,0.637033240966975,NOS2,1
GO:0035967,cellular response to topologically incorrect protein,1/157,102/18888,0.574153925060616,0.68944016187249,0.637033240966975,PIK3R1,1
GO:0043266,regulation of potassium ion transport,1/157,102/18888,0.574153925060616,0.68944016187249,0.637033240966975,ADRA2A,1
GO:0046620,regulation of organ growth,1/157,102/18888,0.574153925060616,0.68944016187249,0.637033240966975,NOG,1
GO:0055092,sterol homeostasis,1/157,102/18888,0.574153925060616,0.68944016187249,0.637033240966975,CYP7B1,1
GO:0032637,interleukin-8 production,1/157,103/18888,0.577712843072192,0.693026501199034,0.640346969250792,NOS2,1
GO:0070167,regulation of biomineral tissue development,1/157,103/18888,0.577712843072192,0.693026501199034,0.640346969250792,BMPR1B,1
GO:0009408,response to heat,1/157,104/18888,0.5812422060553,0.694851245343502,0.642033007779689,HSPA2,1
GO:0010389,regulation of G2/M transition of mitotic cell cycle,1/157,104/18888,0.5812422060553,0.694851245343502,0.642033007779689,HSPA2,1
GO:0032642,regulation of chemokine production,1/157,104/18888,0.5812422060553,0.694851245343502,0.642033007779689,IL1RL1,1
GO:0033045,regulation of sister chromatid segregation,1/157,104/18888,0.5812422060553,0.694851245343502,0.642033007779689,ESPL1,1
GO:0042102,positive regulation of T cell proliferation,1/157,104/18888,0.5812422060553,0.694851245343502,0.642033007779689,TNFRSF13C,1
GO:0061326,renal tubule development,1/157,104/18888,0.5812422060553,0.694851245343502,0.642033007779689,NOG,1
GO:1990830,cellular response to leukemia inhibitory factor,1/157,104/18888,0.5812422060553,0.694851245343502,0.642033007779689,NEFH,1
GO:0034249,negative regulation of amide metabolic process,2/157,234/18888,0.581642746997654,0.694987041553191,0.642158481612449,CLU/GRB7,2
GO:0034762,regulation of transmembrane transport,4/157,489/18888,0.582586467332417,0.695771412169188,0.642883229289276,ADRA2A/CLIC2/PIK3R1/TMEM38A,4
GO:0006885,regulation of pH,1/157,105/18888,0.584742257889271,0.696628503988103,0.643675170358863,SLC9A3,1
GO:0031507,heterochromatin formation,1/157,105/18888,0.584742257889271,0.696628503988103,0.643675170358863,SAMD1,1
GO:0032602,chemokine production,1/157,105/18888,0.584742257889271,0.696628503988103,0.643675170358863,IL1RL1,1
GO:0045639,positive regulation of myeloid cell differentiation,1/157,105/18888,0.584742257889271,0.696628503988103,0.643675170358863,GPR68,1
GO:1905477,positive regulation of protein localization to membrane,1/157,105/18888,0.584742257889271,0.696628503988103,0.643675170358863,PIK3R1,1
GO:0002532,production of molecular mediator involved in inflammatory response,1/157,106/18888,0.588213240453898,0.698359053127127,0.645274173996381,NOS2,1
GO:0018210,peptidyl-threonine modification,1/157,106/18888,0.588213240453898,0.698359053127127,0.645274173996381,GALNT16,1
GO:0030148,sphingolipid biosynthetic process,1/157,106/18888,0.588213240453898,0.698359053127127,0.645274173996381,ABCA8,1
GO:0042472,inner ear morphogenesis,1/157,106/18888,0.588213240453898,0.698359053127127,0.645274173996381,FRZB,1
GO:0048709,oligodendrocyte differentiation,1/157,106/18888,0.588213240453898,0.698359053127127,0.645274173996381,CLU,1
GO:0097306,cellular response to alcohol,1/157,106/18888,0.588213240453898,0.698359053127127,0.645274173996381,SFRP1,1
GO:1990823,response to leukemia inhibitory factor,1/157,106/18888,0.588213240453898,0.698359053127127,0.645274173996381,NEFH,1
GO:0030595,leukocyte chemotaxis,2/157,237/18888,0.588595267789004,0.698470229585971,0.645376899517482,CYP7B1/SFTPD,2
GO:0048285,organelle fission,4/157,493/18888,0.589049163293226,0.698666539420271,0.645558287108304,BRCA2/ESPL1/HSPA2/SHOC1,4
GO:0071219,cellular response to molecule of bacterial origin,2/157,238/18888,0.590893814719709,0.700385808118243,0.647146867773212,NOS2/TNIP3,2
GO:0008637,apoptotic mitochondrial changes,1/157,107/18888,0.591655393645716,0.700385808118243,0.647146867773212,CLU,1
GO:0032963,collagen metabolic process,1/157,107/18888,0.591655393645716,0.700385808118243,0.647146867773212,PEPD,1
GO:1901655,cellular response to ketone,1/157,107/18888,0.591655393645716,0.700385808118243,0.647146867773212,SFRP1,1
GO:0097529,myeloid leukocyte migration,2/157,239/18888,0.593182876351376,0.701850965570607,0.648500653137082,PIK3R1/SFTPD,2
GO:0006641,triglyceride metabolic process,1/157,108/18888,0.595068955394166,0.702366963920404,0.648977428525698,AADAC,1
GO:0010586,miRNA metabolic process,1/157,108/18888,0.595068955394166,0.702366963920404,0.648977428525698,POU5F1,1
GO:1901796,regulation of signal transduction by p53 class mediator,1/157,108/18888,0.595068955394166,0.702366963920404,0.648977428525698,BOP1,1
GO:1902414,protein localization to cell junction,1/157,108/18888,0.595068955394166,0.702366963920404,0.648977428525698,SNAP25,1
GO:1903076,regulation of protein localization to plasma membrane,1/157,108/18888,0.595068955394166,0.702366963920404,0.648977428525698,PIK3R1,1
GO:0065004,protein-DNA complex assembly,2/157,240/18888,0.595462450557494,0.702489067340599,0.64909025040902,H2BC4/H2BC8,2
GO:1903320,regulation of protein modification by small protein conjugation or removal,2/157,241/18888,0.597732535897728,0.704823856837535,0.651247563838758,ADGRB1/LIMK1,2
GO:0002526,acute inflammatory response,1/157,109/18888,0.598454161677612,0.705207487487126,0.651602033290291,F8,1
GO:0007281,germ cell development,3/157,371/18888,0.598640212334241,0.705207487487126,0.651602033290291,BMPR1B/BRCA2/HSPA2,3
GO:0001708,cell fate specification,1/157,110/18888,0.601811246539245,0.707566426756336,0.653781660777943,POU5F1,1
GO:0048144,fibroblast proliferation,1/157,110/18888,0.601811246539245,0.707566426756336,0.653781660777943,SFRP1,1
GO:0051100,negative regulation of binding,1/157,110/18888,0.601811246539245,0.707566426756336,0.653781660777943,NOG,1
GO:0071347,cellular response to interleukin-1,1/157,110/18888,0.601811246539245,0.707566426756336,0.653781660777943,SFRP1,1
GO:0006814,sodium ion transport,2/157,244/18888,0.604485854379891,0.708043551098115,0.654222517117038,CNKSR3/SLC9A3,2
GO:0071826,protein-RNA complex organization,2/157,244/18888,0.604485854379891,0.708043551098115,0.654222517117038,BOP1/ZFAND1,2
GO:2001234,negative regulation of apoptotic signaling pathway,2/157,244/18888,0.604485854379891,0.708043551098115,0.654222517117038,CLU/NOG,2
GO:0006672,ceramide metabolic process,1/157,111/18888,0.605140442102848,0.708043551098115,0.654222517117038,CEL,1
GO:0007040,lysosome organization,1/157,111/18888,0.605140442102848,0.708043551098115,0.654222517117038,HSD17B1,1
GO:0007218,neuropeptide signaling pathway,1/157,111/18888,0.605140442102848,0.708043551098115,0.654222517117038,POMC,1
GO:0014812,muscle cell migration,1/157,111/18888,0.605140442102848,0.708043551098115,0.654222517117038,SEMA6D,1
GO:0030203,glycosaminoglycan metabolic process,1/157,111/18888,0.605140442102848,0.708043551098115,0.654222517117038,ITIH3,1
GO:0080171,lytic vacuole organization,1/157,111/18888,0.605140442102848,0.708043551098115,0.654222517117038,HSD17B1,1
GO:0090398,cellular senescence,1/157,111/18888,0.605140442102848,0.708043551098115,0.654222517117038,BRCA2,1
GO:0010631,epithelial cell migration,3/157,375/18888,0.605924026420405,0.708618055041149,0.654753350870304,ADGRB1/SEMA4A/SYNJ2BP,3
GO:0045333,cellular respiration,2/157,245/18888,0.606717983190488,0.709204128999692,0.655294875159001,ME3/NOS2,2
GO:0002444,myeloid leukocyte mediated immunity,1/157,112/18888,0.608441978588434,0.709405577579988,0.655481010880548,IL13RA2,1
GO:0045833,negative regulation of lipid metabolic process,1/157,112/18888,0.608441978588434,0.709405577579988,0.655481010880548,ADRA2A,1
GO:0046822,regulation of nucleocytoplasmic transport,1/157,112/18888,0.608441978588434,0.709405577579988,0.655481010880548,PIK3R1,1
GO:1905954,positive regulation of lipid localization,1/157,112/18888,0.608441978588434,0.709405577579988,0.655481010880548,ABCA8,1
GO:0009913,epidermal cell differentiation,2/157,246/18888,0.608940625841781,0.709405577579988,0.655481010880548,SULT2B1/TCHH,2
GO:0050769,positive regulation of neurogenesis,2/157,246/18888,0.608940625841781,0.709405577579988,0.655481010880548,EGR2/LIMK1,2
GO:1901873,regulation of post-translational protein modification,2/157,246/18888,0.608940625841781,0.709405577579988,0.655481010880548,ADGRB1/LIMK1,2
GO:0090132,epithelium migration,3/157,378/18888,0.611329800950372,0.711612082729029,0.657519791334659,ADGRB1/SEMA4A/SYNJ2BP,3
GO:0006766,vitamin metabolic process,1/157,113/18888,0.611716084327762,0.711612082729029,0.657519791334659,CUBN,1
GO:0034440,lipid oxidation,1/157,113/18888,0.611716084327762,0.711612082729029,0.657519791334659,SAMD1,1
GO:0048738,cardiac muscle tissue development,2/157,248/18888,0.613357463069445,0.713178960899758,0.658967565245289,MYL3/NOG,2
GO:0043473,pigmentation,1/157,114/18888,0.614962985779722,0.714358472013423,0.660057417315197,POMC,1
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,1/157,114/18888,0.614962985779722,0.714358472013423,0.660057417315197,CLU,1
GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,2/157,249/18888,0.615551664364993,0.714358472013423,0.660057417315197,ADGRB1/ADRA2A,2
GO:1901617,organic hydroxy compound biosynthetic process,2/157,249/18888,0.615551664364993,0.714358472013423,0.660057417315197,CYP7B1/HSD17B1,2
GO:0001818,negative regulation of cytokine production,3/157,381/18888,0.616686346305255,0.715332533884735,0.660957437106761,IL1RL1/POMC/SFTPD,3
GO:0015908,fatty acid transport,1/157,115/18888,0.618182907545599,0.715355471607951,0.660978631247991,NOS2,1
GO:0032355,response to estradiol,1/157,115/18888,0.618182907545599,0.715355471607951,0.660978631247991,SFRP1,1
GO:0048259,regulation of receptor-mediated endocytosis,1/157,115/18888,0.618182907545599,0.715355471607951,0.660978631247991,CLU,1
GO:0051099,positive regulation of binding,1/157,115/18888,0.618182907545599,0.715355471607951,0.660978631247991,CLIC2,1
GO:1904035,regulation of epithelial cell apoptotic process,1/157,115/18888,0.618182907545599,0.715355471607951,0.660978631247991,PKHD1,1
GO:0033002,muscle cell proliferation,2/157,251/18888,0.619911653564308,0.717013383444486,0.662510519015592,NOG/PIK3R1,2
GO:0090130,tissue migration,3/157,383/18888,0.620229907326278,0.717039062312289,0.662534245936776,ADGRB1/SEMA4A/SYNJ2BP,3
GO:1902749,regulation of cell cycle G2/M phase transition,1/157,116/18888,0.621376072384215,0.717678992520062,0.663125532660112,HSPA2,1
GO:2001257,regulation of cation channel activity,1/157,116/18888,0.621376072384215,0.717678992520062,0.663125532660112,CLIC2,1
GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,2/157,253/18888,0.624233793299586,0.720635961568921,0.665857731450966,PIK3IP1/PKHD1,2
GO:0061640,cytoskeleton-dependent cytokinesis,1/157,117/18888,0.624542701226943,0.720649081644428,0.665869854220546,ESPL1,1
GO:0045017,glycerolipid biosynthetic process,2/157,254/18888,0.626380684870458,0.722425723217262,0.667511446633882,MTMR7/PIK3R1,2
GO:0006090,pyruvate metabolic process,1/157,118/18888,0.627683013192601,0.722895034689719,0.667945083989023,ME3,1
GO:0007088,regulation of mitotic nuclear division,1/157,118/18888,0.627683013192601,0.722895034689719,0.667945083989023,ESPL1,1
GO:1904659,glucose transmembrane transport,1/157,118/18888,0.627683013192601,0.722895034689719,0.667945083989023,PIK3R1,1
GO:0006164,purine nucleotide biosynthetic process,2/157,256/18888,0.630646146702044,0.724071507302655,0.669032128525988,HAAO/NOS2,2
GO:0002832,negative regulation of response to biotic stimulus,1/157,119/18888,0.630797225602231,0.724071507302655,0.669032128525988,KLRC1,1
GO:0006906,vesicle fusion,1/157,119/18888,0.630797225602231,0.724071507302655,0.669032128525988,SNAP25,1
GO:0032609,type II interferon production,1/157,119/18888,0.630797225602231,0.724071507302655,0.669032128525988,IL1RL1,1
GO:0032649,regulation of type II interferon production,1/157,119/18888,0.630797225602231,0.724071507302655,0.669032128525988,IL1RL1,1
GO:0043500,muscle adaptation,1/157,119/18888,0.630797225602231,0.724071507302655,0.669032128525988,GTF2IRD1,1
GO:1990748,cellular detoxification,1/157,119/18888,0.630797225602231,0.724071507302655,0.669032128525988,CLIC2,1
GO:0007265,Ras protein signal transduction,1/157,120/18888,0.633885553993751,0.726583441444802,0.67135312117504,ADRA2A,1
GO:0035710,"CD4-positive, alpha-beta T cell activation",1/157,120/18888,0.633885553993751,0.726583441444802,0.67135312117504,SEMA4A,1
GO:0071346,cellular response to type II interferon,1/157,120/18888,0.633885553993751,0.726583441444802,0.67135312117504,NOS2,1
GO:0008645,hexose transmembrane transport,1/157,121/18888,0.636948212136494,0.728055780703405,0.672713542429241,PIK3R1,1
GO:0072009,nephron epithelium development,1/157,121/18888,0.636948212136494,0.728055780703405,0.672713542429241,NOG,1
GO:0090174,organelle membrane fusion,1/157,121/18888,0.636948212136494,0.728055780703405,0.672713542429241,SNAP25,1
GO:0001894,tissue homeostasis,2/157,259/18888,0.636973657849098,0.728055780703405,0.672713542429241,CLDN18/CUBN,2
GO:0002221,pattern recognition receptor signaling pathway,2/157,259/18888,0.636973657849098,0.728055780703405,0.672713542429241,PIK3R1/TNIP3,2
GO:0060249,anatomical structure homeostasis,2/157,259/18888,0.636973657849098,0.728055780703405,0.672713542429241,CLDN18/CUBN,2
GO:0001654,eye development,3/157,393/18888,0.637615807653799,0.728445984027123,0.673074084941398,BMPR1B/MYOM1/TULP3,3
GO:0032409,regulation of transporter activity,2/157,260/18888,0.639064015828974,0.729756268900413,0.674284770169185,ADRA2A/CLIC2,2
GO:0006022,aminoglycan metabolic process,1/157,122/18888,0.63998541204562,0.730464028263191,0.674938730100197,ITIH3,1
GO:0015749,monosaccharide transmembrane transport,1/157,123/18888,0.642997363996426,0.732821507155184,0.677117008219359,PIK3R1,1
GO:0045834,positive regulation of lipid metabolic process,1/157,123/18888,0.642997363996426,0.732821507155184,0.677117008219359,AADAC,1
GO:0032259,methylation,2/157,262/18888,0.643216573161974,0.732821507155184,0.677117008219359,NSD2/PRDM11,2
GO:0150063,visual system development,3/157,397/18888,0.644414358011914,0.732821507155184,0.677117008219359,BMPR1B/MYOM1/TULP3,3
GO:0002286,T cell activation involved in immune response,1/157,124/18888,0.64598427653853,0.732821507155184,0.677117008219359,SEMA4A,1
GO:0010811,positive regulation of cell-substrate adhesion,1/157,124/18888,0.64598427653853,0.732821507155184,0.677117008219359,SFRP1,1
GO:0010951,negative regulation of endopeptidase activity,1/157,124/18888,0.64598427653853,0.732821507155184,0.677117008219359,CST2,1
GO:0032479,regulation of type I interferon production,1/157,124/18888,0.64598427653853,0.732821507155184,0.677117008219359,POLR3D,1
GO:0032606,type I interferon production,1/157,124/18888,0.64598427653853,0.732821507155184,0.677117008219359,POLR3D,1
GO:0033865,nucleoside bisphosphate metabolic process,1/157,124/18888,0.64598427653853,0.732821507155184,0.677117008219359,SULT2B1,1
GO:0033875,ribonucleoside bisphosphate metabolic process,1/157,124/18888,0.64598427653853,0.732821507155184,0.677117008219359,SULT2B1,1
GO:0034032,purine nucleoside bisphosphate metabolic process,1/157,124/18888,0.64598427653853,0.732821507155184,0.677117008219359,SULT2B1,1
GO:0034502,protein localization to chromosome,1/157,124/18888,0.64598427653853,0.732821507155184,0.677117008219359,BRCA2,1
GO:0072522,purine-containing compound biosynthetic process,2/157,264/18888,0.647331658668764,0.734006215962428,0.67821166288675,HAAO/NOS2,2
GO:0000077,DNA damage checkpoint signaling,1/157,125/18888,0.648946356509935,0.734603775136915,0.678763799357244,BRCA2,1
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/157,125/18888,0.648946356509935,0.734603775136915,0.678763799357244,NSD2,1
GO:0046632,alpha-beta T cell differentiation,1/157,125/18888,0.648946356509935,0.734603775136915,0.678763799357244,SEMA4A,1
GO:0014706,striated muscle tissue development,2/157,265/18888,0.649375178599561,0.734603775136915,0.678763799357244,MYL3/NOG,2
GO:0071216,cellular response to biotic stimulus,2/157,265/18888,0.649375178599561,0.734603775136915,0.678763799357244,NOS2/TNIP3,2
GO:0007613,memory,1/157,126/18888,0.651883809050996,0.735723478807788,0.679798390171393,SNAP25,1
GO:0008286,insulin receptor signaling pathway,1/157,126/18888,0.651883809050996,0.735723478807788,0.679798390171393,PIK3R1,1
GO:0033135,regulation of peptidyl-serine phosphorylation,1/157,126/18888,0.651883809050996,0.735723478807788,0.679798390171393,CNKSR3,1
GO:0098659,inorganic cation import across plasma membrane,1/157,126/18888,0.651883809050996,0.735723478807788,0.679798390171393,SLC9A3,1
GO:0099587,inorganic ion import across plasma membrane,1/157,126/18888,0.651883809050996,0.735723478807788,0.679798390171393,SLC9A3,1
GO:0000209,protein polyubiquitination,2/157,267/18888,0.653434234969296,0.737129816998433,0.681097827345243,ANAPC13/PEX12,2
GO:0048880,sensory system development,3/157,403/18888,0.654444323591321,0.737293324366074,0.681248905907372,BMPR1B/MYOM1/TULP3,3
GO:0021987,cerebral cortex development,1/157,127/18888,0.65479683761826,0.737293324366074,0.681248905907372,PHACTR1,1
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,1/157,127/18888,0.65479683761826,0.737293324366074,0.681248905907372,ONECUT2,1
GO:0071902,positive regulation of protein serine/threonine kinase activity,1/157,127/18888,0.65479683761826,0.737293324366074,0.681248905907372,ADRA2A,1
GO:0018108,peptidyl-tyrosine phosphorylation,2/157,269/18888,0.657456067955267,0.73882867799797,0.682667551577072,PPP2R5B/SFRP1,2
GO:0031668,cellular response to extracellular stimulus,2/157,269/18888,0.657456067955267,0.73882867799797,0.682667551577072,CBS/SFRP1,2
GO:0032868,response to insulin,2/157,269/18888,0.657456067955267,0.73882867799797,0.682667551577072,EGR2/PIK3R1,2
GO:0034976,response to endoplasmic reticulum stress,2/157,269/18888,0.657456067955267,0.73882867799797,0.682667551577072,CLU/PIK3R1,2
GO:0006275,regulation of DNA replication,1/157,128/18888,0.657685643998193,0.73882867799797,0.682667551577072,MCM4,1
GO:0002456,T cell mediated immunity,1/157,129/18888,0.66055042832081,0.740672748793056,0.684371447665712,KLRC1,1
GO:0050868,negative regulation of T cell activation,1/157,129/18888,0.66055042832081,0.740672748793056,0.684371447665712,SFTPD,1
GO:0051225,spindle assembly,1/157,129/18888,0.66055042832081,0.740672748793056,0.684371447665712,GPSM2,1
GO:0097237,cellular response to toxic substance,1/157,129/18888,0.66055042832081,0.740672748793056,0.684371447665712,CLIC2,1
GO:0018212,peptidyl-tyrosine modification,2/157,271/18888,0.661440788964678,0.741327899524503,0.684976797943889,PPP2R5B/SFRP1,2
GO:0030900,forebrain development,3/157,408/18888,0.662648355112994,0.742337796523437,0.685909928901225,NOG/PCDH9/PHACTR1,3
GO:0009615,response to virus,3/157,409/18888,0.664272308864623,0.743813006042588,0.687273002236751,CLU/MAP3K14/POLR3D,3
GO:0002821,positive regulation of adaptive immune response,1/157,131/18888,0.666208723112812,0.744260852112192,0.687686805854457,NSD2,1
GO:0007052,mitotic spindle organization,1/157,131/18888,0.666208723112812,0.744260852112192,0.687686805854457,GPSM2,1
GO:0051028,mRNA transport,1/157,131/18888,0.666208723112812,0.744260852112192,0.687686805854457,DDX19A,1
GO:0051983,regulation of chromosome segregation,1/157,131/18888,0.666208723112812,0.744260852112192,0.687686805854457,ESPL1,1
GO:0072329,monocarboxylic acid catabolic process,1/157,131/18888,0.666208723112812,0.744260852112192,0.687686805854457,FAH,1
GO:0000018,regulation of DNA recombination,1/157,132/18888,0.669002625680989,0.746349313403664,0.689616515405359,NSD2,1
GO:0010466,negative regulation of peptidase activity,1/157,132/18888,0.669002625680989,0.746349313403664,0.689616515405359,CST2,1
GO:2000779,regulation of double-strand break repair,1/157,132/18888,0.669002625680989,0.746349313403664,0.689616515405359,NSD2,1
GO:0002244,hematopoietic progenitor cell differentiation,1/157,133/18888,0.671773290415905,0.748062027304516,0.69119903952775,SFRP1,1
GO:0014902,myotube differentiation,1/157,133/18888,0.671773290415905,0.748062027304516,0.69119903952775,ADGRB1,1
GO:0021782,glial cell development,1/157,133/18888,0.671773290415905,0.748062027304516,0.69119903952775,CLU,1
GO:0042476,odontogenesis,1/157,133/18888,0.671773290415905,0.748062027304516,0.69119903952775,RUNX2,1
GO:0002702,positive regulation of production of molecular mediator of immune response,1/157,134/18888,0.674520909365769,0.749742837303301,0.692752084882793,NSD2,1
GO:0031570,DNA integrity checkpoint signaling,1/157,134/18888,0.674520909365769,0.749742837303301,0.692752084882793,BRCA2,1
GO:0043405,regulation of MAP kinase activity,1/157,134/18888,0.674520909365769,0.749742837303301,0.692752084882793,ADRA2A,1
GO:0051384,response to glucocorticoid,1/157,134/18888,0.674520909365769,0.749742837303301,0.692752084882793,MAOB,1
GO:0090596,sensory organ morphogenesis,2/157,278/18888,0.67509681372405,0.750038753596169,0.693025507473361,FRZB/NOG,2
GO:0010927,cellular component assembly involved in morphogenesis,1/157,135/18888,0.677245673001771,0.751048086085297,0.693958116831388,MYOM1,1
GO:0030218,erythrocyte differentiation,1/157,135/18888,0.677245673001771,0.751048086085297,0.693958116831388,HEATR3,1
GO:0038061,non-canonical NF-kappaB signal transduction,1/157,135/18888,0.677245673001771,0.751048086085297,0.693958116831388,MAP3K14,1
GO:0045814,"negative regulation of gene expression, epigenetic",1/157,135/18888,0.677245673001771,0.751048086085297,0.693958116831388,SAMD1,1
GO:0000086,G2/M transition of mitotic cell cycle,1/157,136/18888,0.679947770230946,0.752666133226395,0.695453170167897,HSPA2,1
GO:0006639,acylglycerol metabolic process,1/157,136/18888,0.679947770230946,0.752666133226395,0.695453170167897,AADAC,1
GO:0007041,lysosomal transport,1/157,136/18888,0.679947770230946,0.752666133226395,0.695453170167897,CLU,1
GO:0030168,platelet activation,1/157,136/18888,0.679947770230946,0.752666133226395,0.695453170167897,ADRA2A,1
GO:0006638,neutral lipid metabolic process,1/157,137/18888,0.68262738840894,0.75494225329975,0.697556273855999,AADAC,1
GO:0034219,carbohydrate transmembrane transport,1/157,137/18888,0.68262738840894,0.75494225329975,0.697556273855999,PIK3R1,1
GO:0016482,cytosolic transport,1/157,138/18888,0.685284713352665,0.756844311783017,0.69931374977213,SYBU,1
GO:0046328,regulation of JNK cascade,1/157,138/18888,0.685284713352665,0.756844311783017,0.69931374977213,FZD10,1
GO:0070555,response to interleukin-1,1/157,138/18888,0.685284713352665,0.756844311783017,0.69931374977213,SFRP1,1
GO:0007059,chromosome segregation,3/157,423/18888,0.686417589611132,0.757749955350119,0.700150551990244,ESPL1/GPSM2/SHOC1,3
GO:0042157,lipoprotein metabolic process,1/157,139/18888,0.687919929352859,0.759062445964749,0.701363275292736,SAMD1,1
GO:0007498,mesoderm development,1/157,140/18888,0.690533219186536,0.761252369990801,0.703386735016925,NOG,1
GO:0048813,dendrite morphogenesis,1/157,140/18888,0.690533219186536,0.761252369990801,0.703386735016925,PHACTR1,1
GO:0007018,microtubule-based movement,3/157,426/18888,0.691019852115621,0.761442257426768,0.703562188399891,NEFH/SYBU/TACR2,3
GO:0051258,protein polymerization,2/157,287/18888,0.691997929466718,0.762173253828282,0.704237619035563,C15orf62/FCHSD2,2
GO:0030317,flagellated sperm motility,1/157,141/18888,0.693124764129341,0.762374286431092,0.704423370399627,TACR2,1
GO:0051092,positive regulation of NF-kappaB transcription factor activity,1/157,141/18888,0.693124764129341,0.762374286431092,0.704423370399627,CLU,1
GO:0097722,sperm motility,1/157,141/18888,0.693124764129341,0.762374286431092,0.704423370399627,TACR2,1
GO:0016197,endosomal transport,2/157,289/18888,0.695654650721919,0.764159940993209,0.706073290691278,REPS2/SNAP25,2
GO:0034341,response to type II interferon,1/157,142/18888,0.695694743967805,0.764159940993209,0.706073290691278,NOS2,1
GO:0062013,positive regulation of small molecule metabolic process,1/157,142/18888,0.695694743967805,0.764159940993209,0.706073290691278,NOS2,1
GO:0014074,response to purine-containing compound,1/157,143/18888,0.698243337011498,0.766264323625667,0.708017711342591,TMEM38A,1
GO:0050671,positive regulation of lymphocyte proliferation,1/157,143/18888,0.698243337011498,0.766264323625667,0.708017711342591,TNFRSF13C,1
GO:0034101,erythrocyte homeostasis,1/157,144/18888,0.70077072010508,0.768689621419612,0.710258653195747,HEATR3,1
GO:0009165,nucleotide biosynthetic process,2/157,293/18888,0.702861227805663,0.770285019794261,0.71173277938311,HAAO/NOS2,2
GO:0072659,protein localization to plasma membrane,2/157,293/18888,0.702861227805663,0.770285019794261,0.71173277938311,PHAF1/PIK3R1,2
GO:0032006,regulation of TOR signaling,1/157,145/18888,0.703277068640264,0.770392157506432,0.711831773157753,PKHD1,1
GO:0018209,peptidyl-serine modification,2/157,294/18888,0.704640733906012,0.771537006112279,0.712889597546484,CNKSR3/GALNT16,2
GO:0032946,positive regulation of mononuclear cell proliferation,1/157,146/18888,0.705762556567676,0.771974193169066,0.713293552382735,TNFRSF13C,1
GO:0046467,membrane lipid biosynthetic process,1/157,146/18888,0.705762556567676,0.771974193169066,0.713293552382735,ABCA8,1
GO:1901293,nucleoside phosphate biosynthetic process,2/157,295/18888,0.70641142877536,0.771974193169066,0.713293552382735,HAAO/NOS2,2
GO:0001933,negative regulation of protein phosphorylation,2/157,296/18888,0.70817333486179,0.771974193169066,0.713293552382735,CNKSR3/SFRP1,2
GO:0009799,specification of symmetry,1/157,147/18888,0.708227356408615,0.771974193169066,0.713293552382735,GREM2,1
GO:0009855,determination of bilateral symmetry,1/157,147/18888,0.708227356408615,0.771974193169066,0.713293552382735,GREM2,1
GO:0031333,negative regulation of protein-containing complex assembly,1/157,147/18888,0.708227356408615,0.771974193169066,0.713293552382735,CLU,1
GO:0035264,multicellular organism growth,1/157,147/18888,0.708227356408615,0.771974193169066,0.713293552382735,WDR11,1
GO:0051783,regulation of nuclear division,1/157,147/18888,0.708227356408615,0.771974193169066,0.713293552382735,ESPL1,1
GO:1904019,epithelial cell apoptotic process,1/157,147/18888,0.708227356408615,0.771974193169066,0.713293552382735,PKHD1,1
GO:0043434,response to peptide hormone,3/157,438/18888,0.708925862071938,0.772387961285755,0.713675868439965,EGR2/PIK3R1/POMC,3
GO:0048511,rhythmic process,2/157,297/18888,0.709926474849937,0.773130360650426,0.714361835256989,BMPR1B/NOS2,2
GO:1903038,negative regulation of leukocyte cell-cell adhesion,1/157,148/18888,0.710671639266726,0.773594027102925,0.714790256691216,SFTPD,1
GO:0043087,regulation of GTPase activity,2/157,298/18888,0.711670871655566,0.77433371570071,0.715473718796866,FGD5/SFRP1,2
GO:0002687,positive regulation of leukocyte migration,1/157,149/18888,0.713095574839571,0.774492144511857,0.715620104842543,PIK3R1,1
GO:0008584,male gonad development,1/157,149/18888,0.713095574839571,0.774492144511857,0.715620104842543,SFRP1,1
GO:0010821,regulation of mitochondrion organization,1/157,149/18888,0.713095574839571,0.774492144511857,0.715620104842543,CLU,1
GO:2000377,regulation of reactive oxygen species metabolic process,1/157,149/18888,0.713095574839571,0.774492144511857,0.715620104842543,ADGRB1,1
GO:0018205,peptidyl-lysine modification,1/157,150/18888,0.715499331430114,0.776406532582319,0.717388973127911,EGR2,1
GO:0046546,development of primary male sexual characteristics,1/157,150/18888,0.715499331430114,0.776406532582319,0.717388973127911,SFRP1,1
GO:0034614,cellular response to reactive oxygen species,1/157,151/18888,0.717883075958104,0.778644339440451,0.719456675931331,PEX12,1
GO:0071560,cellular response to transforming growth factor beta stimulus,2/157,302/18888,0.718561493160063,0.779031305476129,0.7198142272338,ONECUT2/SFRP1,2
GO:0044839,cell cycle G2/M phase transition,1/157,152/18888,0.720246973971371,0.780346201928507,0.72102917349733,HSPA2,1
GO:0042391,regulation of membrane potential,3/157,446/18888,0.720418706652412,0.780346201928507,0.72102917349733,KCNK12/NLGN4X/RIMS1,3
GO:0051607,defense response to virus,2/157,307/18888,0.726980888438336,0.787102240410214,0.727271660268641,MAP3K14/POLR3D,2
GO:0007043,cell-cell junction assembly,1/157,156/18888,0.729507364441497,0.788779837802369,0.728821737219278,CLDN18,1
GO:0031960,response to corticosteroid,1/157,156/18888,0.729507364441497,0.788779837802369,0.728821737219278,MAOB,1
GO:0043433,negative regulation of DNA-binding transcription factor activity,1/157,156/18888,0.729507364441497,0.788779837802369,0.728821737219278,PKHD1,1
GO:0016311,dephosphorylation,2/157,309/18888,0.730288956026103,0.788920540363614,0.728951744453493,MTMR7/PPP2R5B,2
GO:0071559,response to transforming growth factor beta,2/157,309/18888,0.730288956026103,0.788920540363614,0.728951744453493,ONECUT2/SFRP1,2
GO:0010720,positive regulation of cell development,3/157,454/18888,0.731559337448653,0.789940577485795,0.729894244745447,EGR2/GPR68/LIMK1,3
GO:0007162,negative regulation of cell adhesion,2/157,310/18888,0.731930299110091,0.789988941374616,0.729938932314501,PIK3R1/SFTPD,2
GO:1901987,regulation of cell cycle phase transition,3/157,455/18888,0.732927325181882,0.790694307168794,0.730590680620999,BRCA2/ESPL1/HSPA2,3
GO:0007249,canonical NF-kappaB signal transduction,2/157,311/18888,0.733563215610355,0.790694307168794,0.730590680620999,MAP3K14/TNIP3,2
GO:0044403,biological process involved in symbiotic interaction,2/157,311/18888,0.733563215610355,0.790694307168794,0.730590680620999,ANPEP/GPR15,2
GO:0072006,nephron development,1/157,158/18888,0.734022685862732,0.790837609056734,0.730723089597382,NOG,1
GO:0008643,carbohydrate transport,1/157,159/18888,0.736252180700936,0.792534569625629,0.732291057857398,PIK3R1,1
GO:0048284,organelle fusion,1/157,159/18888,0.736252180700936,0.792534569625629,0.732291057857398,SNAP25,1
GO:0051146,striated muscle cell differentiation,2/157,313/18888,0.736803871503252,0.792776089196302,0.732514218623729,ADGRB1/MYOM1,2
GO:0060041,retina development in camera-type eye,1/157,160/18888,0.738463105343466,0.793856032464214,0.733512071371602,BMPR1B,1
GO:0070507,regulation of microtubule cytoskeleton organization,1/157,160/18888,0.738463105343466,0.793856032464214,0.733512071371602,GPSM2,1
GO:0007605,sensory perception of sound,1/157,161/18888,0.740655613484275,0.794449909592079,0.734060805681586,SLC1A3,1
GO:0010976,positive regulation of neuron projection development,1/157,161/18888,0.740655613484275,0.794449909592079,0.734060805681586,PPP2R5B,1
GO:0050657,nucleic acid transport,1/157,161/18888,0.740655613484275,0.794449909592079,0.734060805681586,DDX19A,1
GO:0050658,RNA transport,1/157,161/18888,0.740655613484275,0.794449909592079,0.734060805681586,DDX19A,1
GO:1902600,proton transmembrane transport,1/157,161/18888,0.740655613484275,0.794449909592079,0.734060805681586,SLC9A3,1
GO:0042326,negative regulation of phosphorylation,2/157,316/18888,0.741602301544854,0.795113224586824,0.734673699626924,CNKSR3/SFRP1,2
GO:0043524,negative regulation of neuron apoptotic process,1/157,162/18888,0.742829857553425,0.796076953537343,0.735564171941585,CLU,1
GO:0098813,nuclear chromosome segregation,2/157,317/18888,0.743185201972529,0.796105510472121,0.735590558157125,ESPL1/SHOC1,2
GO:0034250,positive regulation of amide metabolic process,1/157,163/18888,0.744985988727414,0.797681726214764,0.737046959855964,CLU,1
GO:0019058,viral life cycle,2/157,319/18888,0.746326297270914,0.797854809571108,0.737206886500142,ANPEP/GPR15,2
GO:0042254,ribosome biogenesis,2/157,319/18888,0.746326297270914,0.797854809571108,0.737206886500142,BOP1/HEATR3,2
GO:0019362,pyridine nucleotide metabolic process,1/157,164/18888,0.747124156939419,0.797854809571108,0.737206886500142,HAAO,1
GO:0046496,nicotinamide nucleotide metabolic process,1/157,164/18888,0.747124156939419,0.797854809571108,0.737206886500142,HAAO,1
GO:0051236,establishment of RNA localization,1/157,164/18888,0.747124156939419,0.797854809571108,0.737206886500142,DDX19A,1
GO:0070665,positive regulation of leukocyte proliferation,1/157,164/18888,0.747124156939419,0.797854809571108,0.737206886500142,TNFRSF13C,1
GO:0031929,TOR signaling,1/157,165/18888,0.749244510889457,0.799062177619667,0.738322477995312,PKHD1,1
GO:0051494,negative regulation of cytoskeleton organization,1/157,165/18888,0.749244510889457,0.799062177619667,0.738322477995312,PIK3R1,1
GO:0060294,cilium movement involved in cell motility,1/157,165/18888,0.749244510889457,0.799062177619667,0.738322477995312,TACR2,1
GO:0060326,cell chemotaxis,2/157,322/18888,0.750976577811952,0.800556897649889,0.739703578775116,CYP7B1/SFTPD,2
GO:0062207,regulation of pattern recognition receptor signaling pathway,1/157,166/18888,0.75134719805446,0.800599610069469,0.739743044464206,PIK3R1,1
GO:0009101,glycoprotein biosynthetic process,2/157,324/18888,0.754036171695371,0.803111524998324,0.74206401936044,BMPR1B/GALNT16,2
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,1/157,168/18888,0.755500155881562,0.804317089030833,0.743177943969555,PCDH9,1
GO:0006790,sulfur compound metabolic process,2/157,326/18888,0.757063545578975,0.804920064702493,0.743735085209048,CBS/SULT2B1,2
GO:0019216,regulation of lipid metabolic process,2/157,326/18888,0.757063545578975,0.804920064702493,0.743735085209048,AADAC/ADRA2A,2
GO:0031647,regulation of protein stability,2/157,326/18888,0.757063545578975,0.804920064702493,0.743735085209048,CLU/PIK3R1,2
GO:0001539,cilium or flagellum-dependent cell motility,1/157,170/18888,0.759584186152301,0.80618444297146,0.744903353364911,TACR2,1
GO:0007009,plasma membrane organization,1/157,170/18888,0.759584186152301,0.80618444297146,0.744903353364911,CLU,1
GO:0060285,cilium-dependent cell motility,1/157,170/18888,0.759584186152301,0.80618444297146,0.744903353364911,TACR2,1
GO:0072524,pyridine-containing compound metabolic process,1/157,170/18888,0.759584186152301,0.80618444297146,0.744903353364911,HAAO,1
GO:0051251,positive regulation of lymphocyte activation,2/157,328/18888,0.760058919540492,0.806334955377605,0.745042424761088,NSD2/TNFRSF13C,2
GO:0007034,vacuolar transport,1/157,171/18888,0.761600709433318,0.807263421552515,0.745900314755377,CLU,1
GO:0007254,JNK cascade,1/157,171/18888,0.761600709433318,0.807263421552515,0.745900314755377,FZD10,1
GO:0009267,cellular response to starvation,1/157,172/18888,0.763600425660223,0.808675221228273,0.747204798266464,SFRP1,1
GO:0044272,sulfur compound biosynthetic process,1/157,172/18888,0.763600425660223,0.808675221228273,0.747204798266464,CBS,1
GO:0046661,male sex differentiation,1/157,173/18888,0.765583474023727,0.810420967694697,0.748817844025784,SFRP1,1
GO:0048660,regulation of smooth muscle cell proliferation,1/157,174/18888,0.767549992569187,0.812147698559445,0.75041331963031,PIK3R1,1
GO:1903008,organelle disassembly,1/157,175/18888,0.769500118205963,0.813855583534866,0.751991381891923,ZFAND1,1
GO:0032635,interleukin-6 production,1/157,176/18888,0.771433986716713,0.815188968511291,0.753223411297755,NOS2,1
GO:0032675,regulation of interleukin-6 production,1/157,176/18888,0.771433986716713,0.815188968511291,0.753223411297755,NOS2,1
GO:0002262,myeloid cell homeostasis,1/157,177/18888,0.7733517327666,0.816147231704011,0.754108833327275,HEATR3,1
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,1/157,177/18888,0.7733517327666,0.816147231704011,0.754108833327275,ONECUT2,1
GO:0030216,keratinocyte differentiation,1/157,177/18888,0.7733517327666,0.816147231704011,0.754108833327275,TCHH,1
GO:0048659,smooth muscle cell proliferation,1/157,178/18888,0.775253489912431,0.817797888749088,0.755634017767205,PIK3R1,1
GO:0015718,monocarboxylic acid transport,1/157,179/18888,0.777139390611722,0.819394207146309,0.757108994042789,NOS2,1
GO:0031667,response to nutrient levels,3/157,490/18888,0.777443388943938,0.819394207146309,0.757108994042789,CBS/POMC/SFRP1,3
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,1/157,180/18888,0.779009566231689,0.820330943223109,0.757974525312847,ONECUT2,1
GO:1905475,regulation of protein localization to membrane,1/157,180/18888,0.779009566231689,0.820330943223109,0.757974525312847,PIK3R1,1
GO:0001936,regulation of endothelial cell proliferation,1/157,181/18888,0.780864147058161,0.82156948921584,0.759118924800242,SYNJ2BP,1
GO:0046631,alpha-beta T cell activation,1/157,181/18888,0.780864147058161,0.82156948921584,0.759118924800242,SEMA4A,1
GO:0006839,mitochondrial transport,1/157,182/18888,0.782703262304425,0.822789627300919,0.760246315633775,SLC25A37,1
GO:0035725,sodium ion transmembrane transport,1/157,182/18888,0.782703262304425,0.822789627300919,0.760246315633775,SLC9A3,1
GO:0022407,regulation of cell-cell adhesion,3/157,496/18888,0.784435267220856,0.823991539969925,0.761356866433161,PKHD1/SFTPD/TNFRSF13C,3
GO:0001764,neuron migration,1/157,183/18888,0.784527040120003,0.823991539969925,0.761356866433161,PHACTR1,1
GO:0050954,sensory perception of mechanical stimulus,1/157,185/18888,0.788129090790479,0.827415976547265,0.764520998800246,SLC1A3,1
GO:0043484,regulation of RNA splicing,1/157,186/18888,0.789907614703536,0.828923848705357,0.765914251965573,PIK3R1,1
GO:0000070,mitotic sister chromatid segregation,1/157,188/18888,0.793420279597488,0.831889141638578,0.768654141911259,ESPL1,1
GO:0042770,signal transduction in response to DNA damage,1/157,188/18888,0.793420279597488,0.831889141638578,0.768654141911259,BRCA2,1
GO:1902107,positive regulation of leukocyte differentiation,1/157,190/18888,0.796874581925746,0.834066654029454,0.770666133455005,GPR68,1
GO:1903708,positive regulation of hemopoiesis,1/157,190/18888,0.796874581925746,0.834066654029454,0.770666133455005,GPR68,1
GO:2000116,regulation of cysteine-type endopeptidase activity,1/157,190/18888,0.796874581925746,0.834066654029454,0.770666133455005,CST2,1
GO:2001242,regulation of intrinsic apoptotic signaling pathway,1/157,190/18888,0.796874581925746,0.834066654029454,0.770666133455005,CLU,1
GO:0000075,cell cycle checkpoint signaling,1/157,191/18888,0.798580148865401,0.834597918365382,0.771157014405147,BRCA2,1
GO:0021543,pallium development,1/157,191/18888,0.798580148865401,0.834597918365382,0.771157014405147,PHACTR1,1
GO:0031503,protein-containing complex localization,1/157,191/18888,0.798580148865401,0.834597918365382,0.771157014405147,SNAP25,1
GO:1901990,regulation of mitotic cell cycle phase transition,2/157,356/18888,0.798760518072236,0.834597918365382,0.771157014405147,ESPL1/HSPA2,2
GO:0046777,protein autophosphorylation,1/157,192/18888,0.800271485263119,0.835816100606845,0.77228259806604,PPP2R5B,1
GO:0002040,sprouting angiogenesis,1/157,194/18888,0.803611937376598,0.838943151864707,0.775171950482145,SYNJ2BP,1
GO:0051260,protein homooligomerization,1/157,195/18888,0.805261286142613,0.840302815612843,0.776428261112131,SAMD1,1
GO:0045664,regulation of neuron differentiation,1/157,196/18888,0.80689687048304,0.841646951037865,0.777670223784824,SFRP1,1
GO:0009060,aerobic respiration,1/157,199/18888,0.811722173646276,0.846315585265295,0.781983977693084,ME3,1
GO:0006403,RNA localization,1/157,200/18888,0.813303832308459,0.847599777044358,0.783170553260161,DDX19A,1
GO:0030522,intracellular receptor signaling pathway,2/157,369/18888,0.814787333117596,0.848780611101427,0.784261627711606,CYP7B1/SFRP1,2
GO:0001935,endothelial cell proliferation,1/157,202/18888,0.816427649971525,0.849758387722833,0.785165079881239,SYNJ2BP,1
GO:0006399,tRNA metabolic process,1/157,202/18888,0.816427649971525,0.849758387722833,0.785165079881239,POLR3D,1
GO:0000302,response to reactive oxygen species,1/157,203/18888,0.817970027096349,0.850632634447127,0.785972871847795,PEX12,1
GO:0022408,negative regulation of cell-cell adhesion,1/157,203/18888,0.817970027096349,0.850632634447127,0.785972871847795,SFTPD,1
GO:0051346,negative regulation of hydrolase activity,1/157,204/18888,0.81949952700247,0.851492001029594,0.786766914767663,CST2,1
GO:0055001,muscle cell development,1/157,204/18888,0.81949952700247,0.851492001029594,0.786766914767663,MYOM1,1
GO:0007623,circadian rhythm,1/157,205/18888,0.821016256517596,0.852702132626766,0.787885059743798,NOS2,1
GO:0016051,carbohydrate biosynthetic process,1/157,206/18888,0.822520321588877,0.853166689031375,0.788314303481552,PPP1R3F,1
GO:0017148,negative regulation of translation,1/157,206/18888,0.822520321588877,0.853166689031375,0.788314303481552,GRB7,1
GO:0032869,cellular response to insulin stimulus,1/157,206/18888,0.822520321588877,0.853166689031375,0.788314303481552,PIK3R1,1
GO:0051347,positive regulation of transferase activity,2/157,376/18888,0.822939750630359,0.853236333915552,0.788378654398045,ADRA2A/SERINC1,2
GO:0045936,negative regulation of phosphate metabolic process,2/157,378/18888,0.825209557110349,0.85514923272098,0.790146146622975,CNKSR3/SFRP1,2
GO:0050851,antigen receptor-mediated signaling pathway,1/157,208/18888,0.825490877828923,0.85514923272098,0.790146146622975,CD22,1
GO:0010563,negative regulation of phosphorus metabolic process,2/157,379/18888,0.826334696414021,0.855657389788268,0.790615676774244,CNKSR3/SFRP1,2
GO:0003341,cilium movement,1/157,209/18888,0.826957576553808,0.855936431800566,0.790873507761312,TACR2,1
GO:0051090,regulation of DNA-binding transcription factor activity,2/157,381/18888,0.828565592103135,0.85723445710115,0.792072865312289,CLU/PKHD1,2
GO:0050863,regulation of T cell activation,2/157,382/18888,0.829671406380772,0.857645815729505,0.792452955035389,SFTPD/TNFRSF13C,2
GO:1903037,regulation of leukocyte cell-cell adhesion,2/157,382/18888,0.829671406380772,0.857645815729505,0.792452955035389,SFTPD/TNFRSF13C,2
GO:0042594,response to starvation,1/157,212/18888,0.831284582590928,0.858946782864858,0.79365503080129,SFRP1,1
GO:0034764,positive regulation of transmembrane transport,1/157,213/18888,0.832702890608342,0.859678772827538,0.794331379473835,PIK3R1,1
GO:0051348,negative regulation of transferase activity,1/157,213/18888,0.832702890608342,0.859678772827538,0.794331379473835,LIMK1,1
GO:0009100,glycoprotein metabolic process,2/157,386/18888,0.834031113588972,0.860397294680299,0.794995283797781,BMPR1B/GALNT16,2
GO:0007286,spermatid development,1/157,214/18888,0.834109350912197,0.860397294680299,0.794995283797781,HSPA2,1
GO:0008544,epidermis development,2/157,387/18888,0.835105296963598,0.860736213433346,0.795308440070969,SULT2B1/TCHH,2
GO:0006282,regulation of DNA repair,1/157,215/18888,0.835504061842195,0.860736213433346,0.795308440070969,NSD2,1
GO:0045619,regulation of lymphocyte differentiation,1/157,215/18888,0.835504061842195,0.860736213433346,0.795308440070969,SFRP1,1
GO:0007601,visual perception,1/157,219/18888,0.840967350370889,0.865996140560498,0.800168540497901,RIMS1,1
GO:0040029,epigenetic regulation of gene expression,1/157,220/18888,0.842304761372644,0.867004731000656,0.801100464212871,SAMD1,1
GO:0048515,spermatid differentiation,1/157,222/18888,0.84494614776683,0.869354107855252,0.803271256160748,HSPA2,1
GO:0050953,sensory perception of light stimulus,1/157,223/18888,0.846250307994014,0.870326219091933,0.804169473592703,RIMS1,1
GO:0006364,rRNA processing,1/157,224/18888,0.847543568194654,0.871286299731516,0.805056574918164,BOP1,1
GO:0006486,protein glycosylation,1/157,225/18888,0.84882601889083,0.871494963015511,0.805249376926845,GALNT16,1
GO:0043413,macromolecule glycosylation,1/157,225/18888,0.84882601889083,0.871494963015511,0.805249376926845,GALNT16,1
GO:0072330,monocarboxylic acid biosynthetic process,1/157,225/18888,0.84882601889083,0.871494963015511,0.805249376926845,CYP7B1,1
GO:0042180,cellular ketone metabolic process,1/157,227/18888,0.851358850129471,0.873725057209144,0.807309953334191,HSD17B1,1
GO:0000819,sister chromatid segregation,1/157,229/18888,0.853849511057386,0.875910002448534,0.809328812727882,ESPL1,1
GO:0002685,regulation of leukocyte migration,1/157,230/18888,0.855079246132363,0.87605834777182,0.80946588176926,PIK3R1,1
GO:0043547,positive regulation of GTPase activity,1/157,230/18888,0.855079246132363,0.87605834777182,0.80946588176926,SFRP1,1
GO:0051091,positive regulation of DNA-binding transcription factor activity,1/157,230/18888,0.855079246132363,0.87605834777182,0.80946588176926,CLU,1
GO:0015931,nucleobase-containing compound transport,1/157,231/18888,0.856298699361927,0.876566124198896,0.8099350602142,DDX19A,1
GO:0045861,negative regulation of proteolysis,1/157,231/18888,0.856298699361927,0.876566124198896,0.8099350602142,CST2,1
GO:0007033,vacuole organization,1/157,234/18888,0.859896218661065,0.879505338512289,0.812650853873322,HSD17B1,1
GO:0022618,protein-RNA complex assembly,1/157,234/18888,0.859896218661065,0.879505338512289,0.812650853873322,BOP1,1
GO:0016358,dendrite development,1/157,235/18888,0.861075391689381,0.880339636416919,0.813421733679156,PHACTR1,1
GO:0031669,cellular response to nutrient levels,1/157,239/18888,0.865694282568659,0.884688418726283,0.817439948807892,SFRP1,1
GO:0007159,leukocyte cell-cell adhesion,2/157,419/18888,0.866338943086808,0.884973817020772,0.817703652912408,SFTPD/TNFRSF13C,2
GO:0070085,glycosylation,1/157,241/18888,0.867946178122512,0.886241839550053,0.818875288314752,GALNT16,1
GO:0043523,regulation of neuron apoptotic process,1/157,244/18888,0.871253864282263,0.889180498472962,0.821590568800694,CLU,1
GO:0050727,regulation of inflammatory response,2/157,425/18888,0.871558424184481,0.889180498472962,0.821590568800694,CEBPA/IL1RL1,2
GO:0007179,transforming growth factor beta receptor signaling pathway,1/157,245/18888,0.872338027729361,0.889601138172847,0.821979234106425,ONECUT2,1
GO:0016032,viral process,2/157,428/18888,0.874097753316448,0.890645670396482,0.822944367535713,ANPEP/GPR15,2
GO:0042692,muscle cell differentiation,2/157,428/18888,0.874097753316448,0.890645670396482,0.822944367535713,ADGRB1/MYOM1,2
GO:0033044,regulation of chromosome organization,1/157,247/18888,0.874479214020855,0.89065965364109,0.822957287861688,ESPL1,1
GO:0034599,cellular response to oxidative stress,1/157,248/18888,0.875536387101631,0.89136155088699,0.823605831277214,PEX12,1
GO:0031331,positive regulation of cellular catabolic process,2/157,432/18888,0.87741210263538,0.892895845623063,0.825023498541715,AADAC/ADRA2A,2
GO:0050870,positive regulation of T cell activation,1/157,253/18888,0.880691001140602,0.895856196876329,0.82775882244299,TNFRSF13C,1
GO:0045860,positive regulation of protein kinase activity,1/157,257/18888,0.88466150612116,0.89951728288222,0.831141615631971,ADRA2A,1
GO:0051259,protein complex oligomerization,1/157,258/18888,0.885633442331722,0.900127653095858,0.831705589326696,SAMD1,1
GO:0043086,negative regulation of catalytic activity,2/157,449/18888,0.890624180692617,0.904820371492247,0.836041596676308,CST2/LIMK1,2
GO:0006417,regulation of translation,2/157,451/18888,0.892089192006105,0.905549045699407,0.83671488163629,DIO2/GRB7,2
GO:0044772,mitotic cell cycle phase transition,2/157,451/18888,0.892089192006105,0.905549045699407,0.83671488163629,ESPL1/HSPA2,2
GO:0016072,rRNA metabolic process,1/157,266/18888,0.893121560737915,0.906217184795655,0.837332232985164,BOP1,1
GO:0071900,regulation of protein serine/threonine kinase activity,1/157,267/18888,0.894022640909977,0.906751606484072,0.837826031285644,ADRA2A,1
GO:1901988,negative regulation of cell cycle phase transition,1/157,273/18888,0.899272775848557,0.911694710383091,0.842393391400953,BRCA2,1
GO:0021537,telencephalon development,1/157,275/18888,0.900964734652313,0.913027860806654,0.843625204083161,PHACTR1,1
GO:0140014,mitotic nuclear division,1/157,277/18888,0.902628450889184,0.913949041828429,0.844476362696006,ESPL1,1
GO:1903039,positive regulation of leukocyte cell-cell adhesion,1/157,277/18888,0.902628450889184,0.913949041828429,0.844476362696006,TNFRSF13C,1
GO:0052548,regulation of endopeptidase activity,1/157,280/18888,0.905072093072321,0.916040371676206,0.846408722753538,CST2,1
GO:0018105,peptidyl-serine phosphorylation,1/157,282/18888,0.906667235547708,0.917271530700313,0.847546296783374,CNKSR3,1
GO:0043410,positive regulation of MAPK cascade,2/157,475/18888,0.90831030097118,0.918550124823464,0.848727700193266,ADRA2A/FZD10,2
GO:0050907,detection of chemical stimulus involved in sensory perception,2/157,476/18888,0.90893434631518,0.918797573779368,0.848956339630117,CST2/PIGR,2
GO:0043122,regulation of canonical NF-kappaB signal transduction,1/157,286/18888,0.909778053098071,0.91926676871236,0.849389869304393,TNIP3,1
GO:0031348,negative regulation of defense response,1/157,291/18888,0.913522066192602,0.922373046550087,0.85226002736559,KLRC1,1
GO:0008380,RNA splicing,2/157,484/18888,0.913786319132341,0.922373046550087,0.85226002736559,PIK3R1/TTF2,2
GO:0051402,neuron apoptotic process,1/157,292/18888,0.914252132096122,0.922373046550087,0.85226002736559,CLU,1
GO:0045785,positive regulation of cell adhesion,2/157,485/18888,0.914375592389248,0.922373046550087,0.85226002736559,SFRP1/TNFRSF13C,2
GO:0048193,Golgi vesicle transport,1/157,294/18888,0.915693941602561,0.923318370758286,0.853133493951113,PHAF1,1
GO:0051054,positive regulation of DNA metabolic process,1/157,301/18888,0.920553163133559,0.927831777407191,0.857303819708674,NSD2,1
GO:0033674,positive regulation of kinase activity,1/157,303/18888,0.921889667918131,0.928298684539331,0.857735235486382,ADRA2A,1
GO:0022613,ribonucleoprotein complex biogenesis,2/157,499/18888,0.922240567998793,0.928298684539331,0.857735235486382,BOP1/HEATR3,2
GO:0051056,regulation of small GTPase mediated signal transduction,1/157,304/18888,0.922549518450111,0.928298684539331,0.857735235486382,FGD5,1
GO:0052547,regulation of peptidase activity,1/157,304/18888,0.922549518450111,0.928298684539331,0.857735235486382,CST2,1
GO:0062197,cellular response to chemical stress,1/157,311/18888,0.927015940916583,0.932018517600649,0.861172310147759,PEX12,1
GO:0071375,cellular response to peptide hormone stimulus,1/157,311/18888,0.927015940916583,0.932018517600649,0.861172310147759,PIK3R1,1
GO:0043588,skin development,1/157,318/18888,0.931226339352968,0.935863151001198,0.864724698608609,TCHH,1
GO:0048872,homeostasis of number of cells,1/157,322/18888,0.933522980069573,0.937782106067402,0.866497786735319,HEATR3,1
GO:0022409,positive regulation of cell-cell adhesion,1/157,325/18888,0.93519530086484,0.939072561647862,0.867690149968862,TNFRSF13C,1
GO:0062012,regulation of small molecule metabolic process,1/157,331/18888,0.938415556293605,0.941915655757609,0.870317129879907,NOS2,1
GO:0016050,vesicle organization,1/157,371/18888,0.956175471529242,0.959344238626274,0.886420901090642,SNAP25,1
GO:1901653,cellular response to peptide,1/157,376/18888,0.958002300906741,0.960779119170239,0.887746711006966,PIK3R1,1
GO:0006979,response to oxidative stress,1/157,398/18888,0.965182134242107,0.967579109741053,0.894029808904985,PEX12,1
GO:0034470,ncRNA processing,1/157,433/18888,0.974173576448791,0.976188830020261,0.901985072199172,BOP1,1
GO:0009150,purine ribonucleotide metabolic process,1/157,446/18888,0.976889306857313,0.97850533548735,0.90412549143644,SULT2B1,1
GO:0009259,ribonucleotide metabolic process,1/157,466/18888,0.980523385619059,0.981739412967904,0.907113734612441,SULT2B1,1
GO:0045859,regulation of protein kinase activity,1/157,470/18888,0.981178950191414,0.981989841885787,0.907345127493235,ADRA2A,1
GO:0019693,ribose phosphate metabolic process,1/157,480/18888,0.982723506685291,0.983016956877124,0.908294167639083,SULT2B1,1
GO:0051345,positive regulation of hydrolase activity,1/157,482/18888,0.983016956877124,0.983016956877124,0.908294167639083,SFRP1,1
